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“Solo la morte m'ha portato in collina  
un corpo fra i tanti a dar fosforo all'aria  
per bivacchi di fuochi che dicono fatui  
che non lasciano cenere, non sciolgon la brina.  
Solo la morte m'ha portato in collina.  
 
Da chimico un giorno avevo il potere  
di sposare gli elementi e di farli reagire,  
ma gli uomini mai mi riuscì di capire  
perché si combinassero attraverso l'amore.  
Affidando ad un gioco la gioia e il dolore. 
… 
Ma guardate l'idrogeno tacere nel mare  
guardate l'ossigeno al suo fianco dormire:  
soltanto una legge che io riesco a capire  
ha potuto sposarli senza farli scoppiare.  
Soltanto la legge che io riesco a capire…” 
 
F. De Andrè 
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Abstract 
 
The work has been focused on the development of a LC-MS/MS method for the evaluation of 
hidden Fumonisins. The application of the method to several batches of raw maize and gluten 
free products let us to discover that hidden FBs are widespread along the maize chain. 
Moreover, further experimental data collected in the work strongly suggest a non-covalent 
interaction between FB1 and the α-Zein (the principal endosperm protein of maize), with an 
inclusion-like mechanism, allowing us to partially explain the masking mechanism of 
Fumonisins.  
 
Keywords: hidden Fumonisins, masked mycotoxins, LC-MS/MS, non-covalent masking, α-
Zein. 
 
 
 
 
Abstract 
 
Nel presente lavoro di tesi è stato sviluppato un metodo per la valutazione delle Fumonisine 
nascoste. L’applicazione del metodo a diversi lotti di campioni di mais grezzo e prodotti 
gluten-free, ha permesso di scoprire una diffusa presenza di Fumonisine nascoste lungo la 
filiera del mais. Tutti i dati sperimentali successivamente ottenuti nel presente lavoro 
suggeriscono fortemente una interazione di tipo non covalente tra FB1 e l’α-Zeina (la 
principale proteina dell’endosperma di mais), per spiegare il fenomeno di mascheramento 
delle Fumonisine. 
 
Parole chiave: Fumonisine nascoste, micotossine mascherate, LC-MS/MS, mascheramento 
non covalente, α-Zeina. 
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1.1  Mycotoxins 
The term mycotoxin was coined in 1962 in the aftermath of an unusual veterinary crisis near 
London, England, during which approximately 100,000 turkey poults died (1). It is difficult to 
define mycotoxins in a few words, all mycotoxins are non-antigenic, low molecular weight 
natural products produced as secondary metabolites by filamentous fungi. Many mycotoxins 
display overlapping toxicity to invertebrates, plants and microorganisms (2). When the 
mysterious turkey X disease was linked to a peanut (groundnut) meal contaminated with 
secondary metabolites from Aspergillus flavus (aflatoxins), it sensitized scientists to the  
possibility that other occult mould metabolites might be deadly. Soon, the mycotoxin rubric 
was extended to include a number of previously known fungal toxins (e.g., the ergot 
alkaloids), some compounds that had originally been isolated as antibiotics (e.g., patulin), and 
a number of new secondary metabolites revealed in screens targeted at mycotoxin discovery 
(e.g., Ochratoxin A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Structures of the most important mycotoxins related to food. 
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While all mycotoxins are of fungal origin, not all toxic compounds produced by fungi are 
called mycotoxins. The target and the concentration of the metabolite are both important. 
Fungal products that are mainly toxic to bacteria (such as penicillin) are usually called 
antibiotics. Other low-molecular weight fungal metabolites, such as ethanol, that is toxic only 
in high concentrations are not considered mycotoxins (3). Finally, although mushroom poisons 
are definitely fungal metabolites that can cause disease and death in humans and other 
animals, they are rather arbitrarily excluded from discussions of mycotoxicology. The 
distinction between a mycotoxin and a mushroom poison is based not only on the size of the 
producing fungus, but also on human intention. Mycotoxin exposure is almost always 
accidental. In contrast, mushroom poisons are usually ingested by amateur mushroom hunters 
who have collected, cooked, and eaten what was misidentified as a delectable species (4). 
Mycotoxins are not only hard to define, they are also challenging to classify, due to their 
different chemical structures and biosynthetic origins, biological effects and their production 
by a wide number of different fungal species. Mycotoxin-producing mould species are 
extremely common, and they can grow on a wide range of substrates under a wide range of 
environmental conditions (Tab.1 and 2).  
For agricultural commodities, the severity of crop contamination tends to vary from year to 
year based on weather and other environmental factors. Mycotoxins occur, with varying 
severity, in agricultural products all around the world. The estimate usually given is that one 
quarter of the world’s crops are contaminated to some extent with mycotoxins (5,6).  
Mycotoxins can enter in human and animal dietary systems by indirect or direct 
contamination,  (Tab. 3); direct contamination occurs when the food or feed becomes infected 
with a toxigenic fungus with subsequent toxin formation. In contrast, indirect contamination 
can take place when a raw material of a formulation has previously been contaminated with 
toxin producing fungi, while the fungus itself may be killed or removed during the processing, 
the mycotoxin will mostly remain in the final products. 
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Tab. 1: Fungal genera and species of major significance and their associated mycotoxins. 
 
 
 
 
 Methods for controlling mycotoxins are largely preventive. They include good agricultural 
practice and sufficient drying of crops after harvest (7). There is considerable on-going 
research on methods to prevent preharvest contamination of crops. These approaches include 
developing host resistance through plant breeding and through enhancement of antifungal 
genes by genetic engineering, use of biocontrol agents, and targeting regulatory genes in 
mycotoxin development (8). 
 
 
Fungi Mycotoxins 
Aspergillus : 
A.flavus  
A.parasiticus 
A. nidulans 
A. carbonarius 
A. ochraceus 
A. niger 
• Aflatoxin B1, B2 
• Aflatoxin G1, G2 
• Aflatoxin M (metabolite of B in 
mammals) 
• Sterigmatocistin 
• Ochratoxin A 
Fusarium : 
F. graminearum 
F. culmorum 
F. sporotrichioides 
F. proliferatum 
F. verticillioides 
 
 
• Trichothecenes type A (e.g. T-2, 
HT-2, DAS) 
• Trichothecenes type B (e.g. 
Nivalenol, Deoxynivalenol and 
acetylated derivatives) 
• Zearalenon 
• Fumonisins 
Penicillium: 
P. verrucosum 
P. expansus 
P. roqueforti 
• Ochratoxin A  
• Patulin 
• Citrinin 
• Roquefortines 
• Cyclopiazonic acid 
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Tab. 2: Principal features of the fungal genera of major mycotoxicological significance 
concerning food. 
 
However, none of these methods has solved the problem. Because mycotoxins are “natural” 
contaminants of foods, their formation is often unavoidable. The end result is that mycotoxins 
are commonly found in foods. Mycotoxins are ranked as the most important chronic dietary 
risk factor, higher than synthetic contaminants, plant toxins, food additives, or pesticide 
residues (9). The economic consequences of mycotoxin contamination are profound. 
Many efforts to address the mycotoxin problem simply involve the diversion of mycotoxin 
contaminated commodities from the food supply through government screening and 
regulation programs. Crops with large amounts of mycotoxins often have to be destroyed. 
Alternatively, contaminated crops are sometimes diverted into animal feed. Giving 
contaminated feeds to susceptible animals can lead to reduced growth rates, illness, and death. 
Moreover, animals consuming mycotoxin contaminated feeds can produce meat and milk that 
contain toxic residues and biotransformation products. Thus, aflatoxins in cattle feed can be 
metabolized by cows into aflatoxin M1, which is then secreted in milk (10). Ochratoxin in pig 
feed can accumulate in porcine tissues (11).  
 
 
Genus Growth Range Areas of  Major Incidence Substrates 
Aspergillus spp. 
10 - 46 °C 
aw 0.77 - 0.99 
pH 2 - 11 
tropical and 
sub-tropical 
climates 
oilseed            
cereals 
species 
dried fruit 
grapes 
Penicillium spp. 
 
0 - 40 °C 
aw 0.80 - 0.99 
pH 2 - 10 
 
temperate and 
continental 
climates 
cereals            
fruit/vegetables 
chilled food 
Fusarium spp. 
 
0 - 40 °C 
aw 0.80 - 0.99 
pH 2 - 10 
 
temperate and 
continental 
climates 
cereals 
other crops 
(phytopathogen) 
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Tab. 3: Routes for mycotoxins contamination of food and feed. 
 
Mould-damaged foodstuffs 
• Agricoltural products : 
cereal 
oilseed 
fruit 
vegetables 
• Consumer’s products (secondary infections) 
• Animal feeds (secondary infections) 
Residues in animal tissues and animal products 
• Milk (human and animal) 
• Dairy products 
• Meat (liver, kidney) 
Mould-ripened foods 
• Cheeses 
• Fermented meat products 
• Oriental fermentations 
Fermented-derived products 
• Microbial proteins 
• Food additives 
 
 
Court actions between grain farmers livestock owners, and feed companies can involve 
considerable amounts of money. The ability to diagnose and verify mycotoxicoses is an 
important forensic aspect of the mycotoxin problem (12). People that have enough to eat 
normally avoid foods that are heavily contaminated by mould, so it is believed that dietary 
exposure to acute levels of mycotoxins is rare in developed countries. Nevertheless, many 
mycotoxins survive processing into flours and meals. When mould-damaged materials are 
processed into foods and feeds, they may not be detectable without special assay equipment. 
It is important to have policies in place that ensure that such “hidden” mycotoxins do not pose 
a significant hazard to human health.  
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1.2  Fumonisins 
Fumonisins were first described and characterized in 1988 (13,14). The most abundantly 
produced members of the family are Fumonisin B1, B2 and B3. Since then, more than 28 
homologues have been discovered and more are likely to be found (15,16). FB1 is the most 
common and, from a toxicological standpoint, the most thoroughly studied. FB2 and FB3 in 
order less prevalent and differ structurally from FB1 in the number and position of hydroxyl 
groups on the hydrocarbon backbone of the molecule. 
Fumonisins are produced by a number of Fusarium species, notably Fusarium verticillioides, 
Fusarium proliferatum, and Fusarium nygamai, as well as Alternaria alternata f.sp. 
lycopersici (17,18). The major species of economic importance is Fusarium verticillioides, 
which grows as a maize endophyte in both vegetative and reproductive tissues, often without 
causing disease symptoms in the plant. However, when weather conditions, insect damage, 
and the appropriate fungal and plant genotype are present, it can cause seedling blight, stalk 
rot, and ear rot (19). Fusarium verticillioides is present in virtually all maize samples (20,21).  
Most strains do not produce the toxin, so the presence of the fungus does not necessarily 
mean that Fumonisin is also present (22). Although it is phytotoxic, Fumonisin B1 is not 
required for plant pathogenesis (23, 24). 
Higher incidences of severe pathologies in humans, such as primary hepatocellular carcinoma 
(25), esophageal cancer (26,27), and neural tube defects (28), were found in populations 
chronically exposed to diets contaminated with FB1. However, neither an illness–exposure 
relationship nor the mechanisms involved in the toxicity of this mycotoxin were clearly 
established yet. 
Some pathological changes appear to be a consequence of the immunotoxic action of FB1, 
which was observed in several experimental models in animals (29,30). 
Beyond the above-mentioned evidences, the knowledge of the early events that trigger FB1 
action mechanism is scarce. 
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1.2.1  Chemistry and biosynthesis 
At least 15 different Fumonisins have so far been reported and other minor metabolites have 
been identified, although most of them have not been shown to occur naturally. They have 
been grouped into four main categories (31):  
Fumonisins A (and AK), Fumonisins B, Fumonisins C and Fumonisins P. 
FB2, FB3 and FB4 differ from FB1 in that they lack hydroxyl groups present in FB1; FA1, FA2 
and FA3 are like FB1, FB2 and FB3, but are N-acetylated; FAK1 is like FA1 but is 15-keto 
functionalized; FCs are like FBs but lack the methyl group adjacent to the amino group;  
FPs have a 3-hydroxypyridium group instead of the amine group in the FBs (31).   
FB1 is chemically described as polyhydroxy alkyl amine, esterified on C14 and C15 with 2 
molecules of tricarballylic acid (CAS No 116355-83-0) (32). The structure of Fumonisin B1, 
the most significant of the Fumonisins in terms of toxicity and occurrence, is reported in the 
following figure : 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Structures and molecular weights of Fumonisins B1, B2 and B3. 
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Fumonisins B1 has 10 stereogenic centers and their absolute configurations were clarified in 
the last years (33,34). Fumonisin B2 and B3 are deoxy analogues of FB1 in which the 
corresponding epimeric units on the backbone have the same configuration (35,36). 
No report concerning the pKs of Fumonisin B1 has been found in the available literature. The 
pKa values for tricarballylic acid are 3.49, 4.56, and 5.83. The aliphatic amino group would 
be expected to have a pK greater than 9; therefore, Fumonisin B1 will be a zwitterion at 
physiological pHs between 6 and 9 (37,38). 
Wild-type strains of F. verticillioides produce predominantly four B-series Fumonisins (B1, 
B2, B3, and B4), with Fumonisin B1 making up to approximately 70% of the total content (39). 
These compounds have a linear 20-carbon backbone with hydroxyl, methyl, and tricarballylic 
acid moieties at various positions along the backbone (40). The backbone originates from a 
C18 polyketide chain and one amino acid. Isotope feeding experiments have shown that the 
carbons 3-20 of the backbone are derived from acetate and that the amino group and C-1 and 
C-2 are derived from alanine (41,43). The origin of several moieties attached to the backbone 
has also been studied. The two methyl groups on C-12 and C-16 are derived from methionine 
(44).  
The hydroxyl group on C-3 is from an acetate-derived carbonyl group, whereas the hydroxyl 
groups on C-5, C-10, C-14, and C-15 are likely derived from molecular oxygen (45). The 
origin of the tricarballylic acid is generally believed to be from the citric acid cycle (46). 
Despite these previous biochemical studies, however, little is known about the biosynthetic 
sequence for these individual steps. 
Recently, a 15-gene cluster (FUM1 and FUM6-FUM19) required for the biosynthesis of 
Fumonisins in F. Verticillioides was cloned and characterized (47,48). 
The identification of this cluster has facilitated direct studies of the biosynthetic genes by 
genetic and biochemical approaches. The proposed pathway of Fumonisin B1 biosynthesis in 
reported in Fig. 3. Among the FUM genes, FUM13 has been characterized by a genetic 
approach (49).  
Butchko et al. (49) found that a FUM13-deleted mutant accumulated the C-3 keto form of 
Fumonisins B3 and B4, indicating that this gene encodes a C-3 keto reductase of Fumonisins 
(49).  
More recently, Butchko et al. (50) generated a FUM3 (also FUM9) deletion mutant and 
showed that this gene is required for the C-5 hydroxylation of Fumonisins.  
It was also demonstrated that, via heterologous expression in yeast, FUM3 encodes a  
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2-ketoglutarate-dependent dioxygenase that catalyzes the conversion of Fumonisin B3 to B1 
(51), directly confirming that FUM3P catalyzes the C-5 hydroxylation (52). Several other FUM 
disruption mutants, including ¢FUM1, ¢FUM6, ¢FUM8, ¢FUM17, ¢FUM18, and ¢FUM19, 
have also been generated by Proctor and co-workers (47,48).  
 
 
 
 
Fig. 3: Proposed biosynthetic pathway of Fumonisins B. (Bojja et al., 2001) 
. 
 
The first three mutants did not accumulate any identifiable intermediates that could have 
provided additional information about the function of these genes, while the latter mutants 
were not or only subtly affected in their ability to produce Fumonisins.  
Very recently, Frisvad et al. (2007) have reported the production of FB2 from strains of 
Aspergillus niger, showing how the biosynthetic pathways for secondary metabolites 
production can be conserved among different fungal genus, as in the case of Ochratoxin A. 
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1.2.2  Toxicology 
When purified FB1 became available, it was possible study its role played by FB1 in 
mediating some agriculturally-important diseases, which had previously been shown to be 
associated with consumption of F. verticillioides-contaminated foods and feeds, including 
were demonstrations that FB1 mediates equine leukoencephalomalacia (ELEM) and porcine 
pulmonary edema (PPE) (53,54). However, most of the research on the toxic effects of FB1 
was devoted to studying its cancer-causing potential (55,56). Initially both field samples of 
maize and culture materials infested with F. verticillioides isolated from field samples, were 
shown to induce benign and malignant tumors in the liver after feeding to rats (57). These 
observations have prompted the International Agency for Research on Cancer (IARC) 
working group to label toxins from F. Verticillioides as possible carcinogenic to humans 
(Group 2B) (57). 
Progress has been made in understanding the mechanism of action of FB1, but unanswered 
questions remain, particularly with respect to the mechanism of tumor promotion. It was 
initially recognized by Riley (81) that FB1 is a structural analog of sphingosine (Fig. 4), and 
this observation led to the discovery that FB1 is an effective inhibitor of ceramide synthetase 
(82,83) a key enzyme in the biosynthesis of sphingolipids (84).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 : Comparison of the chemical structure of Fumonisin B1 and the sphingoid bases 
sphinganine and sphingosine.  
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Ceramide synthase appears to interact with FB1 at both the free amino group (as a sphingosine 
analog), and at the side chains (consistent with the negative charges of one or both side chains 
interacting with the CoA-fatty acid binding site) (83). Consistent with this, intact FB1 is a 
better inhibitor than hydrolysed FB1 (83). Disruption of sphingolipid metabolism by FB1 has 
been confirmed in vivo by measuring elevated levels of sphinganine, the normal ceramide 
synthase substrate, and sphingosine in intact animals (85), tissue slices (86), cultured 
mammalian cells (87–90) and plants (91) in response to exposure to FB1. Altered tissue and 
serum ratios of sphinganane to sphingosine have been proposed as an early biomarker for 
exposure of domesticated animals to Fumonisins in feeds (92).  
Inhibition of ceramide synthase can affect cells in a variety of ways. Ceramide synthase is a 
key enzyme for the de novo synthesis of sphingomyelin and other sphingolipids (84). 
Sphingomyelin is known to be required for membrane stability, because destruction of 
sphingomyelin in membranes by treatment with sphingomyelinase results in cell lysis. (93). 
Blocking sphingomyelin biosynthesis provides a mechanism for delayed necrosis, such as 
occurs in ELEM and PPE. The recent observation that hydrolysed FB1 can be converted by 
the action of ceramide synthase to an FB1 analog of ceramide with markedly enhanced 
cytotoxic activity (66,67), suggests another plausible mechanism of action. 
 
 
Fig. 5: Schematic representation of sphingolipid metabolism showing the inhibition of 
ceramide synthase (×) by Fumonisins. (Merrill et al., 2001; Riley and Voss, 2006). 
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While accumulating ceramide analogs could provide a plausible mechanism of action for 
HFB1, it is not likely to be important in the mechanism of action of FB1, given the lack of 
demonstrable esterase-mediated hydrolysis of FB1 in target tissues. The results of studies on 
the toxicokinetics of FB1, performed during several years, are in general agreement with the 
following conclusions: 
? FB1 has very low oral bioavailability in rats, pigs, chickens, cows, and monkeys; 
? almost all FB1 administered by any route (oral/intragastric, intraperitoneal or intravenous ) 
is rapidly cleared by the biliary route and excreted largely unchanged in the feces;  
? even after feeding periods as long as 12 days, only traces of FB1 are found in liver and 
kidney, and less is found in other organs. 
Thus, a very low oral bioavailability of FB1 seems to be the result of low uptake coupled with 
efficient biliary excretion (94). 
 It has been well established that eating F. verticillioides -contaminated foods and feeds 
produces diseases such as ELEM and PPE in domesticated animals, and that administration of 
purified FB1 replicates the diseases in domesticated and experimental animals. However, 
extensive studies on the toxicokinetics of radiolabelled FB1 in rats, pigs, chickens, cows and 
monkeys indicates that orally administered FB1 is absorbed very poorly, if at all (94). 
For this reason Shier, in the 2000, proposed the term ‘‘fumonisin paradox’’ to describe the 
apparent paradox of FB1 causing disease despite being very poorly absorbed. 
No evidence for functional metabolism of Fumonisins has ever been reported. The most 
probable predicted metabolic processes are first, removal of the free amino group by 
monoamino oxidase action, and then removal of one or both propane-1,2,3-tricarboxylic acid 
side chains by esterase action. Structure-activity relationship studies on FB1 and a series of 
natural and synthetic structural analogs indicated that the free amino group of Fumonisins is 
required for biological activity (58,59–65). Therefore, monoamine oxidase action, if occurred, 
would be a metabolic inactivation process, not activation. Esterase action on FB1 would 
produce HFB1, which retains its biological activity (58), although it is not as effective as an 
inhibitor of ceramide synthase. HFB1 does act as a substrate for ceramide synthase, which 
converts it to a ceramide analog, which is approximately 10 times as more cytotoxic as intact 
FB1 (66,67). Thus, if FB1 were efficiently metabolized to HFB1, a mechanism does exist for 
metabolic activation. However, in extensive studies on the fate of radiolabeled FB1 
administered orally or by injection, metabolism is generally not detected (68–79). In one case 
in which a modest amount of metabolism was observed in vervet monkeys, it was partial 
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hydrolysis to remove the propane-1,2,3-tricarboxylic acid group from the C-14 position, and 
the source of the enzyme was traced to anaerobic bacteria in the gut flora (80). 
Plausibile  explanations for the Fumonisin paradox are reported in the original paper (94), and 
only summarised here : 
. 1: An Unknown Bioavailable Toxin 
 ELEM, PPE and other disease states may not be caused by FB1, but rather by another as yet 
unknown F. verticillioides  toxin, which has good oral bioavailability. 
. 2: Dose-dependent Bioavailability 
FB1 bioavailability may actually be substantially higher than the reported values when the 
toxin is administered at dose levels typically encountered in nature. 
. 3: Dose-dependent Metabolism 
The percent of FB1 metabolized may actually be substantially higher than the reported values 
when the toxin is administered at dose levels typically encountered in nature. Diseases such as 
ELEM and PPE could be mediated by a highly active metabolite of FB1 which is being 
formed in amounts too small to be detectable above background when it is formed from FB1 
radiolabeled at low specific activity. 
. 4: Bioaccumulation of Toxin 
Very little net absorption and metabolism of FB1 occurs, but the little that does occur 
bioaccumulates as the free toxin or an active metabolite(s) until toxic levels are achieved. 
Published studies on bioavailability have been short-term studies, and they were not designed 
to detect low levels of bioaccumulated toxin or metabolite. 
. 5: Uptake of FB1 Derivatives with High Bioavailability 
FB1 in contaminated corn may be converted during cooking and other normal food processing 
treatments into a derivative or derivatives that have high oral bioavailability, and are 
effectively converted back to FB1 or to another active metabolite after the bioavailable 
derivatives have been transported into the body.  
In the last years the last hypothesis have gain supports from several authors, especially after 
that the in vitro reaction between lysine, as a protein model compound, and FB1 was 
demonstrated (120). 
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1.2.3  Methods of analysis and legislation 
Fumonisins mostly occur in maize and maize based products and the development of 
analytical methods has concentrated on this commodity. FB1 and FB2 are the main target 
molecules although the methods must be valid for FB3 as well. Little is known about FB4 and 
its natural occurrence. Fumonisins are produced by Fusarium spp. from the Liseola section 
including F. verticillioides (syn. F. moniliforme) and F. proliferatum. Analytical procedures 
differ in extraction, clean up and determination steps, and the method of choice depends on 
available equipment and analytical requirements such as sensitivity and time required for 
analysis. Most analytical methods include: thin layer chromatography (TLC), liquid 
chromatography (LC), gas chromatography (GC) and immunochemical methods. 
Derivatisation is necessary before fluorescent detection can be performed, as Fumonisins do 
not contain a fluorophore (95). TLC and immunochemical methods such as ELISA tests are 
among the most frequent screening methods. A number of ELISA kits, which are 
commercially available. Additionally dipstick tests have been developed, which claim a 
detection limit of FB1 as low as 0.04-0.06 µg/g in corn based foods (95). Reversed phase TLC 
(on C18 modified silica plates) has also been employed with acidic vanillin or 
fluorescamine/sodium borate buffer as  spray reagents (96).  
Methods suitable for quantification usually include extraction and clean-up steps prior to 
determination of the analyte. Various methods can be employed, but all require varying 
degrees of experience in the field of analytical chemistry and use considerable amounts of 
reagents. While a clean up is usually not necessary for immunoassays, extensive clean-up 
procedures are required before physicochemical methods can be employed. Among the 
commonly used solvent mixtures for extraction are methanol/water (3:1) and 
acetonitirile/water (1:1). Mixtures can be used either with reversed phase cartridges (C18) or 
strong anion exchange columns (SAX). More recently immunoaffinity columns (IAC) have 
become available featuring high selectivity. The analyte molecules are bound to antibodies 
and the toxin can be eluted subsequent by a washing step the toxin can be eluted. Reversed 
phase cartridges (C18) can be also used (97). Reversed Phase (RP-) HPLC separation and 
detection is the most widely used technique for the analysis of Fumonisins, because of their 
polar character. The majority of researchers reported using pre-column derivatisiation with o-
phthaldialdehyde / mercaptoethanol (OPA), despite its limited stability. Naphthalene-2,3-
dicarboxaldehyde/potassium cyanide (NDA) has been proposed as a viable alternative, 
although handling is more tedious requiring additional safety precautions. GC methods have 
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also been developed by determining aminopolyol after clean-up on a XAD-2 column. The 
amino and hydroxy groups are protected with trimethylsilyl (TMS) or trifluoroacetate (TFA) 
and FBs are detected by flame ionisation or mass spectroscopy. The advances being made in 
LC methods caused a shift away from GC methods, as the latter require multiple sample 
handling steps. With the availability of liquid chromatography systems with mass 
spectrometric detection (LC-MS), a powerful method has been established for identification 
and quantification (98). High sensitivity can be achieved, although disadvantages include high 
running and maintenance costs (98). Two LC-methods and an ELISA have received AOAC 
Official Method status (AOAC International, 2000). They were validated for maize and 
certain maize products (99). Detailed reviews of available analytical methods have been given 
by Shephard (100), Dutton (101), Scott (102), Norred (103) and Krska (104). While in 1995 
Fumonisins were only subject of regulations in one country (FAO, 1997), actually in Europe 
specific EU-harmonised limits for Fumonisins in food or feed have has been established with 
the last decision approved from the European Commision (105) concerning the Fusarium 
toxins (Tab.4).  
Tab.4: Limits of FB1+FB2 in maize and maize based food, EC No. 1126/2007. 
 
Material 
Sum of FB1 and FB2 
(µg/Kg) 
Unprocessed maize  with the exception of unprocessed maize intended to be 
processed by wet milling  
4000 
Maize intended for direct human consumption, maize-based foods for direct 
human consumption 
1000 
Maize-based breakfast cereals and maize-based snacks 800 
Processed maize-based foods and baby foods for infants and young children  200 
Milling fractions of maize with particle size > 500 micron and other maize 
milling products with particle size > 500 micron not used for direct human 
consumption  
1400 
Milling fractions of maize with particle size ≤ 500 micron and other maize 
milling products with particle size ≤ 500 micron not used for direct human 
consumption  
2000 
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1.3  Masked mycotoxins 
An emerging issue on mycotoxin research is represented by masked mycotoxins. The terms 
‘masked’, ‘bound’, ‘hidden’ or ‘conjugated’ are generally used in literature to indicate that 
forms of mycotoxins undetectable by the commonly employed methods of analysis, but 
chemically related to the native toxic compounds. The lack of detection, due to slight 
modifications of the chemical structure or to the interactions with the food matrix, occurs 
because the analyte is not extracted, separated or detected. Mycotoxins can undergo 
modifications in each step of the their presence in the food chain, Berthiller et al. reported all 
the forms of conjugated mycotoxins know so far in a very recent review (105).  
The steps whereas mycotoxins can be ‘masked’ are : 
1) During the fungal production. 
Mould do not produce only one form of mycotoxins, but a range of chemically related 
compounds (106) (for Fumonisins it was told that more than 20 analogues can be isolated from 
the fungal culture). Usually the law regulate the presence of few forms of each mycotoxins, 
generally the most abundant and  more toxic.  
2) During the plant-pathogen interactions.  
Plants protective system against xenobiotic compounds (e.g. pesticides, mycotoxins) consist 
in converting them to more polar metabolites, which can be stored in vacuoles or conjugated 
to biopolymers such as cell wall components (107,110). 
3) During the food processing. 
Modifications of the chemical structure and behavior of mycotoxins, can occurs during the 
food processing (upon heating or fermentation) (111,112). Heat treatment of food can promote 
reactions between the mycotoxin and the component of the food matrix.   
The undetected forms are ingested together with the food, with the possibility that the native 
toxic compound be released during digestion. For this reason masked mycotoxins must be 
studied in order to undestand the potential hazard that they represent. 
 
1.3.1  Hidden Fumonisins 
Hidden Fumonisins were early identified as conjugates with sugars, after heating treatments. 
Heating of Fumonisin B1 with reducing sugars can yield N-(carboxymethyl) Fumonisin B1 
(113). This substance, together or N-(1-deoxy-D-fructos-1-yl)Fumonisin B1 (114),  was 
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later found also in corn products (115) (Fig.6). This compounds are well known and, as 
already told, less toxic due to the modification of the amino group, which is essential for the 
biological activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6: Chemical structures of the reaction products of FB1 with reducing sugar upon 
heating. 
 
More recently, other unidentified bound forms were detected in thermally treated food 
products such as corn-flakes (116,118). These forms are not directly detectable, but their 
presence has been inferred from the observation that, upon SDS-extraction and alkaline 
hydrolysis of the food matrix, the amount of released hydrolysed Fumonisins is often higher 
than that expected by the hydrolysis of the Fumonisins detected in the sample using the 
routine procedure (119). The nature of this masking mechanism has been attributed to the 
formation of covalent bonds between the tricarballylic groups of Fumonisins and the hydroxyl 
groups of starch or the amino or sulfidryl groups of the side chains of amino acids in proteins.   
The possibility of such an interaction has been supported by the evidence that the two 
tricarballylic acid (TCA) groups can react with  methyl glucose (as a starch model compound) 
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upon heating, leading to the formation of the diester of FB1 (120). The TCA groups were also 
found to react with protected lysine and cysteine methyl esters (as protein model compounds), 
demonstrating that the free thiol or amino groups of proteins may covalently bound to FB1 
(Fig.7). Thermal processing of food contaminated with Fumonisin mycotoxins studied and the 
effect on the chemical structures and toxicity, was reviewed extensively, for what concerns 
the N-derivatives and the hydrolysed forms of FBs  (121).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7: Proposed binding of Fumonisin B1 to proteins and starch, by TCA groups,  and 
its release, by basic hydrolysis to the hydrolysed derivative HFB1. 
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However the pararadox of FBs, concerning their toxicology, is still unsolved, altought TCA 
groups of FBs seems to play a critical role in both toxicology and masking mechanism of 
Fumonisins. 
The overall knowledge of the masking mechanism that involve the TCA groups of 
Fumonisins is still not totally understood. 
Thus more studies are required to improve the knowledge of  FBs behavior and their 
interactions with the maize matrix . 
 
 
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 28
1.4  The maize chain 
Maize (syn. corn) is widely cultivated throughout the world, and a higher amount of maize is 
produced each year than any other grain. While the United States produce almost half of the 
world's harvest(~42.5%), other top producing countries include China, Brazil, Mexico, 
Argentina, India and France. Italy is the tenth world producer with about 10 millions tonnes 
per year. Worldwide production was around 800 million tonnes in 2007—just slightly more 
than rice (~650 million tonnes) or wheat (~600 million tonnes). In 2007, over 150 million 
hectares of maize were planted worldwide. Because it is cold-intolerant, in the temperate 
zones maize must be planted in the spring. Its root system is generally shallow, so the plant is 
dependent on soil moisture. As a C4 plant (a plant that uses C4 carbon fixation), maize is a 
considerably more water-efficient crop than C3 plants (plants that use C3 carbon fixation) 
(122-125). Maize can undergo basically 3 different types of processes: dry-milling, wet-milling, 
and masa-type process. The principal products of dry milling are cornmeal, flour, and grits 
(Fig.8) (126). 
 
Fig. 8: Flow diagram of a dry-milling process. (Illinois Cereal Mills, Inc.) 
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These products are ingredients for foods such as pasta, breakfast cereals and snack foods, and 
baked goods such as corn bread and muffins. The corn is first cleaned to remove dirt and 
debris and to separate fine and broken kernels from whole corn. The corn is tempered by 
increasing moisture, and the hull (pericarp), germ, and tip cap are removed, leaving the 
endosperm. The endosperm is then converted into flours, meals, and grits through a series of 
mills, sifters, and gravity tables. Corn germ is the raw material for corn oil; bran is generally 
an animal feed item but with further processing is used in some specialty foods as a source of 
fiber. The bran fraction is an animal feed item, and FB residues from the whole corn are 
largely associated with this fraction (127). The principal products resulting from the wet-mill 
process are cornstarch, high-fructose corn syrup (a sweetener), chemicals (zein, xanthophyl) 
and ethanol from fermentation (Fig. 9) (126). 
 
 
Fig. 9: Flow diagram of a wet-milling process. (Corn Refiners Association). 
 
 
The masa-type process is used to produce tortillas and tortilla chips, especially common in 
Latin America and in the Hispanic communities of the United States. In the traditional 
method the corn is 
cooked in alkaline water for a short period of time and then steeped overnight. The steeped 
liquor is discarded, and the cooked-steeped corn (nixtamal) is washed to remove alkali and 
loose pericarp, then ground to form masa. The masa can then be formed into flat discs and 
cooked on a griddle. Although technology and automation have brought greater efficiency to 
the process, most modern food-processing techniques involving masa can be traced in some 
form to ancient Native 
American inhabitants (126). During nixtamalization, FB1 may be converted to its hydrolysed 
form, HFB1, and this compound has been reported in some processed foods (119).  
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2.  Aim of the thesis  
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In this thesis we intend to approach the problem of masked Fumonisins in maize and maize- 
products. The problem is very relevant on account of several implications: scientific, 
toxicological and regulative. The mechanism of masking is still unknown and it may occur at 
two levels: on the plant and following technological treatments. 
More data are required to improve the knowledge of the behaviour of FBs also considering 
their interactions with the maize matrix . 
This PhD work is divided in three principal parts: 
1) development of a LC-MS/MS method for the evaluation of hidden Fumonisins, and 
application of the method to several batches of maize derived materials : raw cereal, gluten-
free foods, reference materials; 
2) screening of the occurence of masked Fumonisins in commercially avalilable products, in 
particular products dedicated to celiacs. 
3) study of the masking mechanism, with particular regard to the non-covalent hypothesis, 
using an endosperm protein as model for the maize matrix. 
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3.  Results and Discussion 
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3.1 Hidden Fumonisins : the general approach 
The presence of hidden forms of mycotoxins in a sample, such as Fumonisins, can be 
assessed in two ways: by using a direct method by extraction and analysis, whenever the 
structures and the chemical properties of the molecules of interest are already known; if this 
information is not available, by using an indirect method based on a hydrolysis step and 
evaluating the concentration of analytes before and after hydrolysis. 
For Fumonisins (FBs), since information regarding hidden forms is still limited, it was 
decided to proceed with an alkaline hydrolysis, in order to achieve several goals : 
? Cleavage of the FB side chains,  which are potential sites of covalent modification;  
? Disruption of the secondary/primary structures of the food macromolecules eventually 
complexing the toxin; 
The hydrolysis, performed with  2 M KOH at room temperature for 1 hour, gives the  
hydrolysed derivatives of Fumonisins (HFBs), which are stable in alkaline media. 
 
  
 
 
 
 
 
 
Fig. 10 : Hydrolysis of Fumonisins. 
 
Moreover, the use of a strong base can lead to the disruption of the macromolecular network 
formed among the main matrix macroconstituents, thus removing thus all the non-covalent 
interactions which could give rise to the formation of inclusion complexes which could 
prevent the extraction. 
 In particular, by this reaction we can obtain : 
? protein denaturation 
? starch swelling 
? saponification of the saponificable lipidic fractions 
We assume that, also in the food matrix, the reaction has a yield of 100%. 
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 After hydrolysis it is possibile to extract the hydrolysed forms, HFBs, which are then 
quantified by LC-MS/MS; starting from these data, we can calculate the concentration of the 
native Fumonisins present in the sample.  
Thus, in order to develop this idea, we divided a sample in two aliquots: the first underwent to 
the “traditional” extraction and analysis for free Fumonisin quantification; the second aliquot 
underwent to hydrolysis with 2 M KOH, followed by an extraction step with acetonitrile and 
finally analysed by LC-MS/MS, thus obtaining the concentration of the hydrolysed FBs.  
From this value we can calculate the total amount of FBs before hydrolysis, expressed as 
Fumonisin equivalents. The amount of hidden Fumonisins occurring in the sample was then 
obtained by the difference between the total Fumonisins amount and the free Fumonisin 
concentration (Fig. 11) 
 
 
 
  
Fig.  11:  Scheme of the approach. 
 
  hydrolysis
Unknow concentration of FBs       HFB concentration by LC-MS/MS 
FBs equivalent  =  native FBs in the sample before hydrolysis (total FBs) 
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Equivalent FBs after hydrolysis  -  free FBs  =  hidden FBs 
 
                         
 
                     
Fig.  12:   Proposed approach for the quantification of hidden Fumonisins. 
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3.2  Fumonisin analysis 
Due to the absence of cromophores or fluorescent group in the molecules, the most 
appropriate technique for analysis of FBs and of their relative hydrolysed form, is represented 
by high pressure liquid cromathography iphenated with mass spectrometry detection, with 
electospray interface (LC-ESI-MS). A particular application of this technique, is the Multiple 
Reaction Monitoring (MRM) with triple quadrupole or ion trap detector, which allowed a 
very high specificity and sensitivity. The MRM mode is based on the selection of fragments, 
produced from the analyte molecular ions, by collision versus an inert gas, as Argon. Mass 
spectrometry detection require the selection of the ionization mode  (positive  o negative) for 
the analytes of interest. In this work, for Fumonisins, the positive mode (M+H)+ was chosen 
on the basis of the experience of our research group and in agreement with the literature, since 
it is facilitated by the protonation of the primary amino group of the analytes.   
 
3.2.1  MS/MS detection  
In order to develop the MS/MS detection of Fumonisins, it was necessary to have reference 
standard solutions. A working standard solution at a proper concentration was infused in the 
mass spectrometer, in order to optimise the ionisation parameters such as voltages and gas 
flows applied in the source.  
The optimization of the source parameters is necessary to maximise response of the analytes, 
so that as many molecules can be protonated and taken to the gas phase.  
The structures of FB1, FB2, FB3 and their molecular weights are reported in the next figure. 
 
 
 
 
 
 
 
 
 
 
Fig. 13: Structures and molecular weights of Fumonisins B1, B2 and B3. 
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Capillary and cone potentials must be chosen in an ESI interface.  
The former is required to produce a good ionization of the analyte, while the latter regulates 
the strenght whereby the ions, once in the gas phase, are attracted from the source at 
atmospherical pressure, to the zone kept at middle vacuum.  
In this zone the ion packet is collimated by lens, in order to send it compact to the first 
quadruple, for the selection of the ion of interest. As it is possible to see in the next figures, 
the higher is the applied potential to the capillary and cone, the higher is the signal relative to 
the molecular ion of  Fumonisin B1 (m/z 722.03), until a maximum value is reached after 
which the signal decreases, due probably to the increase of  the so called ‘in source 
fragmentation’. 
The optimization procedure was then made for  Fumonisin B2 and B3. 
 
9_1_09    ca 4  co 25                                       
m/z
100 125 150 175 200 225 250 275 300 325 350 375 400 425 450 475 500 525 550 575 600 625 650 675 700 725 750 775 800
%
0
100
%
0
100
%
0
100
FB1_4 32 (0.591) Cm (6:49) Scan ES+ 
1.67e6722.0
100.2
380.7125.8 185.9 370.0273.6 390.9
722.8
FB1_3 28 (0.517) Cm (6:49) Scan ES+ 
1.67e6
722.0
100.2
380.7125.8 185.9 390.8
722.8
FB1_2 23 (0.425) Cm (6:51) Scan ES+ 
1.67e6
721.8
100.2
380.7125.8 722.8
 
 
Fig. 14:  Influence of the capillary potential (kV) on the intensity of the m/z 722.03 
(M+H)+ signal of the Fumonisin B1 molecular ion. Infusion of the standard (5 ppm) in 
MeOH, Full scan mode. 
                                                                                                          
          
Capillary  4  kV 
Capillary  3.5  kV 
Capillary  3 kV 
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9_1_09    ca 4  co 50                                       
m/z
100 125 150 175 200 225 250 275 300 325 350 375 400 425 450 475 500 525 550 575 600 625 650 675 700 725 750 775 800
%
0
100
%
0
100
%
0
100
%
0
100
FB1_7 6 (0.111) Cm (6:45) Scan ES+ 
3.64e6722.0
100.2
215.0197.0126.9 352.0334.2 704.0
722.7
744.0 760.0
FB1_6 36 (0.665) Cm (5:48) Scan ES+ 
3.64e6
722.0
100.2
215.0140.8 352.2 370.1
723.0
FB1_5 35 (0.647) Cm (6:47) Scan ES+ 
3.64e6
722.0
100.2
380.7126.0 214.9185.9 370.1
723.0
FB1_4 32 (0.591) Cm (6:46) Scan ES+ 
3.64e6
722.0
100.2 380.7125.8 185.8
722.8
 
 
Fig. 15:  Influence of the cone potential (V) on the intensity of the signal m/z 
722.03 (M+H)+  of the Fumonisin B1 molecular ion. Infusion of the standard (5 ppm) in 
MeOH, Full scan mode. 
      
 
 
9_1_09    ca 4  co 50                           
m/z
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0
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FB2  51 (0.943) Sm (Mn, 1x0.75); Cm (5:51) Scan ES+ 
2.36e6706.0
100.1
215.1196.9126.9 688.0354.2336.2
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Fig. 16:  Signal 706.03  (M+H)+  relative to the molecular ion of Fumonisin B2. 
Infusion of the standard (5 ppm) in MeOH, Full scan mode. 
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m/z
100 125 150 175 200 225 250 275 300 325 350 375 400 425 450 475 500 525 550 575 600 625 650 675 700 725 750 775 800
%
0
100
FB3  7 (0.129) Sm (Mn, 1x0.75); Cm (5:49) Scan ES+ 
6.25e5705.9
100.1
214.8133.0
212.1
149.1
304.1
220.9 295.0 428.9336.2 355.0 412.9 688.0530.1 547.9
706.9
727.9
 
 
Fig. 17:  Signal 705.9  (M+H)+  relative to the molecular ion of Fumonisin B3. 
Infusion of the standard (5 ppm) in MeOH, Full scan mode. 
 
Once the source parameters are optimized, so as the molecular ion formation of the analytes is 
maximized,  the fragmentation can be developed.  
In this phase, the molecular ion coming from the first quadrupole is fragmented, after 
acceleration,  versus molecules of an inert gas (Argon). 
The fragmentation magnitude depends from the energy given to the precursor ion (collision 
energy), and from the pressure of the inert gas in the collision cell, (higher pressure 
corresponds, with equal volume and temperature, to a higher number of gas molecules and 
then higher frequencies of collision).  
The parameters are optimized in order to obtain intense and stable signals of the daughter 
ions, which are next analyzed from the third quadrupole. The selected ions arrive to the 
photomultiplier which, representing the detector in sensu strictu, transforms and amplifies the 
electric current signal, into  a digital electric signal.  
The step sequence just described represents what happens in the MRM technique, where 
production and selection of ions are repeated twice (source and collision cell); this double 
selection brings about a significant reduction of the background noise and an increase of the 
technique sensitivity. Moreover, the choice of the fragment produced specifically from the 
precursor ion of interest (previously produced in the source) minimizes the possibility that 
other molecules can be detected togheter with the analytes,  making the MRM technique 
extremely specific. 
Capillary 4 kV 
 
Cone  50 V 
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In theory, it is sufficient to choose one daughter ion from those produced from the precursor 
fragmentation, in order to get this benefit. In practice at least two ions are choosen for 
different purposes. The former, usually called ‘QUANTIFIER’, is the most intense; it is 
generally used for quantification purposes. Under controlled conditions, the most intense ion 
is assumed to be the most stable, thus contributing in a predominant way to the total ion 
current; for this reason, it results very useful for quantification purposes. The latter fragment 
chosen is called ‘QUALIFIER’: it is generally less intense then the quantifier, and its 
presence is used as further proof of the identity of the precursor ion.  
In the following figures the results of the fragmentation test for FB1, FB2 and FB3 are reported 
In order to develop the MRM detection, standard solutions of known concentration were 
infused in the mass spectrometer, and the parameters were changed in order to find the 
conditions to produce intense, stable and specific fragment of the analytes.  
 
 
9_1_09    ca 4  co 50  ce 40                             
m/z
200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 660 680 700 720
%
0
100
%
0
100
%
0
100
%
0
100
FB1_12  11 (0.203) Sm (Mn, 1x0.75); Cm (6:47) Daughters of 722ES+ 
3.76e5334.2
186.2 316.2
254.2236.3
352.2
353.2
510.1 528.0
FB1_10  27 (0.499) Sm (Mn, 1x0.75); Cm (5:48) Daughters of 722ES+ 
3.15e5352.1334.2
186.2 316.3
254.2236.3 299.2
353.2 722.0704.1528.1510.0 546.1 668.0
FB1_9  17 (0.314) Sm (Mn, 1x0.75); Cm (5:48) Daughters of 722ES+ 
1.01e6722.0
704.0352.2334.1 546.0370.2 528.0
722.9
FB1_8  38 (0.702) Sm (Mn, 1x0.75); Cm (5:48) Daughters of 722ES+ 
1.95e6722.0
722.9
 
 
Fig. 18:  Infusion of the Fumonisin B1 standard, (5 ppm) in MeOH; daughter ion scan 
mode. Influence of the collision energy (eV) applied to the precursor ion m/z 722.03 
(M+H)+  of Fumonisin B1  on the profile of the produced fragments. 
 
 
              
 
 
Ce 40 eV 
Ce 35 eV 
Ce 25 eV 
Ce 15 eV 
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Tab. 5:  Proposed assignment for FB1  ion fragments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9_1_09    ca 4  co 50    ce 15                      
m/z
100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 660 680 700 720
%
0
100
%
0
100
%
0
100
FB2_4  18 (0.333) Sm (Mn, 1x0.75); Cm (6:48) Daughters of 706ES+ 
6.22e5336.2
318.3
159.2109.1 177.1
354.2
512.0355.2 688.0530.1 706.1
FB2_3  48 (0.887) Sm (Mn, 1x0.75); Cm (5:49) Daughters of 706ES+ 
7.16e5706.0
336.2318.3 688.1354.2 530.1512.1 670.1
707.0
FB2_2  11 (0.203) Sm (Mn, 1x0.75); Cm (5:51) Daughters of 706ES+ 
1.62e6706.1
707.0
 
 
Fig. 19: Infusion of the Fumonisin B2 standard, (5 ppm) in MeOH; daughter ion scan 
mode. Influence of the collision energy applied (eV) to the precursor ion m/z 706.03 
(M+H)+  of Fumonisin B2  on the profile of the produced fragments. 
 
 
 
m/z ion 
722.03 (M  + H)+ :  molecular ion 
704.02 (M - H2O + H)+ 
668.01 (M - 2H2O + H)+ 
546.10 (M - TCA + H)+ 
528.11 (M - TCA - H2O + H)+ 
510.11 (M - TCA - 2H2O + H)+ 
370.19 (M - 2TCA + H)+ 
352.19 (M - 2TCA - H2O + H)+ 
334.19 (M - 2TCA - 2H2O + H)+ 
316.19 (M - 2TCA - 3H2O + H)+ 
Ce 35 eV 
Ce 25 eV 
Ce 15 eV 
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Tab. 6:  Proposed assignment for FB2  ion fragments. 
 
 
 
              
 
 
 
 
 
 
 
 
 
ca 4  co 50   ce 35             
m/z
100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 660 680 700 720
%
0
100
%
0
100
%
0
100
FB3_4  21 (0.388) Sm (Mn, 1x0.75); Cm (5:49) Daughters of 706ES+ 
1.06e5336.2
318.1
109.2 170.1 188.2 238.4 256.2 301.2
354.2
706.0688.1355.1 512.1494.2 530.0
FB3_3  39 (0.721) Sm (Mn, 1x0.75); Cm (6:48) Daughters of 706ES+ 
1.77e5706.0
336.3318.3 687.9354.1 530.2
706.9
FB3_2  35 (0.647) Sm (Mn, 1x0.75); Cm (5:49) Daughters of 706ES+ 
3.39e5706.0
707.0
 
 
Fig. 20:  Infusion of the Fumonisin B3 standard, (5 ppm) in MeOH; Daughter scan 
mode. Influence of the collision energy applied to the precursor ion m/z 706.03 (M+H)+  
of Fumonisin B3  on the profile of the produced fragments. 
 
 
 
 
m/z ion 
706.03 (M  + H)+ :  molecular ion 
688.12 (M - H2O + H)+ 
670.13 (M - 2H2O + H)+ 
530.12 (M - TCA + H)+ 
512.09 (M - TCA - H2O + H)+ 
354.19 (M - 2TCA + H)+ 
336.19 (M - 2TCA - H2O + H)+ 
318.26 (M - 2TCA - 2H2O + H)+ 
Ce 35 eV 
Ce 15 eV 
Ce 25 eV 
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Tab. 7:  Proposed assignment for FB3  ion fragments. 
                
 
              
 
 
 
 
 
 
 
 
 
 
 
For all Fumonisins it is possible to see a common fragmentation pathway, the molecular ion 
can lose several molecules of water and the two tricarballylic chains. 
 
 
 
Fig. 21:  Proposed pathways for Fumonisin B1, B2 and B3  fragmentation. 
m/z ion 
706.03  (M  + H)+ :  molecular ion 
688.12 (M - H2O + H)+ 
670.13 (M - 2H2O + H)+ 
529.97 (M - TCA + H)+ 
512.07 (M - TCA - H2O + H)+ 
494.18 (M - TCA - 2H2O + H)+ 
354.19 (M - 2TCA + H)+ 
336.19 (M - 2TCA - H2O + H)+ 
318.26 (M - 2TCA - 2H2O + H)+ 
TCA  loss TCA  loss
II serie
III serie
(M - TCA + H)+ 
(M - 2TCA + H)+ 
I serie 
(M + H)+: Molecular  Ion
- H2O 
(M - H2O + H)+
- H2O 
(M - 2H2O + H)+ 
(M – TCA -H2O + H)+
- H2O 
(M – TCA -2H2O + H)+ 
- H2O 
(M – 2TCA -H2O + H)+
TCA  loss 
- H2O 
TCA  loss TCA  loss
(M – 2TCA -2H2O + H)+
TCA  loss 
- H2O 
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By increasing the collision energy provided to the precursor (molecular) ion, the fragments of 
the third serie increase significantly, while those of the first and second series remain 
approximatively low for all the tested energies. This may suggest that all the routes of 
possible fragmentation of Fumonisins lead to the formation of the third series fragments, 
which are thermodynamically favored. 
Once the parameters of collision are optimized, the most suitable transition can be chosen in 
order to perform the method MRM detection. In this work two transitions per analyte were 
chosen; the former for quantification purposes, while the latter for the identification of the 
molecular ion. 
In the following table the transitions used for Fumonisins MRM detection are reported. Is 
possible to see that while FB1 has a specific channel, the detection of FB2 and FB3 require one 
common channel. This fact is due to the isomeric nature of  Fumonisins B2 and B3, which 
differ only for the position of an hydroxy group on the backbone. This little difference implies 
that this mycotoxins respond to the same transition, at least in a MS/MS experiment; maybe 
with more fragmentation should be possible to distinguish them in two single channels. Thus, 
the common response of two analytes require their  prevuoius separation, in order to prevent 
co-elution and then the co-detection. 
 
Tab. 8: MRM detection method: Transitions, potentials and collision energies used for 
Fumonisin B1, B2 and B3. 
 
 
 
 
Transition Cone potential (V) Collision energy (eV) function 
FB1    
722.40  ?  334.40 50 40 QUANTIFIER 
722.40  ?  352.40 50 35 QUALIFIER 
    
FB2 - FB3    
706.40  ?  318.40 50 35 QUANTIFIER 
706.40  ?  336.40 50 35 QUALIFIER 
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Once the detection method has been developed, it is necessary to set the parameters for the 
chromatographic separation of the analytes. A standard solution of the three Fumonisins was 
prepared and  several test were performed in order to achieve the baseline separation of the 
analytes in HPLC using a 2.5 x 25 mm, 5µ, C18 X-Terra column and H2O-MeOH eluents as 
reported in the experimental part. In the following figure is reported a chromatogram obtained 
by injection of 1 ppm standard of Fumonisin B1 B2 and B3. It is possible to see the peaks of 
Fumonisins B2 and B3 well separetd despite the isomeric nature of the two analytes. The 
elution order is  FB1< FB3 <  FB2. 
 
Time
2.50 5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 35.00 37.50 40.00 42.50 45.00 47.50
%
0
100
2.50 5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 35.00 37.50 40.00 42.50 45.00 47.50
%
0
100
FBs 1000 ppb 2: MRM of 3 Channels ES+ 
TIC
1.43e519.40
FBs 1000 ppb 1: MRM of 3 Channels ES+ 
TIC
8.22e422.83
21.40
 
 
Fig. 22:  MRM, TIC, cromathograms of Fumonisin B1, B2 and B3, (1 ppm) standard in 
MeOH. 
 
Tab. 9 :  Retention times of Fumonisin B1, B2 and B3. 
 
 
 
 
 
 
 
 
analyte retention time (min.) 
Fumonisin B1 19.4 
Fumonisin B2 22.8 
Fumonisin B3 21.4 
FB1 
FB2FB3
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By comparing the retention times it is possible to observe that FB1 is the most polar  
compound, due to the presence of two hydroxyl groups in the backone and is eluted first. 
Fumonisin B2 and  B3, which only differ for the position of one hydroxy group, elute slighlty 
later with the higher retention time for FB2, suggesting that the latter is better retained on the 
column, probably due to a different conformation which interact better with the stationary 
phase. 
 
3.2.2 Calibration and matrix effect  
Calibration and matrix effects must be evaluated in order to quantify the analytes. First, the 
linearity response of the detector is checked by the external standard method. Then the matrix 
effect can be evaluated by means of matrix matched calibrations, produced with a blank maize 
extract. Based on the past experience, we know that Fumonisins are affected from matrix 
effect, at least on the instrument used for this work. Matrix effects concern the variation of the 
analyte response in the presence of co-eluting compounds. For this reason we decide to use 
directly matrix matched calibration in order to correct the matrix effect and to get a more 
accurate Fumonisin quantification. All the three analytes show a good linearity in the 50-2000 
ppb range. Matrix matched calibration curves were determined by diluting an opportune stock 
of the three Fumonisins, with an extract of blank sample. This procedure was repeated with 
each batch of samples (three replicates for each point), according to the procedure reported in 
the Experimental Part. 
 
Tab. 10:  Matrix matched calibration curves for Fumonisin B1, B2 and B3. 
  
 
 
 
 
 
 
 
 
 
 
 
analyte curve equation R2 
Fumonisin B1 y = 14.31x + 239.45 0.9988 
Fumonisin B2 y = 6.66x + 267.46 0.9931 
Fumonisin B3 y = 5.58x + 264.32 0.9932 
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3.2.3 Recovery and Limits of Detection 
The efficiency of the extraction step can be evaluated by means of spiking experiments or 
using a certified reference material. In the former case, a blank sample is spiked at proper 
concentration levels with an analyte standard solution and then analysed according to the 
described procedure. After quantification, the concentration found for each analyte is 
compared with that initially added to the sample. This method is commonly used for method 
validation, but it shows some limitations: the spiked analyte is subject to a different 
environment in the matrix when compared to a natural contaminant. The use of a certified 
reference material may thus overcome this limitation, since it is a naturally contaminated 
sample, already measured by several certified laboratories, and provided of a certified 
contamination level which should be considered as a “true value”. The method recovery is 
thus obtained by comparison of the concentration measured with the given or nominal 
concentration. 
Assuming that the recovery evaluation by means of reference material could be affected from 
error due to the unknown nature of the analyte masking phenomenon (hidden Fumonisins), 
we decided to evaluate the extraction recovery by means of the spiking procedure, reported in 
the Experimental Part (Fig. 23).  
Recovery% =  (experimental concentration / reference concentration) x 100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 23: Schematic procedure of Fumonisin extraction for the recovery evaluation. 
MeOH / H2O  70:30 
Homogeneization 10’
 
Stirring 60’ 
 
Centrifuge 
solid residue extract 
LC-MS/MS of FBs 
Blank spiked 
sample 
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Blank maize was spiked with an opportune volume of Fumonisins stock solution, on two 
levels, 250 and 1000 ppb, and then analyzed with two injections per level, with a matrix 
matched calibration. In the following tables the results for the extraction recovery of the three 
Fumonisins are reported. 
Tab. 11: Recovery evaluation for Fumonisin B1. 
 
 
 
 
 
 
Tab. 12: Recovery evaluation for Fumonisin B2. 
 
 
 
 
 
 
Tab. 13:  Recovery evaluation for Fumonisin B3. 
 
 
 
 
 
 
Tab. 14: Mean recovery for Fumonisin B1  B2 and B3. 
 
 
 
 
 
 
 
 
 
 
analyte expected µg/Kg found µg/Kg recovery RSD % 
FB1 248.98  262.25 105.3 % 4.5 
FB1 996.91  865.4  86.8 % 4.3 
analyte expected µg/Kg found µg/Kg recovery RSD % 
FB2 250.45  277.25  110.9 % 4.7 
FB2 1002.84  895.6  89.3 % 1.7 
analyte expected µg/Kg found µg/Kg recovery RSD % 
FB3 250  228.4  91.4 % 7.9 
FB3 1000  829.1  82.9 % 1.4 
analyte mean recovery 
FB1 96.1 % 
FB2 100.1 % 
FB3 87.3 % 
 49
It is possible to see that the recovery values are higher for the lower levels, and lower by 
increasing the tested concentrations. Although we used a matrix matched calibration, several 
recovery values were higher than 100%: they can be explained by a slight imprecision in the 
spiking volume of the common standard solution for FB1 and FB2. However the mean values 
are satisfactoy and have been used to correct the data. 
A reference material was also tested in order to check the results of the spiking procedure. 
In the following table the results of the recovery for  FB1 and FB2, obtained by analysis of a 
reference material are reported. 
 
Tab. 15: Reference material mean recovery for Fumonisin B1 and B2. 
 
 
 
 
 
 
 
The results concerning FB1 are consistent with those obtained from spiking experiments, 
according to which a high analyte concentration usually corresponds to a lower extraction 
efficiency. On the other hand, the results obtained for FB2 do not agree with those previously 
obtained: this is probably due to the high standard deviation in the reference material. The 
reliability of certified material, for extraction efficiency evaluation, in Fumonisins analysis, 
will be further discussed in the chapter of maize analysis. 
 
 
 
 
 
 
 
 
 
 
 
analyte certified µg/Kg found µg/Kg recovery RSD % 
FB1 2406 ± 630  1937.8  80.5 % 8.9 
FB2 603 ppb ± 114  747.5 118.7 % 5.3 
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The limit of detection was evaluated by the signal to noise ratio (S/N), calculated by 
MASSLYNX software (Waters Inc.), at 10 and 5 ppb levels. Matrix matched standard  were 
used, in order to correct matrix effects. 
 
Tab. 16: Evaluation of the limit of detection (LOD) and quantification (LOQ) for 
Fumonisin B1. 
 
 
 
 
 
  
Tab. 17: Evaluation of the limit of detection (LOD) and quantification (LOQ) for 
Fumonisin B2. 
 
 
 
 
 
Tab. 18: Evaluation the limit of detection (LOD) and quantification (LOQ)  for 
Fumonisin B3. 
 
 
 
 
It’s generally accepted to consider a S/N = 3 for calculating the LOD and  S/N = 10 for 
calculating the LOQ. The LODs and LOQs were evaluated as reported in Tab. 16,17 and 18.  
However In the present work, 10 ppb was considered as limit of quantification for  Fumonisin 
B1  B2 and B3. 
analyte level LOD µg/Kg LOQ µg/Kg 
FB1 10 ppb 2 6 
FB1 5 ppb 1 7 
analyte level LOD µg/Kg LOQ µg/Kg 
FB2 10 ppb 1 4 
FB2 5 ppb 1 4 
analyte level LOD µg/Kg LOQ µg/Kg 
FB3 10 ppb 2 6 
FB3 5 ppb 2 5 
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3.3 Analysis of Hydrolysed Fumonisins: optimization of the 
method 
3.3.1  Standard preparation 
The evaluation of hidden Fumonisins requires the comparison of the toxin concentration  
before and after alkaline hydrolysis of the sample. Standards of hydrolysed Fumonisins 
(HFBs) are not commercially available, thus we prepared the standards as described in the 
Experimental Part, according to the following reaction : 
 
 
 
 
 
 
 
Fig. 24: Hydrolysis of Fumonisin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 25:  Structures and molecular weights of hydrolysed Fumonisins HB1, HB2 and HB3. 
 
 HFB1 HFB2 HFB3 
R1 OH OH H 
R2 OH H OH 
MW 
[g/mol] 
405.35 389.35 389.35 
OH
H3C OH CH3
OH
R2
R1
NH2
OH
H3C O CH3
O
OH
O
COOH
COOH
HOOC
O
OH
NH2
KOH 2M
rt, 1h
OH
H3C OH CH3
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OH
OH
NH2
HOOC FB1 HFB1 
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The standard preparation was performed by alkaline hydrolysis of a proper amount of a 
FBsstandard solution, as reported in the experimental part. The hydrolysed derivatives are 
stable also in alkali solution, while an acidic pH can promote loss of water, by protonation of 
the hydroxyl groups. 
For the reaction, we used potassium hydroxyde (KOH) at a concentration of  2 M. The choice 
of concentration and type of alkali was based on several observations: 
- When NaOH is used as alkali, HFBs tend to form sodium adducts, (M+Na)+ during the 
ionization step in the MS detector, decreasing then the analyte response as molecular 
ion. This phenomenon is remarkly lower with the potassium cation. The use of 
potassium hydroxyde instead sodium hydroxyde can thus minimize adducts formation, 
increasing the  sensitivity of the technique. 
- High concentration of the base is needed firstly to disrupt the matrix and then to reach a 
complete analyte hydrolyzation in a reasonable time.  
- The high concentration is also useful during the liquid phase extraction of the 
hydrolysed derivatives of Fumonisins, since acetonitrile doesn’t mix with concentrated 
aqueous solutions at high ionic strenght and the organic phase is easily recoverable.  
Production of hydrolysed Fumonisins (HFBs) for standard preparation or for total Fumonisins 
evaluation, requires some preliminary considerations.  
Although the use of mass concentration (ppm, ppb), which is generally accepted for risk 
assessment and contamination limit definition, is also useful for calibration purposes, the 
hydrolysis of Fumonisins is performed on the basis of reaction molar yields, and thus molar 
concentrations of analytes are required.  
The “Hidden Fumonisins” quantification sequence is as follows: 
1) HFBs mass concentration in the sample, after hydrolysis, is found by LC-ESI-MS/MS 
analysis; 
2) The corresponding moles of HFBs are calculated starting from the found mass 
concentration; 
3) the moles of HFBs after hydrolysis are considered equal to the total FBs moles before 
hydrolysis; 
4) FBs moles can be used to calculate the mass concentration of total FBs in the sample. 
The procedure is reported in the following scheme. 
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Fig. 26: Analogies of HFB production in standard and sample preparation. 
 
 
Tab. 19:  Molecular weight ratios for Fumonisin B1, B2 and B3 and their hydrolysed 
analogues . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 FB (g/mol) HFB (g/mol)
Mass ratio 
MWHFB/MWFB 
1 721.39 405.35 0.56 
2 705.39 389.35 0.55 
3 705.39 389.35 0.55 
known amount 
of FBs 
unknown amount 
of FBs 
hydrolysis
ACN extraction
known amount 
of HFBs 
known amount 
of HFBs 
LC-ESI-MS/MS 
calculation 
STANDARD PREPARATION SAMPLE PREPARATION
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3.3.2 MS/MS detection  
Once the standards were obtained, the LC-ESI-MS/MS analysis of hydrolysed Fumonisins 
was developed.  
 
5_2_08       Ca 4  Co 30  
m/z
384 386 388 390 392 394 396 398 400 402 404 406 408 410 412 414 416 418 420 422
%
0
100
%
0
100
%
0
100
HFB3_1  20 (0.370) Sm (SG, 1x0.75); Cm (3:51) Scan ES+ 
2.69e5390.3
391.3
404.8
HFB2_1  34 (0.628) Sm (SG, 1x0.75); Cm (6:51) Scan ES+ 
3.72e5390.2
391.3
HFB1_2  41 (0.758) Sm (SG, 1x0.75); Cm (6:52) Scan ES+ 
1.16e5406.3
388.2
407.2
408.3
 
 
Fig. 27:  Zoom of the molecular ion (M+H)+ of hydrolysed Fumonisin B1, B2 and B3. 
Capillary: 4 kV, Cone: 30 V. Infusion of the standard (5 ppm) in MeOH, Full scan 
mode. 
 
As far as the ionization process of hydrolysed derivatives of Fumonisins is concerned, it’s 
interesting to note that the optimal capillary voltage is approximately the same as for native 
Fumonisins; this can be explained by assuming that the positive charge carried by the amino 
group (for (M+H)+), in both forms of Fumonisins, native and hydrolysed, provide a common 
ionization pathway, in positive mode. The comparison of cone voltages show a significant 
lower value for HFBs in respect to those of FBs. In the following figures the results of the 
fragmentation test for HFB1, HFB2 and HFB3 are reported. In order to develop the MRM 
detection, standard solutions of know concentration were infused in the mass spectrometer, 
and the analyser parameters were changed in order to obtain intense, stable and specific 
fragments of the analytes. Fragmentation comparison between Fumonisins and their 
hydrolysed derivatives reflects the  lack of the TCA chains of HFBs. It’s possible to see that 
the HFBs fragmentation derives only from the loss of the hydroxyl groups, as a water 
molecules.  
 
HFB3 
HFB1 
HFB2 
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5_2_08       Ca 4  Co 30  Ce 25
m/z
100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420
%
0
100
%
0
100
%
0
100
HFB1_4  35 (0.647) Sm (SG, 1x0.75); Cm (5:48) Daughters of 406ES+ 
1.03e4334.2
127.3
109.3
135.3
175.1147.2 236.4208.3186.1 254.1 316.2272.2
352.2
335.3
370.2
353.2 388.1
389.2 406.3
HFB1_5  44 (0.813) Sm (SG, 1x0.75); Cm (5:48) Daughters of 406ES+ 
1.58e4370.2
352.1
334.2
127.3109.2 254.3135.1 175.0147.2 236.4186.3 226.3 272.4 316.3279.3 335.2
353.1
388.3
371.2
406.3
389.3 407.3
HFB1_3  31 (0.573) Sm (SG, 1x0.75); Cm (6:48) Daughters of 406ES+ 
5.68e4406.4
388.5
370.4352.4 389.4
407.5
 
 
Fig. 28:  Infusion of  the hydrolysed Fumonisin B1 standard, (5 ppm) in MeOH, 
daughter ion scan mode. Influence of the collision energy (eV) applied to the precursor 
ion m/z 406.3 (M+H)+  of  HFB1  on the profile of produced fragments. 
 
 
Tab. 20:  Proposed assignment for HFB1  ion fragments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
m/z ion 
406.3  (M  + H)+ : molecular ion 
388.3 (M - H2O + H)+ 
370.2 (M - 2H2O + H)+ 
352.1 (M - 3H2O + H)+ 
334.1 (M - 4H2O + H)+ 
316.3 (M - 5H2O + H)+ 
Ce 25 eV 
Ce 20 eV 
Ce 15 eV 
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5_2_08       Ca 4  Co 30  Ce 25
m/z
100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420
%
0
100
%
0
100
%
0
100
HFB2_4  40 (0.739) Sm (SG, 1x0.75); Cm (5:48) Daughters of 390ES+ 
5.15e4336.3
318.2238.3109.3 123.3 149.2 222.3163.1 177.3 256.2 319.2
354.3 372.2
390.1
HFB2_3  13 (0.240) Sm (SG, 1x0.75); Cm (6:48) Daughters of 390ES+ 
5.19e4336.3
318.3
127.3109.3 256.2238.4135.1 149.4 177.1 203.2 274.4
372.2354.2
337.2 355.3
390.3
373.2 391.2
HFB2_2  26 (0.480) Sm (SG, 1x0.75); Cm (5:48) Daughters of 390ES+ 
1.94e5390.3
372.2354.1336.2
391.3
 
 
Fig. 29:  Infusion of the hydrolysed Fumonisin B2 standard, (5 ppm) in MeOH,  
daughter ion scan mode. Influence of the collision energy (eV) applied to the precursor 
ion m/z 390.3 (M+H)+  of  HFB2  on the profile of produced fragments. 
 
 
Tab. 21:  Proposed assignment for HFB2  ion fragments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
m/z ion 
390.3  (M  + H)+ :  molecular ion 
372.2 (M - H2O + H)+ 
354.2 (M - 2H2O + H)+ 
336.3 (M - 3H2O + H)+ 
318.2 (M - 4H2O + H)+ 
Ce 25 eV 
Ce 15 eV 
Ce 20 eV 
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5_2_08       Ca 4  Co 30  Ce15
m/z
100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420
%
0
100
%
0
100
%
0
100
HFB3_4  25 (0.462) Sm (SG, 1x0.75); Cm (5:48) Daughters of 390ES+ 
4.00e4336.3
238.3210.4
194.4170.5151.1 224.3 318.2256.4
337.4 354.2 372.2
HFB3_3  33 (0.610) Sm (SG, 1x0.75); Cm (5:49) Daughters of 390ES+ 
5.04e4336.3
256.4238.4210.4177.1151.4 188.1 318.2
372.3354.3
337.3
355.2
390.3
373.3 391.3
HFB3_2  8 (0.148) Sm (SG, 1x0.75); Cm (5:48) Daughters of 390ES+ 
1.34e5390.2
372.2
354.2336.2 373.3
391.3
 
 
Fig. 30:  Infusion of  the hydrolysed Fumonisin B3 standard, (5 ppm) in MeOH,  
daughter ion scan mode. Influence of the collision energy (eV) applied to the precursor 
ion m/z 390.3 (M+H)+  of  HFB3  on the profile of produced fragments. 
 
 
 
Tab. 22:  Proposed assignment for HFB3  ion fragments. 
 
 
 
 
 
 
 
 
 
Since the HFB fragmentation is due to the loss of water, which is a thermodynamically 
preferred process in comparison to the loss of TCA side chains recorded for FBs, a lower 
collisional energy is required for the MRM analysis.  
Once the collision parameters are optimized, the most suitable transition can be chosen in 
order to perform the MRM detection. In the following tables the transitions used for 
hydrolysed Fumonisins MRM detection are reported. It is possible to see that, as for native 
m/z ion 
390.3 (M  + H)+ :  molecular ion 
372.2 (M - H2O + H)+ 
354.2 (M - 2H2O + H)+ 
336.3 (M - 3H2O + H)+ 
318.2 (M - 4H2O + H)+ 
Ce 25 eV 
Ce 15 eV 
Ce 20 eV 
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Fumonisins, HFB1 has a specific channel, while HFB2 and HFB3 require one common 
channel. Being isomers HFB2 and HFB3 give rise to the same transitions. 
 
Tab. 23:  Transitions, potentials and collision energies used for  hydrolysed Fumonisin 
B1, B2 and B3  MRM detection method. 
 
 
Once the detection method is developed, it is necessary to optimize the chromatographic 
separation of the analytes. A standard solution of the three hydrolysed Fumonisins was 
prepared and analyzed with the optimized conditions. 
The column used for the analytical separation, as for the native Fumonisins, is a 2.5 x 25 mm, 
5µ, C18 X-Terra, with a flow rate of 0.2 ml/min. 
 
 
 
 
 
 
 
 
 
 
Transition Cone potential (V) Collision energy (eV) function 
HFB1    
406.4  ?  334.1 30 25 QUANTIFIER 
406.4  ?  352.1 30 20 QUALIFIER 
    
HFB2 - HFB3    
390.4  ?  354.2 30 25 QUANTIFIER 
390.4  ?  336.3 30 20 QUALIFIER 
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The chromatograms obtained by injection of 1 ppm standard of hydrolysed Fumonisin B1, B2 
and B3 are reported in the following figure. It is possible to see the peaks corresponding to 
HFB2 and HFB3 on the same channel.  
 
Time
2.50 5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 35.00 37.50 40.00 42.50 45.00 47.50
%
0
100
2.50 5.00 7.50 10.00 12.50 15.00 17.50 20.00 22.50 25.00 27.50 30.00 32.50 35.00 37.50 40.00 42.50 45.00 47.50
%
0
100
HFBs 1000 ppb 2: MRM of 3 Channels ES+ 
TIC
6.57e417.07
HFBs 1000 ppb 1: MRM of 3 Channels ES+ 
TIC
1.04e519.69
20.82
 
Fig. 31:  MRM, TIC, chromathogram of  hydrolysed Fumonisin B1,  B2 and B3, 
  1 ppm standard in MeOH. 
 
 
Tab. 24:  Retention time of  hydrolysed Fumonisin B1,  B2 and B3. 
 
 
 
 
 
 
 
 
 
The elution order is  HFB1< HFB3 < HFB2. Comparison of the retention times shows that, as 
in the case of the native Fumonisins, HFB1 is the most polar  compound, due to the presence 
of two hydroxyl group in the backbone. Hydrolysed Fumonisin B2 and  B3, which only differs 
for the position of one hydroxyl group, elute slightly later with a little difference between 
analyte retention time (min.) 
 hydrolysed Fumonisin B1 17.6 
 hydrolysed Fumonisin B2 20.3 
hydrolysed Fumonisin B3 21.4 
HFB1
HFB2HFB3 
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them. It’s interesting to note that the retention times for the hydrolysed derivatives of 
Fumonisins, are always slightly lower, if compared with the respective native analogues. 
Removal of TCA chains of Fumonisins diminish the interactions with the column. 
 
3.3.3 Calibration and matrix effect  
The same approach adopted for the calibration experiment performed for the native forms was 
used for hydrolysed Fumonisins. Matrix matched calibration was used in order to correct the 
matrix effect and get a more accurate data. Also hydrolysed Fumonisins show a good linearity 
in the 50-2500 ppb range. Matrix matched calibration curves were prepared by adding a 
proper amounts of HFBs stock solution in a hydrolysed blank sample extract. The spiked 
extracts were then analyzed (three replicates for each point), as reported in the Experimental 
Part.  
 
Tab. 25:  Matrix matched calibration curves for hydrolysed Fumonisin B1  B2 and B3. 
 
 
 
 
 
 
 
 
 
3.3.4 Recovery and Limits of Detection 
The efficiency of extraction step regarding HFBs cannot be evaluated by analysis of the 
reference material, because we assume the presence of masked mycotoxins. Then the 
extraction recovery can be evaluated only by spiking of free FBs and assuming 100% of 
hydolysis. However,  also this procedure, could not be effective representative of the real 
samples; until the mechanism of masking remain unknown, or cannot be assumed with a 
reasonable certainty,  recovery can only be indirectly evaluated. 
 
 
 
analyte curve equation R2 
 hydrolysed Fumonisin B1 y = 15.46x - 555.39 0.9958 
hydrolysed Fumonisin B2 y = 9.18x - 273.6 0.9962 
hydrolysed Fumonisin B3 y = 3.01x - 109.1 0.9968 
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Fig. 32: Schematic procedure of sample hydrolysis for HFB recovery evaluation. 
 
The spiking experiment was performed at two concentration levels (250 - 1000 ppb for HFB1 
and HFB2 and 500 - 2000 ppb for HFB3) and each level was analysed in duplicate using a 
matrix matched calibration. 
In the following tables the results obtained for the extraction recovery of the three hydrolysed 
Fumonisins are reported. 
 
 
KOH  2M 
Homogeneization 10’ 
 
Stirring 50’ 
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FB  Spiked sample 
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Tab. 26: Recovery evaluation for hydrolysed Fumonisin B1. 
 
 
 
 
 
 
 
Tab. 27: Recovery evaluation for hydrolysed Fumonisin B2. 
 
 
 
 
 
 
 
Tab. 28:  Recovery evaluation for hydrolysed Fumonisin B3. 
 
 
 
 
 
 
 
 
Tab. 29: Mean recovery for hydrolysed Fumonisin B1  B2 and B3. 
 
 
 
 
 
 
 
 
analyte expected found recovery RSD % 
HFB1 250.00 ppb 204.45 ppb 81.8 % 3.0 
HFB1 1000.00 ppb 731.25 ppb 73.1 % 9.7 
analyte expected found recovery RSD % 
HFB2 250.45 ppb 244.15 ppb 97.7 % 2.8 
HFB2 1002.84 ppb 987.05 ppb 98.7 % 6.3 
analyte expected found recovery RSD % 
HFB3 500.00 ppb 475.05 ppb 95.0 % 14.4 
HFB3 2000.00 ppb 2192.3 ppb 109.6 % 5.9 
analyte mean recovery 
HFB1 77.4  % 
HFB2 98.2 % 
HFB3 102.3 % 
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It’s important to note that recovery is influenced by two factors, the hydrolysis of the sample, 
and the extraction in sensu stricto.  
Differences in recovery could be also explained by the slight different  polarity of the 
analytes, and then by their solubility in acetonitrile.  
Limits were evaluated by the signal to noise ratio (S/N), calculated by MASSLYNX software 
(Waters Inc.), on 10 ppb level for HFB1 and HFB2, and 50 ppb for HFB3. Matrix matched 
standard  were used in order to correct matrix effect. 
 
 
Tab. 30: Evaluation of the limits of detection (LOD) and quantification (LOQ) for 
hydrolysed Fumonisin B1  B2 and B3. 
 
 
 
 
 
 
 
 
 
It’s generally accepted to consider a S/N = 3 for calculating the LOD and  S/N = 10 for 
calculating the LOQ. The LODs and LOQs were evaluated as reported in Tab. 26, 27 and 28.   
However, in the present work, 10 ppb were considered as limit of quantification (LOD) for  
hydrolysed HFB1 and HFB2, while 50 ppb was considered for HFB3. 
 
 
 
 
 
 
 
 
 
 
analyte level LOD µg/Kg LOQ µg/Kg 
HFB1 10 ppb 2 6 
HFB2 10 ppb 3 10 
HFB3 50 ppb 10 35 
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3.4  The indirect approach 
As already discussed in the introduction chapter, hidden Fumonisins were first identified in 
corn flakes as N-derivatives of the amino group of FBs (115), following the reaction with 
reducing sugars, giving rise to the formation of  Shiff base like compounds.  
This covalent modification of Fumonisins is well know, and is promoted by high temperature 
like that used in some maize based foodstuff preparation. The investigation proposed in this 
work is not focused on this reaction, but rather on masking mechanisms involving the TCA 
chains, which contain 4 carboxylic acid groups. 
These groups are essential for some observed properties of FBs  (i.e.: ceramide synthase 
irreversible inhibition). Moreover the FBs derivatives produced by covalent modification of 
the amminic group, are usually less toxic compound (58,59–65). 
When performing the  basic hydrolysis, several effects are obtained: 
? the elimination of direct covalent modifications at the carboxylic groups  
? the loss of TCA chains by cleaving the ester of FBs, producing the hydrolysed form 
(HFBs); 
? the disruption of non covalent interactions among matrix macroconstituents with the 
consequent loss of the matrix tridimensional structure. 
On the other side, chemical hydrolysis has a low specificity and doesn’t offer much 
information about the type of modification undergone by the toxin. 
Thus, we decided to use an indirect approach to investigate the masking phenomenon: firstly 
the extraction of free FBs was performed on a maize sample aliquot, then a second aliquot 
underwent to the hydrolysis procedure to obtain the total FBs. 
The presence of hidden Fumonisins in a sample can be calculated by the following formula: 
 
Total FBs (calculated from HFBs)  -  free FBs  =  hidden FBs 
 
If the sample doesn’t contain hidden FBs  (hidden FBs = 0):  
 
Total FBs (calculated from HFBs)  =   free FBs   
 
Then the total FBs concentration, found by analysis of HFBs, should be a value similar to free 
FBs. 
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Fig. 33: Schematic procedure of sample preparation for free Fumonisin evaluation. 
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Fig. 34: Schematic procedure of sample hydrolysis for total Fumonisins evaluation,  
by HFB analysis. 
 
 
3.5  Analysis of maize based food 
3.5.1  The first screening   
The presence of hidden Fumonisins was checked as first in corn-based food. The products 
were purchased from traditional and organic retails, and included pasta, snack and breakfast 
cereals, in order to analyse both low and high temperature-treated foods.  
The protocol of the method is schematized in the previous figures (33,34) and described in the 
Experimental Part. The extraction step was repeated twice for each sample, in order to allow 
for the highest extraction yield of the target analytes (free FBs). Each extract was preliminary 
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Acetonitrile 
Homogeneization 10’
 
Centrifuge 
gel residue 
HFBs 
total  FBs   
ground sample 
organic phase 
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analyzed in order to check the presence of HFBs before the hydrolysis, although the 
occurrence of HFBs is generally negligible in corn-based food. Starting from these 
preliminary data, a proper sample concentration/dilution step was set to fit in the range of 
matrix matched calibration. 
Five samples of corn pasta (low temperature treated products), and five corn-based snacks and 
corn flakes (high temperature treated products) were analysed for free and total FBs. 
A chromatogram is reported in fig. 35 as example. The results obtained for corn-based 
products are reported in the following figures. 
The collected data underlined a widespread FBs contamination in corn-based food, which had 
been randomly selected from different shops and brands. When free Fumonisins are 
considered, all the analysed products coped with the EU legal limits. After hydrolysis, the 
total Fumonisin concentration was increased and, for several samples, turned out to be higher 
than the legal limit.  
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Fig. 35 : MRM (TIC) cromathogram of a FBs naturally contaminated sample of maize 
based food. 
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Fig. 36: Results of a preliminary screening of maize pasta samples. Graphic comparison 
of free FBs (FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3 after 
sample hydrolysis). The dotted red line represents the legal limit of FBs contamination 
in maize based food (1000 µg/kg), except corn-flakes (800 µg/kg). 
 
Tab. 31: Result of a preliminary screening on maize pasta samples. Contamination of 
free FBs (FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3 after sample 
hydrolysis).  
sample 
Free FBs 
(FB1+FB2+FB3) 
I extraction 
(µg/kg) 
Free FBs  
(FB1+FB2+FB3)
II extraction 
(µg/kg) 
 
FBs tot  
(HFB1+HFB2+HFB3) 
(µg/kg) 
 
Hidden FBs 
(FBs tot - free 
FBs) 
(µg/kg) 
Maize pasta 1 10 < LOD 44 33 
Maize pasta 2 55 < LOD 240 185 
Maize pasta 3 35 < LOQ 193 159 
Maize pasta 4 445 96 1822 1281 
Maize pasta 5 29 < LOQ 127 98 
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Fig. 37: Results of a preliminary screening on maize based food. Graphic comparison of 
free FBs (FB1+FB2+FB3, blue bars) and total FBs (calculated from HFB1+HFB2+HFB3 
after sample hydrolysis, purple bars). The dotted red line represents the legal limits of 
FB contamination in maize based food (1000 µg/kg), excluded corn-flakes (800 µg/kg). 
 
Tab. 32: Results of a preliminary screening on maize based food. Contamination of free 
FBs (FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3 after sample 
hydrolysis).  
sample 
Free FBs 
(FB1+FB2+FB3) 
I extraction 
(µg/kg) 
Free FBs  
(FB1+FB2+FB3) 
II extraction 
(µg/kg) 
 
FBs tot  
(HFB1+HFB2+HFB3) 
(µg/kg) 
 
Hidden FBs 
(FBs tot - free 
FBs) 
(µg/kg) 
corn flakes 1 < LOD < LOD 70 70 
maize chips < LOD < LOD 108 108 
maize snack 1 660 152.53 5549 4736 
maize snack 2 712 242.14 3733 2769 
corn flakes 2 < LOQ < LOD 94 94 
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The following figure summaryzed the preliminary results obtained. 
 
Tab. 33: Summary of preliminary screening on maize based food samples.  
 
 
From this preliminary screening we can draw the following considerations. 
I) The method proposed for the indirect evaluation of hidden Fumonisins seems to work well; 
in all cases the Fumonisin concentrations calculated after sample hydrolysis increase when 
compared with the concentrations obtained from the analysis of the free FBs; thus the 
presence of some forms of FBs that are not extracted by conventional method is proven.  
II) In agreement with Kim et al. (2003), hidden Fumonisins seem to be present in corn-based 
food. Probably the reaction between FBs and the matrix components, so far unknown, is 
promoted by heating steps applied during processing. 
III) Since FB N-derivatives are stable under alkaline hydrolysis, the hidden forms detected by 
our procedure indirectly detected by this method should be different; in particular, the FB 
tricarballylic chains could be involved in the masking mechanism. 
IV) The presence of hidden FBs also in low temperature treated food  raises new questions. 
It is known that high temperatures are not required for pasta production in contrast with snack 
and corn-flakes. Thus, other mechanisms could be involved in the masking of Fumonisins. 
 
 
 
 
 
 
 
 
 
Samples 
analysed 
Positive samples for  
free 
FBscontamination 
Mean  free FB  
contamination 
(FB1+FB2+FB3) 
(µg/kg) 
Mean tot FB 
contamination 
(HFB1+HFB2+HFB3)
(µg/kg) 
10 7 305.87 1198.1 
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Tab. 34: Ratio of hidden and free FBs in low temperature processed products.  
 
 
 
 
 
 
 
 
 
Tab. 35: Ratio of hidden and free FBs in high temperature processed products. 
 
 
 
 
 
 
 
 
The values of the hidden / free FBs ratios indicate the amount of hidden form compared with 
the free ones. While the ratio observed for the products heated at high temprature is as 
expected, the one obtained at low temperature is still high. Probably a different mechanism is 
occuringin the two cases. 
 
 
 
 
 
 
 
 
 
 
 
Low T treated 
products 
Positive sample for free 
FBs contamination 
 
hidden FBs /  free FBs 
 
5 5 3.4 
High T treated 
products 
Positive sample for free 
FBs contamination 
 
hidden FBs /  free FBs 
 
5 2 4.4 
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3.5.2  Survey on gluten free products   
After the first screening, other products were collected from retail among organic food, 
especially those sold with the claim ‘gluten free’, intended for people with celiac disease.  
In order to widen the screening and get more data, several samples of corn pasta, crackers, 
corn-flakes and polenta were analysed. In particular, the following analyses have been 
performed: 
I) Two extractions of free FBs from each sample; 
II) Two sample preparations for both free FB and total FB evaluation; 
III) Two injections for each preparation. 
The survey results are reported in the following figures. 
 
 
 
 
Fig. 38: Results of the survey on gluten free maize pasta samples. Graphical comparison 
of free FBs (FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3 after 
sample hydrolysis, purple bar). The dotted red line represents the legal limit of FBs 
contamination in maize based food (1000 µg/kg), excluded corn-flakes (800 µg/kg). 
(Error bars = RSD%). 
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Tab. 36: Results of the survey on gluten free maize pasta samples. Contamination of free 
FBs (FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3 after sample 
hydrolysis).  
 
sample 
Free FBs 
(FB1+FB2+FB3) 
 (µg/kg) 
RSD % 
(4 replicates) 
 
tot FBs  
(HFB1+HFB2+HFB3) 
(µg/kg) 
RSD %) 
(4 replicates) 
Maize pasta 1 < LOD 0 < LOD 0 
Maize pasta 2 103 12 767 13 
Maize pasta 3 194 32 625 8 
Maize pasta 4 < LOD 0 < LOD 0 
Maize pasta 5 186 9 767 15 
Maize spaghetti < LOD 0 113 3 
 
 
Tab.  37: Hidden Fumonisin estimation in gluten free maize pasta samples. 
 
sample 
 
Hidden FBs 
(FBs tot - free FBs) 
(µg/kg) 
Maize pasta 1 N.D. 
Maize pasta 2 664 
Maize pasta 3 431 
Maize pasta 4 N.D. 
Maize pasta 5 581 
Maize spaghetti 113 
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Fig. 39: Results of the survey on gluten free maize based food samples. Graphic 
comparison of free FBs (FB1+FB2+FB3) and total FBs (calculated from 
HFB1+HFB2+HFB3). The dotted red line represents the legal limits of FBs 
contamination in maize based food (1000 µg/kg), excluded corn-flakes (800 µg/kg). 
(Error bars = RSD%). 
 
 
Tab.  38: Results of the survey on gluten free maize based food samples. Contamination 
of free FBs (FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3 after 
sample hydrolysis).  
sample 
Free FBs 
(FB1+FB2+FB3) 
 (µg/kg) 
RSD % 
(4 replicates) 
 
FBs tot  
(HFB1+HFB2+HFB3) 
(µg/kg) 
RSD % 
(4 replicates) 
maize bread < LOD 0.00 < LOD 0.00 
cracker 1 38 13 276 55 
cracker 2 < LOD 0.00 < LOD 0.00 
crispy cracker 54 7 613 26 
 polenta 70 5 245 42 
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Tab.  39: Hidden Fumonisin estimation in gluten free maize based food samples. 
 
sample 
Hidden FBs 
(FBs tot - free FBs) 
(µg/kg) 
 bread N.D. 
cracker 1 238 
cracker 2 N.D. 
crispy cracker 560 
 polenta 175 
 
 
 
 
 
Fig. 40: Results of the survey on gluten free corn flakes samples. Graphic comparison of 
free FBs (FB1+FB2+FB3) and total FB (calculated from HFB1+HFB2+HFB3 after sample 
hydrolysis). The dotted red line represents the legal limits of FBs contamination in corn-
flakes (800 µg/kg). (Error bars = RSD%). 
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Tab. 40: Results of the survey on gluten free corn flakes samples. Contamination of free 
FBs (FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3 after sample 
hydrolysis).  
sample 
Free FBs 
(FB1+FB2+FB3) 
 (µg/kg) 
RSD % 
(2 replicates) 
 
FBs tot  
(HFB1+HFB2+HFB3) 
(µg/kg) 
RSD % 
(2 replicates) 
corn flakes 1 124 1 308.55 3 
corn flakes 2 95 2 137.56 6 
corn flakes 3 390 4 548.24 9 
corn flakes 4 108 5 143.33 8 
 
 
 
Tab. 41: Hidden Fumonisin estimation in gluten free corn flakes. 
 
sample 
Hidden FBs 
(FBs tot - free FBs) 
(µg/kg) 
corn flakes 1 184 
corn flakes 2 43 
corn flakes 3 158 
corn flakes 4 35 
 
 
Also in the second batch of products it is possible to see a widespread FB contamination 
among maize based food, randomly selected from different shops and brands. The mean 
concentration found of  free  Fumonisins, 90.84 ppb, is under the fixed limit; unfortunately 
hidden FBs are still present at higher concentration in almost all samples, reaching in some 
case values close to the limit. The results are reported in Fig. 52. 
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Tab. 42: Summary of the survey on maize based food samples.  
 
 
 
The new analysis has confirmed the results obtained with the first screening: hidden 
Fumonisins are present in maize based food; where the term ‘hidden’ means not extractable, 
or not directly analysable.  
The proposed method for indirect evaluation of hidden Fumonisin is a first approach to 
estimate the amount of hidden FBs in a sample. Concerning the reproducibility of the method, 
it is possible to see that the relative standard deviation can reach high values in some cases, 
especially in the analysis of total Fumonisins, on account of the close dependence of the 
hydrolythic step from the matrix.  
The presence of  some additives, necessary for these class of products, as stabilyzers, 
emulsifers, swelling agents and lipids can affect the hydrolysis and the acetonitrile extraction. 
However, the difference between total and free FBs is significative and the hidden FBs appear 
to be constantly in a ratio 3:1 relative to free FBs. The widespread presence of hidden 
Fumonisin in gluten free products can represent a problem for celiac consumers, that must 
consume this type of food. Moreover the survey has shown that also low temperature treated 
food can contain considerable amounts of hidden FBs.  
As already discussed in the Introduction chapter, some authors have proved the in vitro 
reaction of Fumonisin B1 with lysine and glucose upon heating above 100°C, as models of the 
reaction with proteins and starch. This reaction can lead to covalent TCA-derivatives of FBs, 
amidation and transesterification respectively. However, the temperatures reached in the 
maize pasta production technology are not so high to justify such a high formation of 
conjugates FBs. During processing, indeed, the technological transformation is aimed at 
Samples 
analysed 
Positive 
samples for  
free FB 
contamination 
Mean free FB  
contamination 
(FB1+FB2+FB3)
(µg/kg) 
Mean tot FB  
contamination 
(HFB1+HFB2+HFB3)
(µg/kg) 
 
Mean  
hidden FBs / free 
FBs 
 
15 10 91 303 3.52 
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starch gelification. Moreover maize proteins, like cereal proteins in general, lack or have a 
poor content of lysine, which is the limiting amino acid for this product.  
Although the heat-induced degradation may contribute to the loss or masking of free 
Fumonisins, the limited contribution of the reaction at low temperature suggests the occurring 
of other types of masking mechanisms in corn, as already said before. On the other side 
metabolites of Fumonisins are not known in maize, making poorly reliable then the 
hypothesis of covalent modification of FBs by endogenous maize enzymes. In order to check 
if hidden Fumonisin are already present in the raw material, we applied the indirect approach 
also to raw maize samples.  
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3.6  Analysis of raw maize  
3.6.1  The first screening   
The presence of hidden Fumonisins was checked also in raw maize (harvest 2007). For a first 
screening two samples of dry cereals were kindly provided by the farmers of Pianura Padana. 
The sample preparation procedure is the same previously used for food products, and reported 
in the experimental part.  
The extraction step was repeated twice consecutively to extract as much as possible of the 
native (free) forms of FBs and each extract was preliminarly analysed injected in order to 
check the presence of hydrolysed Fumonisins before the hydrolysis. The results obtained for 
maize are reported in the following figures. It is possible to see that free forms of Fumonisins 
have been detected in both samples in high concentration, moreover seem that their high 
contamination so that make them unsuitable for direct consuption. Surprisingly, hidden 
Fumonisins seem to be present already in the raw cereal, as shown by the analysis of total FBs 
after hydrolysis.  
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Fig. 41: MRM (TIC) chromathogram of a Fumonisin  naturally contaminated sample  
of raw maize. 
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Fig. 42: Results of the analyses of raw maize samples. Graphic comparison of free FBs 
(FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3). The dotted red line 
represents the legal limits of FB contamination in raw maize for food industries (4000 
µg/kg), except maize for direct human consumption (1000 µg/kg). 
 
Tab.  43: Results of the preliminary screening of raw maize samples. Concentration of 
free FBs (FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3).  
 
sample 
Free FBs 
(FB1+FB2+FB3) 
I extraction 
(µg/kg) 
Free FBs  
(FB1+FB2+FB3)
II extraction 
(µg/kg) 
 
FBs tot  
(HFB1+HFB2+HFB3) 
(µg/kg) 
 
Hidden FBs 
(FBs tot - free 
FBs) 
(µg/kg) 
maize 1 5283 209 10379 4887 
maize 2 2746 255 13183 10182 
 
 
The results of the preliminary screening confirm the hypothesis previously advanced: hidden 
Fumonisins are already present in raw maize. For this reason it was decided to proceed with a 
more extended survey. 
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3.5.2  Survey on Italian raw maize   
In order to get more accurate data, six other samples of raw maize, harvested in 2007 in the 
Pianura Padana, were collected and analysed by : 
I) Double extraction of free FBs from the same sample; 
II) Two sample preparation for both free FB and total FB evaluation; 
III) Two injections for each preparation. 
The results are reported in the following figures. 
Once again it is possible to see a widespread presence of Fumonisin in all the samples 
collected.  
All the collected samples are not suitable for human consumption, due to the high 
contamination, and must be assigned to feed industries. 
 
 
 
Fig. 43: Results of the survey of italian maize samples. Graphic comparison of free FBs 
(FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3). The dotted red line 
represents the legal limits of FB contamination in raw maize for food industries (4000 
µg/kg), except maize for direct human consumption (1000 µg/kg). 
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Tab. 44: Results of the survey of raw maize samples. Concentration of free FBs 
(FB1+FB2+FB3) and total FBs (calculated from HFB1+HFB2+HFB3 after sample 
hydrolysis).  
 
 
Tab.  45: Hidden Fumonisin estimation in Italian maize samples. 
 
sample 
hidden FBs 
(FBs tot - free FBs) 
(µg/kg) 
maize 1 15874 
maize 2 8731 
maize 3 2165 
maize 4 24688 
maize 5 9897 
maize 6 4423 
 
 
 
 
 
 
sample 
Free FBs 
(FB1+FB2+FB3) 
 (µg/kg) 
RSD % 
(4 replicates) 
 
FBs tot  
(HFB1+HFB2+HFB3) 
(µg/kg) 
RSD % 
(4 replicates) 
maize 1 13133 26 29006 20 
maize 2 4227 7 12958 16 
maize 3 2081 3 4246 9 
maize 4 24372 8 49059 10 
maize 5 7225 3 17121 9 
maize 6 3653 22 8076 24 
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As far as  the reproducibility of the analysis of raw maize samples the standard deviation can 
reach high values in some cases. Problems concerning sampling and the homogeneity of  the  
sample may be responsible. 
However, the method for the indirect evaluation of hidden Fumonisins seems to shows that 
also in raw cereals there are some forms of FBs which are not detected by conventional 
methods. This fact provides new clues to understand the mechanism of FBs masking. If the 
previous hypothesis was based on the heat dependent reaction between carboxyl group of FBs 
and the hydroxyl or amino groups of the matrix components, as proteins and starch, the 
presence of hidden FBs also in raw maize (hidden FBs/free FBs = 1,20), is difficult to 
explain, altought the ratio between hidden and free forms is significantly lower than that 
found in maize based products.  
Thus, the problem is very complex: 
I) hidden Fumonisins are present in high temperature treated products; 
II) hidden Fumonisins are present in low temeperure treated products; 
III) hidden Fumonisins are present in raw maize (no heat treatment); 
The higher ratio between hidden and free forms found in food products is consistent with the 
idea that there can be at least 2 mechanisms of masking, the former occuring in the field, the 
latter  promoted by the processing temperature.  
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3.5.3  Survey on non european raw maize   
The survey continued with the analysis of several samples of Canadian maize, kindly 
provided by professor Krska of IFA-Tulln (BOKU. Wien, Austria). The analysis, performed 
at the IFA-Tulln  Department, required the preliminary development and in house validation 
of the LC-MS/MS method for both free and hydrolysed Fumonisins. For this second batch of 
sample it was decide to check also the presence of hidden Fumonisin already in the extract of 
free FBs. Briefly (the procedure is reported in the experimental part), the methanol/water  
extract obtained for the analysis of free FBs was divided in two aliquots : 
I) the former was used  for the normal MRM analysis of free Fumonisins (free FBs); 
II) the latter was hydrolysed for the indirect evaluation of hidden FBs, by MRM analysis of 
HFBs (total FBs in the extract). The procedure is reported in the following figure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  44: Schematic procedure of the analysis of total Fumonisins in the extract for free 
FBs . 
extract  for 
free FBs  
solid residue 
hydrolysis  
LC-MS/MS for 
free FBs  
LC-MS/MS for 
HFBs  total FBs extracted  
ground sample 
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The presence of hidden FBs in the extract can be calculated in the same way as before, by the 
difference of the concentrations found by the two analyses.  
The samples of maize has been prepared with the same procedure already used (see 
Experimental Part). 
Results on Canadian maize samples are reported in the following figures; 
 
 
 
Fig. 45: Results of the survey of Canadian maize samples (maize 2-7), and a reference 
material (maize RM). Graphic comparison of free FBs (FB1+FB2+FB3), total FBs 
extracted (calculated from HFB1+HFB2+HFB3, after hydrolysis of the extract) and total 
FBs (calculated from HFB1+HFB2+HFB3, after sample hydrolysis). The dotted red line 
represents the legal limits of FB contamination in raw maize for food industries (4000 
µg/kg), except maize for direct human consumption (1000 µg/kg). 
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Tab. 46: Results of the survey on Canadian maize samples (maize 2-7), and a reference 
material (maize RM).  Concentration of free FBs (FB1+FB2+FB3) and total FBs 
(calculated from HFB1+HFB2+HFB3 after sample hydrolysis).  
 
sample 
Free FBs 
(FB1+FB2+FB3) 
 (µg/kg) 
RSD % 
(2 replicates) 
 
FBs tot  
(HFB1+HFB2+HFB3) 
(µg/kg) 
RSD %) 
(2 replicates) 
maize RM 3486 16 6406 6 
maize 2 1701 7 3079 8 
maize 3 810 8 1512 9 
maize 4 388 8 590 16 
maize 5 752 8 2014 8 
maize 6 1059 20 1472 12 
maize 7 1739 12 3196 16 
 
 
Tab. 47: Results of the survey on Canadian maize samples (maize 2-7), and a reference 
material (maize RM).  Concentration of free FBs (FB1+FB2+FB3) and total FBs in the 
extract (calculated from HFB1+HFB2+HFB3  after extract hydrolysis).  
 
sample 
Free FBs 
(FB1+FB2+FB3) 
 (µg/kg) 
RSD % 
(2 replicates) 
 
FBs tot in the extract 
(HFB1+HFB2+HFB3) 
(µg/kg) 
RSD %) 
(2 replicates) 
maize RM 3486 16 5578 7 
maize 2 1701 7 2481 10 
maize 3 810 8 1188 12 
maize 4 388 8 536 22 
maize 5 752 8 1032 14 
maize 6 1059 20 1561 9 
maize 7 1739 12 2686 8 
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Tab.  48: Hidden Fumonisin estimation (total and extracted) in Canadian maize samples 
(maize 2-7), and a reference material (maize RM). 
 
sample 
total hidden FBs 
(FBs tot - free FBs) 
(µg/kg) 
hidden FBs in the extract 
(FBs tot extract  - free FBs) 
(µg/kg) 
maize RM 2920 2092 
maize 2 1378 780 
maize 3 702 378 
maize 4 202 148 
maize 5 1262 280 
maize 6 413 502 
maize 7 1457 947 
 
 
The mean concentration found appears significantly lower than that found in Italian maize 
samples. The new data confirm the results obtained with the first batch of maize samples. 
Moreover, the hydrolysis of the extract of ‘free FBs’, revealed that hidden forms are co-
extracted with the free forms, being already present in the first extraction altough in a hidden 
FB /free FB ratio lower than that found on the products. Considerations on this experimental 
evidence will be made to the next chapter. 
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The same analysis was then made on grain samples used as a reference material (calibrator) 
for an ELISA kit for Fumonisins B1 analysis in  raw cereals. 
 
 
 
Fig. 46: Results of the analysis of an ELISA kit reference materials (calibrator). Graphic 
comparison of free FBs (FB1+FB2+FB3), total FBs extracted (calculated from 
HFB1+HFB2+HFB3, after hydrolysis of the extract) and total FBs (calculated from 
HFB1+HFB2+HFB3, after sample hydrolysis). The light blue bars represent the 
reference value of FB1 concentration, as µg/kg,  in each point (200-5000, ND: blank for 
the ELISA kit). 
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Tab. 49: Results of the analysis of an ELISA kit reference material (calibrator). 
Concentration of free FBs (FB1+FB2+FB3) and total FBs (calculated from 
HFB1+HFB2+HFB3  after sample hydrolysis). 
 
sample 
Free FBs 
(FB1+FB2+FB3) 
 (µg/kg) 
RSD % 
(2 replicates) 
 
tot FBs   
(HFB1+HFB2+HFB3) 
(µg/kg) 
RSD %) 
(2 replicates) 
ND 142 7 363 30 
200 310 21 544 26 
1000 1680 24 2717 12 
2000 4180 11 5036 6 
5000 10010 12 15840 10 
 
 
Tab. 50: Result of the analysis of an ELISA kit reference material (calibrator). 
Concentration of free FBs (FB1+FB2+FB3) and total FBs extracted (calculated from 
HFB1+HFB2+HFB3  after extract hydrolysis). 
 
sample 
Free FBs 
(FB1+FB2+FB3) 
 (µg/kg) 
RSD % 
(2 replicates) 
 
FBs tot in the extract 
(HFB1+HFB2+HFB3) 
(µg/kg) 
RSD %) 
(2 replicates) 
ND 142 7 324 15 
200 310 21 439 30 
1000 1680 24 2319 13 
2000 4180 11 5236 12 
5000 10010 12 12220 10 
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Tab. 51: Hidden Fumonisin estimation (total and extracted) of an ELISA kit reference 
material (calibrator). 
 
sample 
hidden FBs 
(FBs tot - free FBs) 
(µg/kg) 
hidden FBs extracted 
(FBs tot extract  - free FBs) 
(µg/kg) 
ND 221 182 
200 234 128 
1000 1037 639 
2000 855 1056 
5000 5830 2210 
 
 
 
Is possible to see that the LC-MS/MS is more sensitive than the ELISA kit, the ND (not 
detectable) sample for the ELISA test being contaminated. Moreover, our method allows to 
analyse also Fumonisin B2 and B3, while the reference value of the ELISA kit only regard 
FB1. Results emerging from this survey show the presence of hidden FBs also in the reference 
materials for the ELISA kit. 
The lack of detection of hidden Fumonisin by antibodies can be explained in several ways, 
further discussed in the next chapter. 
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3.7  Hidden Fumonisin: the non covalent hypothesis 
It is useful at this point to make some considerations, on the basis of the results obtained and 
of what is actually know from the literature.  
I)  Hidden Fumonisins were first isolated as N-derivatives at the ammino group of FBs, in 
heat treated foods. The derivatives are known, isolated, and generally less toxic (114,115). 
II) Hidden Fumonisins were also found in corn-flakes, after SDS extraction and basic 
hydrolysis, as HFBs derivatives. The use of SDS support the idea of protein bound derivatives 
of FBs. 
III) The reaction of Fumonisin B1 with protected lysine and glucose, after heating, was proved 
in vitro. 
From these experimental data the presence of TCA-derivatives is indirectly proved, as a 
consequence of the reaction of  TCA chains of FBs with food matrix components, especially 
with the protein fraction, in treated maize based foods. 
In this work, by application of the newly developed method, it was observed that: 
1) Hidden Fumonisins are present in maize based food as corn-flakes, bread substitutives and 
snacks, in agreement with the previous hypothesis. 
 2) Hidden Fumonisin are present in maize pasta. This does not agree with the previous 
hypothesis because the significantly lower temperature involved in pasta production, 
compared with other processes, was expected to induce a lower incidence of masking. Indeed 
our results show a hidden / free FBs ratio of the same order of magnitude as observed for high 
temperature treated foods. 
3) Hidden Fumonisins are present in raw maize. This fact seem to account for a reaction 
occuring at room temperature. However the hidden / free FBS ratio is significantly lower. 
4) Hidden Fumonisins seem to be present also in reference materials for ELISA kits. This 
means that antibodies can’t detect them. So, either the structures of FBs have been modified 
by endogenous enzymes in the plant or are masked by non-covalent inteactions with the 
matrix components. 
The hypothesis of heat-dependent Fumonisin masking seem not to be able to explain all the 
new experimental data. The presence of hidden FBs also in raw maize could require a 
mechanism active already at room temperaure. For this reason a non covalent binding 
mechanism is a better candidate than the covalent bond formation, to explain the presence of 
hidden Fumonisins. 
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Moreover, the significantly different ratios of hidden / free FBs in maize based products and 
in the raw cereals seem to be consistent with the new hypothesis. The non covalent 
mechanism of FB masking should occur already present in the plants and in the cereal, while 
the covalent modifications, occuring during the heating process, can explain the higher ratios 
hidden / free FBs found in products.  
In order  to explain this possibility we investigated the non covalent hypothesis in the raw 
cereal. Cereals are complex matrix where several compound, or classes of compounds, such 
as polysaccharides, proteins and lipids, are potentially candidates for a non covalent 
interaction with Fumonisin. 
In particular, the most used maize fraction for food production is the maize endosperm.  
Maize endosperm is composed almost totally of starch and proteins: on account of their 
chemical properties, we decided to preliminary test proteins in order to understand the 
masking mechanism of Fumonisins 
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3.8 Hidden Fumonisins: understanding the masking 
mechanism 
3.8.1  Association with maize protein 
Proteins were the best candidates to be studied to prove the “non-covalent binding” 
hypothesis, being easily separated on the basis of their solubility.   
The separation of cereal proteins on the base of their relative solubility in different solvents, 
the so called ‘Osborne fraction’, is made by consecutively extracting the sample with  
different solvents in order to separate selectively one protein class from others. 
Accordingly  four fractions were obtained as reported in the following table. 
 
 
Tab. 52 :Osborne fractions, and solvent mixture used in this work. 
 
 
On each fraction the presence of hidden Fumonisins was checked, by indirect evaluation; then 
also the solid residue of the extraction was analysed after hydrolysis. The residue of a maize 
sample, after the Osborne fraction extraction, still contains polysaccharides and lipids, which 
can also interact with FBs. 
The schematic procedure of sample preparation is reported in the next figure, while details are 
reported the Experimental Part. 
The presence of hidden Fumonisins in maize Osborne fraction are reported in following 
figures. 
 
 
 
 
Fraction Solvent 
globulins Bidistilled Water 
albumins NaCl  0.2 M 
prolammines Ethanol/Water  60:40 
glutelins Isopropanol/Water 50:50 + 2% DTT 
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Fig.  47: Schematic procedure for Osborne fractions extraction used in this work. 
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Fig.  48: Results of the survey on the Osborne fractions of maize sample A and the solid 
residues of the extractions. Graphical comparison of free FBs (FB1+FB2+FB3) and total 
FBs (calculated from HFB1+HFB2+HFB3 after fraction hydrolysis).  
 
Tab. 53: Results of the survey on Osborne fractions of maize sample A and the solid 
residues of the extraction. Concentration of free FBs (FB1+FB2+FB3) and total FBs 
(calculated from HFB1+HFB2+HFB3 after hydrolysis).  
 
fraction 
Free FBs 
(FB1+FB2+FB3) 
 (µg/kg) 
RSD % 
(2 replicates) 
 
FBs tot  
(HFB1+HFB2+HFB3) 
(µg/kg) 
RSD %) 
(2 replicates) 
globulins 14695 19 17923 8 
albumins 3604 3 4208 2 
prolammines 91 5 1119 3 
glutelins 45 9 288 6 
solid residue < LOD 0.00 < LOD N.D. 
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Tab. 54: Hidden Fumonisin evaluation on Osborne fractions of maize sample A and the 
solid residues of the extractions. 
 
fraction 
hidden FBs 
(FBs tot - free FBs) 
(µg/kg) 
hidden FBs /  free FBs 
globulins 3228 0.22 
albumins 604 0.17 
prolamines 1029 11.35 
glutelins 243 5.34 
solid residue N.D. 0 
 
 
 
 
 
Fig. 49: Results of the survey on Osborne fractions of maize sample B and the solid 
residues of the extraction . Graphic comparison of free FBs (FB1+FB2+FB3, blue bar) 
and total FBs (calculated from HFB1+HFB2+HFB3 after hydrolysis,  purple bar).  
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Tab. 49: Result of  the survey on Osborne fractions of maize sample B and the solid 
residues of the extractions. Concentration of free FBs (FB1+FB2+FB3) and total FBs 
(calculated from HFB1+HFB2+HFB3 after hydrolysis).  
 
fraction 
Free FBs 
(FB1+FB2+FB3) 
 (µg/kg) 
RSD % 
(2 replicates) 
 
FBs tot  
(HFB1+HFB2+HFB3) 
(µg/kg) 
RSD %) 
(2 replicates) 
globulins 18243 4 45338 1 
albumins 7281 6 17824 2 
prolammines 3422 4 11122 2 
glutelins 361 10 1959 3 
solid residue < LOD 0 6060 4 
 
 
 
 
Tab. 56: Hidden Fumonisin evaluaion on Osborne fractions of maize sample B and the 
solid residues of the extractions. 
 
fraction 
hidden FBs 
(FBs tot - free FBs) 
(µg/kg) 
hidden FBs /  free FBs 
globulins 27095 1.49 
albumins 10542 1.45 
prolammines 7699 2.25 
glutelins 1598 4.43 
solid residue 6060 0 
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Tab. 57: Mean hidden FBs / free FBs ratios  found in Osborne fractions of maize 
samples.  
 
sample 
mean found 
hidden/free FB 
between samples 
globulins 0.85 
albumins 0.81 
prolamines 6.80 
glutelins 4.88 
 
 
By considering the amounts found in the diffrent extractions, it appears that hidden Fumonisin 
seem to be distributed in all the Osborne fraction analysed; moreover hidden FBs seem still 
present in the final solid residue in one sample. 
Althought the amounts of hidden FBs are higher in globulins and albumins, the relative 
amounts of hidden to total FBs is higher in prolamines and glutelins.  
These classes are present almost exclusively in the endosperm being the maize storage 
proteins. The endosperm fraction of maize is used in the food industries and so prolamines 
and glutelins seem to be the protein classes more involved in  FB masking. 
The presence of hidden FBs in the raw cereal and in low temperature treated products can be 
explained as endogenous to the plant without involving the mechanism supported by heating 
dependent covalent reaction of Fumonisin TCA chains. The presence of  hidden FBs in the 
final solid residue can imply interactions with other matrix contituents.  
Zeins and in particular α-Zein, are group well known maize proteins, belonging to the 
prolamines class. The α-Zein protein is the most abundant protein, representing almost the  
60 % of the maize protein content. Several reasons suggested to use α-Zein as a model protein 
to investigate the hypothesis of Fumonisin non covalent masking mechanism. 
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3.8.2  The α-Zein model 
The α-Zein protein was chosen for several reasons. It’s the most abundant maize protein and 
seems to be involved, together with the glutelins, in the Fumonisin masking mechanism. 
Moreover, it is commercially available as standard and this is a not negligible fact, since the 
availability of a standard for the protein chosen as model can facilitate the study. 
The standard is sold with the claim ‘alcohol soluble mixture of two polypeptides’. The 
prolamines of cereal are soluble in aqueous alcohol, and the Osborne fraction is obtained by 
Ethanol/Water 60:40 mixture. This solvent mixture is similar to that used for free FB 
extraction, except for the type of alcohol, ethanol instead of methanol. Moreover from the 
previous data hidden form seem to be already present in the extract of free FBs. 
Free Fumonisins, hidden Fumonisins and maize prolamines seems to have the same solubility 
in  quite similar conditions. The α-Zein protein should be the best candidate also in the case of 
covalent reactions, being the most abundant protein in maize. 
The UPLC-MS method used for experiments with α-Zein was adapted from past works of the 
group on peptides (128). Briefly, the separation of α-Zein is performed on Acquity system 
(Waters Inc.) with a C18 column, using a gradient elution with water and acetonitrile both 
acidified  with 0.2% of formic acid.  
Detection was performed with a single quadrupole mass spectrometer operating in scan mode 
from 200 to 2000 m/z ratio. The α-Zein prolamine is a large and low polar storage protein of 
maize, thus it is expected to have high retention time. Moreover, the low polarity can create 
problems to the electrospray ionisation of analytes, decreasing the sensitivity of the method. 
The mass spectrometry detection of α-Zein was then optimised by trial and error method. 
Accurate protein mass measurement, sufficient for protein sequence identification, can’t be 
achieved on a quadrupole  instrument, due to the low resolution power of the instrument. 
Moreover, proteins usually produce multicharged profiles on ESI interfaces, so that the 
molecular weight must be deconvoluted by means of a software. 
However, a sufficient level of accuracy in protein identification can be achieved by measuring 
at least two attribute of the protein. The former, the average molecular mass of native α-Zein, 
was evaluated on the standard directly dissolved in methanol and injected in the UPLC. 
The chromatograms of the α-Zein standard are reported in the following figures. The α-Zein 
peak seems to be composed by different peaks, not totally resolved. However more then two 
polypeptides, as reported from the seller, seem to be present. It must be said that probably the 
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seller refers to the presence of 2 polypeptides in SDS-PAGE, where conditions are totally 
different. Moreover the purity of the standard is not declared.  
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Fig. 50: Zoom of the α-Zein peak in the UPLC-MS chromatogram of a 500 ppm Zein 
standard in MeOH, 5 µl injection. MS scan (TIC) of  the  200-2000 m/z range . 
 
 
The mass spectra corresponding to  the different parts of the α-Zein chromatographic peak 
were separately analyzed. In this way it was possible to evaluate the different isoforms 
present in the standard, and their masses can be compared with those reported in the literature. 
 
 
α-Zein peak 
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Fig. 51: Zoom of the α-Zein peak in the UPLC-MS chromatogram of a 500 ppm Zein 
standard in MeOH, 5 µl injection. Peak division in time period (1-5); the red trait show 
the zone chosen for mass spectrum analysis.  
 
Analysis of the mass spectra in the different part of the α-Zein peak is reported in the 
following figures, the observed molecular masses are reported in Tab. 38. 
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Zone 1 
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Fig. 52: Mass spectrum analysis of  Zone 1 of the α-Zein peak. A: multicharged spectra, 
B: deconvoluted spectra of  Zone 1, showing one predominant mass. 
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Zone 2 
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Fig. 53: Mass spectrum analysis of Zone 2 of the α-Zein peak. A: multicharged spectra, 
 B: deconvoluted spectra of  Zone 2, showing one predominant mass. 
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Zone 3 
UPLC
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Fig.  54: Mass spectrum analysis of Zone 3 of the α-Zein peak. A: multicharged spectra,  
B: deconvoluted spectra of  Zone 3, showing one predominant mass 
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Zone 4 
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%
0
100
zeina controllo 3  4088 (75.241) Sm (SG, 10x1.00); Sb (1,40.00 ); M1 [Ev-135676,It14] (Gs,0.750,200:2000,1.00,L33,R33); Cm (4080:4133) Scan ES+ 
1.80e623141.0
22288.0
21105.020650.0 22150.0 22888.0
29454.0
24880.023516.0 24195.0
26030.0 28396.0
27005.026721.0 27470.0 28804.0
29750.0
 
 
Fig. 55: Mass spectrum analysis of zone 4 of the α-Zein peak. A: multicharged spectra,  
B: deconvoluted spectra of  Zone 4, showing one predominant mass. 
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Zone 5 
UPLC
m/z
200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900
%
0
100
zeina controllo 3  4299 (79.127) Mk [Ev-125428,It9] (Gs,0.750,200:2000,1.00,L33,R33); Cm (4290:4332-(4100:4244+4365:4472)) Scan ES+ 
2.97e4978.3
304.4
327.1
964.3
949.5
875.5
848.7428.5
436.0 701.6501.9 809.8
749.1
1064.3
982.3
1168.1
1074.3
1358.1
1226.2
1443.0
1510.0 1634.8
1610.4 1642.4
1648.9 1886.3
 
 
UPLC
mass
20000 20500 21000 21500 22000 22500 23000 23500 24000 24500 25000 25500 26000 26500 27000 27500 28000 28500 29000 29500
%
0
100
zeina controllo 3  4299 (79.127) Sm (SG, 10x1.00); Sb (1,40.00 ); M1 [Ev-125428,It9] (Gs,0.750,200:2000,1.00,L33,R33); Cm (4290:4332-(4100:4244+4365:447 Scan ES+ 
3.79e424509.0
24432.0
24084.0
20866.0
20680.0
20315.0
23072.022213.0
21894.0
21503.0
22414.0
24022.0
23391.0
28457.025762.0
25518.0
25411.0
25040.0
26896.0
25955.0
26131.0
26181.0
28175.0
27975.0
29293.0
28884.0
29618.0
29736.0
 
 
Fig. 56: Mass spectrum analysis of zone 5 of α-Zein peak. A: multicharged spectra,  
B: deconvoluted spectra of  Zone 5, showing 3 predominant mass. 
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Tab.  58: Observed molecular masses on the different zone of α-Zein peak. 
 
 
 
Although the masses obtained in this way were not accurate, it was possible to compare them 
with the masses of the α-Zein isoforms present in the literature, in partiuclar those reported by 
the work by Adams et al. (2004) on MALDI-TOF mass measurement of α-Zein . 
 
 
Tab. 59: Observed Zein molecular masses in the cited paper by Adams et al. (2004). 
Dotted red box shows the masses which are in agreement with those observed in the 
Fluka α-Zein  standard. 
 
 
 
 
 
α-Zein peak Observed molecular masses 
zone 1 23360 Da 
zone 2 23358 Da 
zone 3 23358 Da 
zone 4 23141 Da 
zone 5 24084, 24432, 24509 Da 
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Comparison of α-Zein masses, by different sources,  is reported in the following table. 
 
Tab.  60: Comparison of α-Zein molecular masses. 
 
The identified protein sequences were retrieved from Expasy data bank, which have been 
deduced from the corresponding coding DNA. The signal peptide, a sort of  tag able to ‘drive’ 
the protein in cellular location where it is needed, present in the databank sequences, was 
removed  from the retrieved sequences. by SignalP (SwissProt) analysis, a software which 
calculates the probability of cleavage for the signal peptide present in the polipeptidic chain. 
In fact, the α-Zein standard, as well as that extracted from maize and products, is the mature 
form of the protein, lacking then of the signal peptide 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  57 : Retrieved sequences of mature α-Zein (without the signal peptide) . 
 
 
 
 
MALDI-TOF 
masses 
(from Adams) 
Observed 
molecular masses 
(α-Zein standard) 
Calculated 
From genomic 
sequence 
GenBank accession 
number 
23318  Da 23358-23360 Da 23359 Da AF371269 
24069 Da 24084 Da 24087 Da AF371271 
24515 Da 24509 Da 24706 Da AF371268 
GenBank accession number: AF371269 
TIFPQCSQAPIASLLPPYLSPAVSSVCENPILQPYRIQQAIAAGILPLSPLFLQQSSALLQQLPLVHLL
AQNIRAQQLQQLVLANLAAYSQQQQFLPFNQLAALNSASYLQQQQLPFSQLSAAYPQQFLPFNQ
LTALNSPAYLQQQQLLPFSQLAGVSPATFLTQPQLLPFYQHAAPNAGTLLQLQQLLPFNQLALTN
PTAFYQQPIIGGALF 
 
GenBank accession number: AF371271 
TIFPQCSQAPIASLLPPYLPSIIASICENPALQPYRLQQAIAASNIPLSPLLFQQSPALSLVQSLVQTIR
AQQLQQLVLPLINQVALANLSPYSQQQQFLPFNQLSTLNPAAYLQQQLLPFSQLATAYSQQQQLL
PFNQLAALNPAAYLQQQILLPFSQLAAANRASFLTQQQLLPFYQQFAANPATLLQLQQLLPFVQL
ALTDPAASYQQHIIGGALF 
 
GenBank accession number: AF371268 
TIIPQCSQQYLSPVTAARFEYPTIQSYRLQEAIAASILRSLALTVQQPYALLQQPSLMNLYLQRIAA
QQLQQQLLPIINQVVAANLAAYLQQQQFLPFNQLAGVNPAAYLQAQQLLPFNQLVRSPAAFLLQ
QQLLPFHLQVVANIAAFLQQQQQLLPFYPQVVGNINAFLQQQQLLPFYPQDVANNVAFLQQQQL
LPFNQLALTNPTTLLQQPTIGGAIF 
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The poor accuracy of the mass measured by quadrupole did not allow to be sure that the 
sequences retrieved on Expasy correspond strictly to the masses observes in the α-Zein 
standard. A sufficient level of certainty can be achieved by finding other matching properties 
between sequences and standard. It was thought then to compare the peptides derived from a 
chymotryptic digestion of the standard with those obtained by the software simulated 
chymotryptic digestion of the retrieved sequences of α-Zein. 
 
 
 
Fig. 58: Process used for confirming the α-Zein sequences. 
 
 
The simulated digestion was performed by BioLynx (Waters Inc.). This software needs as 
inputs the sequences, the proteases, and some parameters concerning the ionisation process of 
the peptides, and the action of the enzyme. Conditions used for simulated digestion are 
reported in the Experimental Part. 
 
 
 
 
MATCHING ?
Expasy sequences of α-Zein α-Zein standard
chymotryptic digestion simulated chymotryptic 
digestion 
theoretical  
chymotryptic peptides chymotryptic peptides 
yes
no
Sequences confirmed
Sequences not confirmed
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An example of the software output, for a α-Zein sequence,  is reported in the following table. 
The software provide the masses of each potential peptides released from chymotrypsin action 
on the given sequence. It is also possible to choose the number of missed cleavage sites, and 
the charge status of the released peptides. All the sequences have been virtually digested with 
the BioLynx (Waters Inc.) software. 
 
Tab. 61: BioLynx (Waters Inc.) software output for the  AF371269 sequence. Simulated 
chymotryptic digestion with one missed cleavage site. Columns on the right represent 
the masses for different charge status of the released peptides. 
Untitled   
Chymotrypsin:/Y-\P /F-\P /W-\P   
Frag# Res# Sequence Theor(Bo) [M+H] [M+2H] [M+3H] [M+4H] [M+5H]
Y1 1-18 1945.00 1946.01 973.51 649.34 487.26 390.01(-)TIFPQCSQAPIASLLPP
Y(L)
Y2 19-35 1815.91 1816.92 908.96 606.31 454.98 364.19(Y)LSPAVSSVCENPILQPY
(R)
Y3 36-52 1807.07 1808.08 904.54 603.37 452.78 362.42(Y)RIQQAIAAGILPLSPLF
(L)
Y4 53-89 4109.83 4110.84 2055.92 1370.95 1028.47 822.97(F)LQQSSALLQQLPLVHLL
AQNIRAQQLQQLVLANLAAY
(S)
Y5 90-95 764.35 765.35 383.18 255.79 192.09 153.88(Y)SQQQQF(L)
Y6 96-98 375.22 376.22 188.62 126.08 94.81 76.05(F)LPF(N)
Y7 99-109 1150.56 1151.57 576.29 384.53 288.65 231.12(F)NQLAALNSASY(L)
Y8 110-117 1000.53 1001.54 501.27 334.52 251.14 201.11(Y)LQQQQLPF(S)
Y9 118-128 1238.59 1239.60 620.30 413.87 310.66 248.73(F)SQLSAAYPQQF(L)
Y10 129-131 375.22 376.22 188.62 126.08 94.81 76.05(F)LPF(N)
Y11 132-142 1190.59 1191.60 596.30 397.87 298.66 239.13(F)NQLTALNSPAY(L)
Y12 143-151 1113.62 1114.63 557.82 372.21 279.41 223.73(Y)LQQQQLLPF(S)
Y13 152-162 1076.55 1077.56 539.28 359.86 270.15 216.32(F)SQLAGVSPATF(L)
Y14 163-171 1055.60 1056.61 528.81 352.88 264.91 212.13(F)LTQPQLLPF(Y)
Y15 172-172 181.07 182.08 91.54 61.37 46.28 37.22(F)Y(Q)
Y16 173-191 2060.38 2061.39 1031.20 687.80 516.10 413.08(Y)QHAAPNAGTLLQLQQLL
PF(N)
Y17 192-202 1188.61 1189.62 595.31 397.21 298.16 238.73(F)NQLALTNPTAF(Y)
Y18 203-203 181.07 182.08 91.54 61.37 46.28 37.22(F)Y(Q)
Y19 204-213 1042.58 1043.59 522.30 348.53 261.65 209.52(Y)QQPIIGGALF(-)
Y1-2 1-35 3745.38 3746.38 1873.70 1249.47 937.35 750.08(-)TIFPQCSQAPIASLLPP
YLSPAVSSVCENPILQPY(R)
Y2-3 19-52 3607.28 3608.28 1804.65 1203.43 902.83 722.46(Y)LSPAVSSVCENPILQPY
RIQQAIAAGILPLSPLF(L)
Y3-4 36-89 5900.01 5901.02 2951.01 1967.68 1476.01 1181.01(Y)RIQQAIAAGILPLSPLF
LQQSSALLQQLPLVHLLAQN
IRAQQLQQLVLANLAAY(S)
Y4-5 53-95 4856.61 4857.62 2429.31 1619.88 1215.16 972.33(F)LQQSSALLQQLPLVHLL
AQNIRAQQLQQLVLANLAAY
SQQQQF(L)
Y5-6 90-98 1121.55 1122.56 561.78 374.86 281.40 225.32(Y)SQQQQFLPF(N)
Y6-7 96-109 1507.77 1508.77 754.89 503.60 377.95 302.56(F)LPFNQLAALNSASY(L)  
 
The α-Zein standard was digest by chymotrypsin (from Sigma), using the protocol provided 
with the enzymes, reported in the Experimental Part. The digestion products were analysed by 
the UPLC-MS method, previously used for the native α-Zein standard.  
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UPLC
Time
10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00 80.00 85.00
%
0
100
10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00 80.00 85.00
%
0
100
zeina controllo 3 Scan ES+ 
TIC
1.01e974.21
73.35
71.76
71.56
46.18
13.4610.10 20.52 42.1840.7125.91 33.52
71.05
74.58
76.01
79.13
79.77
83.60
zeina dig 7 Scan ES+ 
TIC
1.01e9
27.11
25.48
19.6117.27
12.269.48
32.43
74.4532.78
73.2538.19
75.94
78.33
 
UPLC
Time
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00
%
0
100
zeina controllo 3 Scan ES+ 
TIC
3.07e991.79
91.75
91.40
90.82
74.21
71.76
1.99 46.18
75.24 90.32
90.1079.13
92.64
94.53
95.35
 
Fig. 59: UPLC-MS chromatograms of the α-Zein standard digestion. A: α-Zein peak  
zoom in the control experiment, B: α-Zein peak  disappearing in the digestion 
experiment, C: Overlaid chromatograms. 
 
In the following figures the UPLC-MS chromatograms of α-Zein standard digested by 
chymotrypsin are reported. It is possible to see that after the protease treatment the α-Zein 
peaks disappear, while several peaks, reasonably released from Zein digestion, appear at a 
lower retention time. The peaks were then checked for matching with the masses found by the 
virtually digestion.  Example of the process used for peak matching is reported in the next 
figures. An enlarged portion of the chromatogram is reported in the following figure. 
α-Zein peak control 
released chymotryptic  peptides
A  
B  
C  
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UPLC
Time
18.00 19.00 20.00 21.00 22.00 23.00 24.00 25.00 26.00 27.00
%
0
100
zeina dig 7 Scan ES+ 
TIC
6.98e827.11
25.4823.78
19.61
19.3317.43
18.11 18.35
19.70
22.29
20.23
21.15
20.51 21.94
23.58
22.92
25.03
24.63
24.15
26.6926.54
25.77
27.37
27.69
 
 
Fig. 60: UPLC-MS chromatogram of the α-Zein standard digestion. Zoom on peptide 
peaks. Selection of the peak at a retention time 23.78 min. 
 
The mass spectrum, of the selected peak at 23.78 min shows that the molecular ion of the 
unknown peptide is the 1122.6 m/z ion, while the 562.0 m/z is its doubly charged ion. 
UPLC
m/z
250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100 1150 1200 1250
%
0
100
zeina dig 7  1292 (23.783) Sm (SG, 2x1.00); Cm (1280:1299) Scan ES+ 
1.71e6562.0
263.1
387.7
382.7264.0
274.1 374.9
393.6 533.4
458.6
401.3 473.3
860.5
581.0
747.4
681.7595.9 806.6
861.5
1122.6
 
 
Fig. 61: Mass spectrum of the selected peak at the retention time 23.78 min, showing  
the molecular ion, m/z 1122.6, and its doubly charged ion 562.0 m/z.  
 
 
(M+H)+ 
(M+2H)+/2 
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A more detailed analysis of the spectrum shows also that the peptide is fragmented in the ion 
source, producing the two fragments at 860.5 and 263 m/z. These values can be used now as 
input for a BioLynx research in the given protein sequences, in order to check the presence of 
the same peptides. Results for these two values are reported in the next table.  
 
Tab. 62: BioLynx (Waters Inc.) software output for searching of 1122.6 m/z ion (M+H)+, 
and 562.0 m/z  (M+2H)+/2 among the AF371269 sequence.  
Untitled   
Mass 1 of 2: 1121.98
Mass tolerance: 1.00
Number of hits = 2
Hit# Res# Mass Sequence C-Term Total Mass Dev S-S
1 90-98 1121.55 (Y)SQQQQFLPF(N) -OH 1121.55 -0.43 -
2 17-27 1121.54 (P)PYLSPAVSSVC(E) -OH 1121.54 -0.44 -
 
 
The peptide with  mw 1122.6 Da is present in the given protein sequence. The matching is 
then made by checking its presence also in the list of virtual peptides. From the list for 
AF371269 sequence, pag. 84, is possible to see that peptide #1 is present in the list as 
fragment ‘y 5-6’, while the second peptides is not present. 
Confirmation of matching for peptide #1 comes from the peptide sequence and the mass 
spectrum. 
 
Tab. 63:  Proposed assignment for spectrum of the selected peak at retention time 23.78 
min. 
 
 
 
 
 
 
 
 
 
 
 
m/z Ion: sequences 
1122.6  (M  + H)+:  (Y)SQQQQFLPF(N) 
860.5 (M - PF + H)+ :  SQQQQFL 
562.0 (M  + 2H)+/2:  SQQQQFLPF 
263.1 (M  + H)+ :  PF 
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From the matching it is possible to consider the peptides present in the sequence, and in the α-
Zein standard. All the peaks released from the α-Zein standard digestion have been matched 
by the reported procedure. Several examples of the peptides identified after α-Zein standard 
digestion are reported in the following figures. 
 
UPLC
m/z
200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000
%
0
100
zeina dig 7  808 (14.875) Sm (SG, 2x0.75); Cm (806:809) Scan ES+ 
1.73e6501.4
263.0
232.9
347.2
342.5264.0
382.8
386.8
424.5498.1
739.5
573.3
520.4
687.3
660.5
627.0
791.2
983.8887.2808.5 844.7
826.9
918.5 1002.1
 
 
Fig. 62: Mass spectrum of the peak selected at retention time 14.90 min, showing the 
molecular ion, m/z 1002.1, and its doubly charged ion 501.4 m/z. 
 
 
 
Tab. 64:  Proposed assignment for spectrum of the selected peak at retention time 14.90 
min. 
 
 
 
 
 
 
 
 
 
m/z Ion: sequences 
1002.1  (M  + H)+:  LQQQQLPF 
739.5 (M - PF + H)+ :   LQQQQL 
501.4 (M  + 2H)+/2:  LQQQQLPF 
263.0 (M  + H)+ :  PF 
(M+H)+ 
(M+2H)+/2 
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UPLC
m/z
200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100
%
0
100
zeina dig 7  1211 (22.293) Sm (SG, 1x1.00); Cm (1208:1216) Scan ES+ 
8.44e5544.9
263.1
200.1
226.1
376.3
264.1
279.0 371.0
382.7
385.6
391.0 442.5
489.9
545.4
826.6
563.9
695.8667.0573.8
632.0
770.0716.8
827.6
909.2835.1
1088.3960.8
1044.3972.3
 
 
Fig. 63: Mass spectrum of the selected peak at retention time 22.29 min, showing the 
molecular ion, m/z 1088.3, and its doubly charged ion 544.9 m/z.  
 
 
 
Tab.  65:  Proposed assignment for spectrum of the selected peak at retention time 22.29 
min. 
 
 
 
 
 
 
 
 
 
 
m/z Ion: sequences 
1088.3  (M  + H)+:  SQQQQLLPF 
826.6 (M - PF + H)+ :  SQQQQLL 
544.9 (M  + 2H)+/2:  SQQQQLLPF 
263.1 (M  + H)+ :  PF 
(M+H)+ 
(M+2H)+/2 
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UPLC
m/z
200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100
%
0
100
zeina dig 7  1338 (24.629) Sm (SG, 1x1.00); Cm (1334:1341) Scan ES+ 
1.19e6557.9
385.0263.1
200.1
228.0 264.0 380.8
376.2
284.1 356.8
391.1
454.8
398.7 494.8
510.6
852.6682.7577.1
622.8 780.9701.6 827.4 853.7 981.0885.5 1023.5 1064.4
 
 
Fig. 64: Mass spectrum of the selected peak at retention time 24.63 min, showing the 
molecular ion, m/z 1114.9, and its doubly charged ion 557.9 m/z.  
 
 
Tab. 66:  Proposed assignment for spectrum of the selected peak at retention time 24.63 
min. 
 
 
 
 
 
 
 
Results of the α-Zein peptide matching are reported in the following tables. Ten peptides were 
identified for both AF371269 and AF371271, thus confirming  the sequence of the protein 
standard. From this first screening, only one peptide was found to match with the AF371268 
sequence, which seem to have a low correspondence with the sequence. 
 
 
m/z Ion: sequences 
1114.9  (M  + H)+:  LQQQQLLPF 
852.6 (M - PF + H)+ :  LQQQQLL 
557.9 (M  + 2H)+/2:  SQQQQLLPF 
263.1 (M  + H)+ :  PF 
(M+2H)+/2 
(M+H)+ 
1115.02 
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Tab. 67: α-Zein peptides identified after chymotryptic digestion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tab. 68: α-Zein sequences found for the protein standard, and matched peptides found 
after chymotryptic digestion (bold, italic) 
 
Once that the sequences have been proved, a rapid analysis of their primary structures show s 
that lysine residues are totally absent in α-Zein. Thus these result do not account for covalent 
eaction at least at the level of the carballylic esters, and more in favour of the non covalent 
hypothesis previously discussed. 
peptide  
retention time 
(min.) 
 
peptide sequence 
 
 
(M+H)+ 
(Da) 
α-Zein sequence 
14.90 (Y)LQQQQLPF(S) 1001.54 AF371269 
22.29 (Y)SQQQQLLPF(N) 1088.38 AF371271 
23.78 (Y)SQQQQFLPF(N) 1122.55 AF371269, AF371271 
24.63 (Y)LQQQQLLPF(S) 1114.63 AF371269 
25.03 (Y)QQPIIGGALF(-) 1043.64 AF371269 
25.46 (F)LTQQQLLPF(Y) 1087.75 AF371271 
27.13 (F)YQQPIIGGALF(-) 1206.78 AF371269 
28.07 (F)LTQPQLLPF(Y) 1056.61 AF371269 
29.39 (Y)LQQQLLPF(S) 986.57 AF371271 
31.00 (F)LLQQQLLPF(H) (Y)LQQQILLPF(S) 
1099.55 
(isobars) 
AF371268, 
AF371271 
GenBank accession number: AF371269 
TIFPQCSQAPIASLLPPYLSPAVSSVCENPILQPYRIQQAIAAGILPLSPLFLQQSSALLQQLPL 
VHLLAQNIRAQQLQQLVLANLAAYSQQQQFLPFNQLAALNSASYLQQQQLPFSQLSAAYP 
QQFLPFNQLTALNSPAYLQQQQLLPFSQLAGVSPATFLTQPQLLPFYQHAAPNAGTLLQLQ 
QLLPFNQLALTNPTAFYQQPIIGGALF 
 
GenBank accession number: AF371271 
 TIFPQCSQAPIASLLPPYLPSIIASICENPALQPYRLQQAIAASNIPLSPLLFQQSPALSLVQSLV 
QTIRAQQLQQLVLPLINQVALANLSPYSQQQQFLPFNQLSTLNPAAYLQQQLLPFSQLATA 
YSQQQQLLPFNQLAALNPAAYLQQQILLPFSQLAAANRASFLTQQQLLPFYQQFAANPATL 
LQLQQLLPFVQLALTDPAASYQQHIIGGALF 
 
GenBank accession number:  AF371268 
TIIPQCSQQYLSPVTAARFEYPTIQSYRLQEAIAASILRSLALTVQQPYALLQQPSLMNLYLQ 
RIAAQQLQQQLLPIINQVVAANLAAYLQQQQFLPFNQLAGVNPAAYLQAQQLLPFNQLVR 
SPAAFLLQQQLLPFHLQVVANIAAFLQQQQQLLPFYPQVVGNINAFLQQQQLLPFYPQDVA 
NNVAFLQQQQLLPFNQLALTNPTTLLQQPTIGGAIF 
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3.8.3  In vitro reaction between α-Zein and Fumonisin B1 
In order to get further information about the Fumonisin potential reactivity with maize 
prolamines, an in vitro reaction was performed in order to investigate the presence of 
potential covalent adducts. The in vitro reaction was performed by heating FB1 and the α-Zein 
standard (5:1 molar ratio), simulating the conditions of high temperature processed products 
(about 150 °C). The procedure is reported in the Experimental Part. Afterwards, the reaction 
mixture was suspended in methanol, followed by centrifugation and analysis by the UPLC-
MS system. The same reaction was performed also for α-Zein (control solution), in order to 
check which modification may occur in the protein upon heating.  
 
 
 
Fig.  65: Schematic procedure of  the experiment for covalent reaction evaluation 
between Fumonisin B1 and α-Zein after heating. 
 
In the next figures the results of UPLC-MS analysis of the reaction are reported. Significant  
differences are observed between α-Zein heated alone, or in presence of Fumonisin B1, which 
seems to be present, unchanged, after heating.  
α-Zein (control) 
(B) 
drying under nitrogen flow
 
150 °C / 1 hour 
 
resuspension / centrifuge 
UPLC-MS analysis
α-Zein + FB1
(A) 
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UPLC
Time
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00
%
0
100
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00
%
0
100
bianco zeina Scan ES+ 
TIC
5.80e989.18
78.7076.22
1.88
91.61
94.53
reaz4 Scan ES+ 
TIC
4.69e989.17
78.64
1.84
91.58
94.52
 
 
Fig. 66: UPLC-MS chromatogram of the in vitro reaction between Fumonisin B1 and the 
Zein standard at 150 °C for 1 hour: (A) reaction mixture;(B) α-Zein standard alone .  
MS scan (TIC) in the 200-2000 m/z range. 
 
UPLC
Time
30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00 80.00 85.00
%
0
100
30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00 80.00 85.00
%
0
100
bianco zeina Scan ES+ 
TIC
5.80e9
78.7076.22 80.03
reaz4 Scan ES+ 
TIC
2.80e9
78.6477.15
64.3135.75
79.90 83.12 86.81
 
 
Fig. 67: UPLC-MS chromatogram of  the in vitro reaction between Fumonisin B1 and 
the Zein standard at 150 °C for 1 hour: (A) reaction mixture; (B) α-Zein standard alone.  
 
 
α-Zein peak 
α-Zein peak 
B 
A 
FB1  peak α-Zein  peak 
B 
A 
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UPLC
Time
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00
%
0
100
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00
%
0
100
reaz4 Sm (SG, 1x1) Scan ES+ 
722
2.90e735.75
34.97
91.38
90.99 92.54
reaz4 Sm (SG, 1x1) Scan ES+ 
TIC
4.63e989.17
78.79
1.84
91.58
92.22
 
 
Fig. 68: UPLC-MS chromatograms of in vitro reaction between Fumonisin B1 and Zein 
standard at 150 °C for 1 hour. Scan, Total Ion Current (A), extracted ion 722 m/z of FB1 
(B).  
 
The lack of significant differences on the UPLC-MS profiles of the protein suggest that no 
reaction between FB1 and α-Zein took place under the tested conditions. Thus this result 
supports thus the non covalent hypothesis.  
 
 
Fig. 69: Schematic procedure of the second experiment for covalent reaction evaluation 
between Fumonisin B1 and α-Zein after heating. 
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The same experiment was repeated, focusing the analysis on FB1. For this purpose, the 
solution containing FB1 and  α-Zein and the control solution (FB1) were analysed by LC-
MS/MS after heating. 
In the next figures the results of  HPLC-MS-MS analysis of FB1 heated alone and in presence 
of α-Zein are reported. All the experiments were performed on the same amount of  FB1. 
In lane 1 it is possible to see the FB1  peak in the control experiment (room temperature). In  
lane 2 the chromatogram obtained for the same amount of FB1 heated alone at 150 °C: the 
absence of any peak seems to suggest that the toxin has been destroyed during heating. In lane 
3, FB1 was heated in presence of α-Zein with a molar ratio of 5:1; the absence of peak could 
suggest that a reaction took place or that the toxin was destroyed as before. In lane 4 the 
chromatogram obtained for the FB1 heated in presence of α-Zein with a molar ratio of 1:2 is 
reported. Surprisingly FB1 is still present, as proved by its peak.  
 
 
 
Fig. 70: HPLC-MS-MS, MRM, TIC, chromatogram of the in vitro reaction between 
Fumonisin B1 and the Zein standard. (1) Fumonisin B1  control at room temp. for 1 hour, 
(2) Fumonisin B1  heated alone at 150 °C for 90 min; (3) Fumonisin B1 heated with α-
Zein (5:1 molar ratio) at 150 °C for 90 min; (4) Fumonisin B1 heated with α-Zein (1:2 
molar ratio) at 150 °C for 90 min.   
 
The experiment was repeated ones more time, using also an α-Zein digested sample and lower 
reaction time (60 min.). Results are reported in the next figure. In lane 1 it is possible to see 
the FB1  peak in the control experiment, heated alone at 150 °C for 60 min: the lower duration 
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of treatment didn’t induce the complete destruction of the toxin. In lane 2 the chromatogram 
obtained for the same amount of FB1 heated at 150 °C for 60 min., in the presence of α-Zein 
with a molar ratio of 5:1 is reported; The higher FB1 peak area seems to suggest lower 
thermal degradation, as if the protein would protect the toxin from degradation. 
In lane 3, FB1 was heated in presence of α-Zein with a molar ratio of 1:2, and ones more it is 
possible to see the great increase of FB1 peak, suggesting that the toxin is much less 
destroyed with a protein excess. In lane 4 FB1 was heated in the presence of α-Zein 
chymotryptic digestion product, assuming a molar ratio of 1:2 of toxin with the native protein. 
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Fig. 71: HPLC-MS-MS, MRM, TIC, chromatograms of the replicate reactions between 
Fumonisin B1 and the Zein standard. (1) FB1  heated alone at 150 °C for 60 min; (2) FB1 
heated with α-Zein (5:1 molar ratio) at 150 °C for 60 min; (3) FB1 heated with α-Zein 
(5:1 molar ratio) at 150 °C for 60 min ; (4) Fumonisin B1 heated with chymotryptic 
digested α-Zein (1:2 molar ratio) at 150 °C for 60 min. 
 
The replicate seem is in agreement with the previous one, pointing to the new hypothesis for 
Fumonisin masking. These experiments showed that no significant differences, in the UPLC-
MS profile of the protein, exist between the α-Zein standard heated at 150 °C alone, or in 
presence of a molar excess of FB1. On the other side, FB1 is destroyed when heated alone at 
150 °C,  whereas when the same amount is heated in the presence of a molar excess of 
protein, it seems to be protected. These results confirm the hypothesis that FB1 can interact 
4 
3 
2 
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non-covalently with α-Zein, forming aggregates that prevent the thermal degradation of the 
toxin. 
 
3.8.4 Preliminary evidence for an inclusion-like mechanism of FB1 
masking 
The next step was to find new evidence for substantiating the new hypothesis of  FB1/α-Zein 
non covalent interaction previously proposed. We thought that, if the new hypothesis is 
correct, a treatment able to release hidden FBs, without hydrolyzing them must exist. 
Prolamines extract from highly contaminated maize sample was obtained, and 4 experiments 
were carried out, as reported in the Experimental Part, with the aim of to investigate which  
treatment would be able to release the protein bound Fumonisin.  
Thus, we investigated the hydrolysis method, the chymotryptic digestion, and urea treatment. 
It must be noted that only basic hydrolysis can cleave potential covalent bonds between 
tricarballylic chains of Fumonisins and proteins, whereas the other methods can either cleave 
the protein itself or disrupt secondary and tertiary protein structures, thus releasing the toxin. 
In the next figure, the  MRM chromatograms of the 4 experiments, made on 4 equal aliquots 
of maize are reported.  
In lane 1 the prolamine  fraction was analysed to check the presence of free FBs, which 
resulted absent or under the limit of detection. 
 In lane 2 it can be seen that after basic hydrolysis of the prolamine fraction, hydrolysed FB1 
is released. This result is consistent with the first report of hidden FBs in corn-flakes, of Kim 
et al. (2003). Lane 3 represents the urea treatment, and as it can be seen nothing is released in 
appreciable amount. Lane 4, representing chymotryptic digestion, surprisingly shows the FB1 
peak. Releasing of the whole toxin after enzymatic digestion of the protein could became very 
important for several reasons.  
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Fig. 72: Schematic procedure of the second experiment for covalent reaction evaluation 
between Fumonisin B1 and α-Zein after heating. 
 
 
 
Fig. 73 : HPLC-MS-MS, MRM, TIC, chromatograms of the experiments made on the 
prolamine fraction aliquots (PFA), extracted from a highly contaminated maize sample. 
Lane 1: analysis of free FBs in PFA; Lane 2: basic hydrolysis of PFA; Lane 3: urea 
denaturation of PFA; Lane 4: chymotryptic digestion of PFA. 
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If these results will be confirmed, the hypothesis of covalent binding of proteins with 
Fumonisin should be dismissed, leading to account for a more probable non-covalent 
interaction which is quite strong, since a denaturation with urea is not enough to loose the 
complex and release the toxin. On the other side, if  in vitro enzymatic digestion is able to 
release Fumonisin from the food matrix, it is probable that also durig human or animal 
digestion, unknown amount of toxins may be released in the gastro-intestinal tract. Moreover, 
a method able to analyse the real Fumonisin amount in maize and related products is urgently 
required. In order to explore the possible non covalent association, an ESI-MS titration 
experiment was performed. Three solutions of Fumonisins B1 and α-Zein, at different molar 
ratios in methanol, were infused in the mass spectrometer and the FB1 molecular ion (M+H)+  
monitored. In the following figures the results for the ESI-MS titration experiments are 
reported.  
 
Tab.  69: Molar ratios of three FB1-zein mixtures in methanol,  
used in ESI-MS titration experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
FB1- zein molar ratio FB1 / Zein experiments 
FB1  10 µM –  α-Zein 5 µM 2 A 
          FB1  5 µM –  α-Zein 5 µM 1 B 
FB1  5 µM –  α-Zein 10 µM 0.5 C 
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3.40e5
1359.7722.1 1317.21094.7934.3781.7 896.1 992.7 1125.0 1438.1 1487.3 1602.1 1704.1
FB1 COMPLEX PROVA 3  26 (0.481) Sm (SG, 1x1.00); Cm (4:26) Scan ES+ 
1.91e6
1188.51134.61039.0964.5915.7787.8766.0 1317.6
1362.2 1480.0 1577.41612.5 1704.8 1815.7
 
 
Fig. 74: ESI-MS  infusion of three FB1-Zein mixtures in methanol, at different molar 
ratios. A:2 (10:5), B:1 (5:5), C:0.5 (5:10) (µM/µM). 
 
As shown, the intensities of the FB1 molecular ion (M+H)+ are strongly influenced by the 
presence of α-Zein in solution. This strong effect of ion suppression could be explained in two 
ways. The former is the general explanation given for ion supression phenomenon, based on 
the competition for the protons of the analytes. The latter explanation involves the formation 
of non covalent interactions between FB1 and Zein in solution. The variation of the FB1 
response seems to be strictly dependent upon the molar ratios of the two compounds (protein 
and toxin), with a linear or quadratic trend (see the Experimental Part). A small variation of the 
Zein concentration produces a large decrease of FB1 ion count, as show in Fig. 74-76. This 
suggest that different mechanisms might contribute to the decrease, of the FB1 response in 
solution, and not only competition for the protons. 
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Fig. 75: ESI-MS  infusion of three FB1- α-Zein mixtures in methanol at different molar 
ratios. A:2 (10:5), B:1 (5:5), C:0.5 (5:10) µM/µM. Zoom on FB1 molecular ion (722.3 
m/z). 
 
 
Fig. 76: Ion counts of FB1 molecular ion (722.3 m/z) is the ESI-MS  titration 
experiments. 
 
Maize prolamines were found to be the Osborne fraction more active in Fumonisin masking.  
However also other classes of compounds, such as glutelins or starch, could be involved in 
the masking.  
 < LOD 
63100
245000 
0
50000
100000
150000
200000
250000
300000
0.5 1 2 
FB1 / zein molar ratio
FB1  
ion count 
C
B
A
? 
 128
Thus, from these experiments, we were not able to find any modifications of the protein, 
whereas the mycotoxin appearsto be strongly affected by the presence of the protein. Infact, 
heating Fumonisin B1 in the presence of α-Zein standard, no significant changes in the UPLC-
MS chromatogram of α-Zein were observed. In contrast, the toxin seems to be less destroyed 
in the presence of an excess of protein, and the phenomenon seem to be accentuated when the 
protein is previously digested with chymotrypsin. 
Finally, the fact that upon chymotrypsin digestion the native form of FB is release from 
prolamines fraction, is a strong evidence for a complex formation between FB1 and α-Zein 
standard, with an inclusion-like mechanism. 
This new hypothesis seems to be consistent with data concerning the widespread presence of 
hidden Fumonisins along the maize chain. 
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3.9  Conclusions 
In this PhD thesis the presence of masked Fumonisins has been verified not only in finished 
products, but also in maize, raw materials and even in a standard material. An LC-MS/MS 
method for indirect evaluation of hidden Fumonisins was developed in our laboratory. The 
method is based on the comparison of the toxin concentration before and after the basic 
hydrolysis of the sample. The optimized alkaline hydrolysis of the sample turned out to be a 
suitable tool to  approach the problem of  the indirect quantification of hidden FBs. 
The application of the method to several batches of gluten free products and raw cereal let to 
discover that hidden FBs are widespread along the maize chain.  
Hidden Fumonisins are present in all type of maize based products and also in the raw cereal. 
Unexpectedly no significant differences in hidden / free FBs ratio were found between high 
and low temperature treated food. Significantly lower, but still evident was the same ratio in 
the raw cereal, suggesting that in the raw cereal the masking mechanism is already active. 
While the presence of hidden FBs in maize based products was already reported in the 
literature, this is the first evidence of the presence of hidden Fumonisins in the raw cereal.  
The hypothesis of covalent binding of Fumonisins to the protein in the matrix due to thermal 
treatments can not explain the presence of hidden Fumonisins in the raw cereal.  
Hidden FBs were also found in maize samples used as reference materials for ELISA kit, 
suggesting that a masking phenomenon is occuring so that antibodies are not able to detect 
hidden form of Fumonisins. Results of the first part of the work suggest a non-covalent 
mechanism for FBs masking explanation.  
The second part of this work was dedicated to investigate the mechanism of masking. 
In agreement with the literature, maize prolamines were found to be the Osborne fraction 
more active in Fumonisins masking. A commercial standard of α-Zein, the most abundant 
prolamine and maize protein, was checked for sequencing by UPLC-MS and was found to be 
completely devoid of lysine. 
Moreover, when Fumonisin B1 is heated in the presence of the α-Zein standard, no covalent 
modification of the protein seems to occur; on the other hand, the toxin is less destroyed in the 
presence of an excess of protein. This phenomenon seems to be accentuated when the protein 
is previously digested with chymotrypsin. Also this facts seems to be consistent with the non 
covalent hypothesis. 
By chymotrypsin digestion the native forms of FBs from the prolamines fraction were 
released, as if free from binding interactions. 
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Moreover α-Zein standard was found to be able to strongly suppress the FB1 molecular ion 
(M+H)+, in the ESI-MS infusion experiments. 
All the experimental data collected in the second part of the work strongly suggest a non-
covalent interaction between FB1 and the α-Zein standard, with an inclusion-like mechanism. 
The results of this work can have important consequences in Fumonisin analysis and exposure 
data. First, the hypothesis of covalent binding of proteins with Fumonisins should be furtherly 
verified looking for the presence of conjugated products. Most important, if in vitro 
enzymatic digestion is able to release Fumonisins from the food matrix, it is probable that also 
durig human or animal digestion, unknown amounts of toxins may be released in the gastro-
intestinal tract, so that the toxicity may increase dangerously. Moreover, a method able to 
analyze the real Fumonisin amount in maize and related products should be adopted officially 
with eventual revision of the legal limits. 
A more extended survey will be useful to understand the implications of this phenomenon in 
Fumonisin analysis and related risk assessment. The study of  interaction between mycotoxins 
and food components.     
Finally, a “Pandora vase” has been opened concerning the bioavailability and relative toxicity 
of masked mycotoxins in food. 
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4.  Experimental Part 
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4.1 Reagents and solvents 
• Fumonisins B1+B2 standard solution (Biopure, Austria). 
• Fumonisin B3  standard solution  (Biopure, Austria). 
• α-Zein standard  (powder, Fluka, Germany) 
• Bovine chymotrypsin (powder, Sigma, Germany) 
• Methanol HPLC grade (Carlo Erba, Italy ) 
• Acetonitrile HPLC grade (Carlo Erba, Italy) 
• Formic acid HPLC grade (Acros Organics) 
• Acetic acid HPLC grade (Carlo Erba, Italy) 
• Ammonium bicarbonate  (Fluka, Germany) 
• Calcium chloride (Carlo Erba, Italy) 
• Potassium hydroxide (Carlo Erba, Italy) 
• Sodium hypochloride 
• Buffers (Carlo Erba, Italy) 
• Bidistilled water HPLC grade,  obtained with Millipore Alpha-Q-System 
 
4.1.1 Precautions 
Extreme care is required during organic solvent and mycotoxin standard handling, always 
using  personal protective equipment. Glassware used for contaminated samples or standard 
solutions requires hypochlorite treatment, in this way  mycotoxins are destroyed  by 
oxidation. Glassware is  washed with soap, water, and then air dried. During standard 
preparations, glasses and gloves were worn, and all the operations were conducted under 
hood,  in order to minimyze risk of exposure to mycotoxins. 
 
4.2  Instruments 
HPLC system: Alliance Waters 2695 (Automated Rheodyne injector, with 20µl loop) 
Triple quadruple detector :  ‘Micromass Quattro Micro API’ (Waters) 
UPLC  system: Acquity Waters 
Single quadruple detector: Acquity SQD (Waters) 
Data acquisition and elaboration : MassLynx 4.01  
(Water Chromatography Division, Milford, Massachusetts) 
pH-meter : InoLab pH Level 1 WTW (Chemifarm s.r.l., Parma, Italy) 
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4.3  Mobile phase preparation for HPLC and UPLC analysis  
The mobile phase, for both HPLC and UPLC, was freshly prepared before each batch of 
analyses, using graduate cilynders  to measure the correct volume of water and organic 
modifier. For all the analysis, the following eluents were used: 
? Bidistiled water   + 0.2%  Formic acid 
? Methanol  + 0.2%  Formic acid  
? Acetonitrile + 0.2%  Formic acid 
The eluents were filtered with vacuum pump and Millipore 0.45 µm filter. 
 
4.4 Fumonisin analysis 
4.4.1  MS/MS detection  
In order to develop an MRM  detection method, 5 ppm standard solutions of each Fumonsin 
were prepared. The calculated volumes were taken from stock solutions and placed into vials, 
dried under nitrogen flow and resuspended in a final volume with methanol in order to obtain 
the desired concentration. Analytes were infused in the mass spectrometer in order to develop 
the parameters necessary for the MRM detection method. The operative conditions of the 
mass spectrometer, used for MRM analysis of Fumonisin, are reported in the next tables.  
 
Tab.70 : Conditions of the ion souce used in the MRM analysis of Fumonisin. 
Parameter Value 
Polarity ES+ 
Capillary  4.00 kV 
Cone  50.00V 
Extractor  2.00 V 
RF Lens  0.2 V 
Source Temperature  120 °C 
Desolvation Temperature  350 °C 
Cone Gas Flow  50 L/hr 
Desolvation Gas Flow  700 L/hr 
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Tab. 71: Mass analyzer conditions used in the MRM analysis of Fumonisin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Once the detection method has been developed, it was necessary to set the parameters for the 
chromatographic separation of the analytes. A standard solution of the three Fumonisins was 
prepared and  several test were performed in order to achieve the baseline separation of the 
analytes in HPLC using a 2.5 x 25 mm, 5µ, C18 X-Terra column. The flow rate used in the 
analysis was 0.2 ml/min, with an injection volume of 10 µl. The gradient used for the HPLC 
analysis of Fumonisin, is reported in the next table.  
 
 
 
 
 
 
 
 
 
 
Parameter Value 
LM 1 Resolution  9.4 
HM 1 Resolution  8.5 
Ion Energy 1 0.5 eV 
Entrance -2 
Collision energy specific for each transition 
Exit 2 
LM 2 Resolution 15.0 
HM 2 Resolution 15.0 
Ion Energy 2 2.0 
Multiplier (V) 650 
Gas Cell Pirani Pressure 2.93e-3 mbar 
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Tab. 72: Mobile phase gradient used in the MRM analysis of Fumonisin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4.2  Calibration and matrix effect 
Linearity of response was first evaluated by calibration curves. Five standard solutions, each 
containing all the three FBs, were prepared in a final volume of methanol in order to obtain 
the desired concentration. Linearity was checked with single injections of  standard solutions 
in the 50-2000 ppb range; curve equations are reported in the next table. 
 
Tab. 73:  Standard calibration curves for Fumonisin B1, B2 and B3. 
 
 
 
 
 
 
 
 
Time 
 
% A 
 (H2O + 0.2 % HCOOH) 
 
% B  
(ACN + 0.2 % HCOOH) 
0 70 30 
2 70 30 
5 55 45 
25 10 90 
35 10 90 
36 70 30 
50 70 30 
analyte curve equation R2 
Fumonisin B1 y =  2.72x - 42.19 0.9982 
Fumonisin B2 y =  5.68x + 16.70 0.9994 
Fumonisin B3 y =  3.21x + 12.10 0.9985 
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Once linearity was checked, calibration curves were prepared. Based on the past experience, 
Fumonisins are known to be affected from matrix effects at least on the instrument used for 
this work. For this reason we decided to use directly matrix matched calibrations in order to 
correct the matrix effect and get a more accurate Fumonisin quantification. Matrix matched 
calibrations were determined by triplicate injection of 6 standards solutions in the range 50-
2000 ppb, previously prepared by diluting an opportune stock of the three Fumonisins with an 
extract of  blank maize sample. Calibration curves have been obtained by plotting the signal 
area of the analyte versus its concentration and are reported in the next table. 
Matrix matched calibrations were injected with each batch of samples. 
 
 
Fig. 77:  Matrix matched calibration curves for Fumonisin B1, B2 and B3. 
 
4.4.3  Recovery and Limits of Detection 
Fumonisin recovery was first evaluated by spiking procedure at 250 and 1000 ppb levels. Five 
grams of blank maize were spiked with a calculated volume of FB stock solution and allowed 
to rest overnight, in order to evaporate the solvent. The day after, the sample was extracted 
with 50 ml of  a MeOH/H2O 70:30 solvent mixture for 70 minutes (10 min. Turrax + 60 min. 
magnetic stirring), then the surnatant was recovered by centrifuge. 
The surnatant was centrifuged, placed in a vial and directly injected in HPLC; matrix matched 
calibration solutions were also injected in order to quantify the analytes. 
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Recovery was calculated by the following formula: 
 
Recovery% =  (found concentration / reference concentration) x 100 
 
Recovery values at the 2 levels were used to calculate the average recovery. 
Limits of the method were evaluated on matrix matched standards of Fumonisin at 10 and 5 
ppb. The standard was prepared by placing an opportune stock of the three FBs in a vial, 
drying under nitrogen, and resuspending them with an opportune volume of an extract of  a 
blank maize sample. 
After the analysis, the signal to noise ratio of the peaks of Fumonisins, at both levels, was 
evaluated by a special function of MASSLYNX software (Water Micromass Inc.). The 
software needs inputs as the peak widht at half height and the value of the background noise 
at the baseline of the peak. 
Results from the software were compared with those generally accepted, for limit evaluation: 
.S/N = 3, Limit of detection , LOD; 
.S/N = 10, Limit of quantification, LOQ; 
In the present work, 10 ppb was considered as limit of quantification for  Fumonisin B1  B2 
and B3. 
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4.5 Hydrolysed Fumonisin analysis: optimization of the 
method 
4.5.1  Standard preparation 
Standards of hydrolysed Fumonisins (HFBs) are not commercially available and were 
prepared in house. Calculated volumes of  FB stock solutions were placed in a 4 ml vial, dried 
under a nitrogen flow, resuspended in 1ml of KOH, and allowed to react overnight at room 
temperature. The day after, the solution was extracted twice with 1 ml of acetonitrile. 
 Two extracts were combined, dried under a nitrogen flow, and then resuspend in the 
calculated volume of methanol, in order to obtaine the desired standard stock solution of 
hydrolysed Fumonisins. 
Example of a standard preparation: 
1 ml of a 5 ppm standard of each hydrolysed Fumonisin were prepared in MeOH starting 
from 50 ppm commercial Fumonisin stock solutions in ACN/H2O 1:1 . 
1) The volume of Fumonisin stock solution to be hydrolysed was clculated as follows. 
5 mg/ml x 1ml = 5 mg of each HFB 
5 mg / 405.35 mg/mmol = 0.0123 mmol of HFB1 
5 mg / 389.35 mg/mmol = 0.0128 mmol of HFB2 
5 mg / 389.35 mg/mmol = 0.0128 mmol of HFB3 
by assuming that in the hydrolytic reaction the molar ratio is 1:1  : 
0.0123 mmol of HFB1 = 0.0123 mmol of FB1 
0.0128 mmol of HFB2 = 0.0128 mmol of FB2 
0.0128 mmol of HFB3 = 0.0128 mmol of FB3 
 
0.0123 mmol of FB1 x 721.39 mg/mmol =  8.87 mg of FB1 
0.0128 mmol of FB2 x 705.39 mg/mmol =  9.03 mg of FB2 
0.0128 mmol of FB3 x 705.39 mg/mmol =  9.03 mg of FB3 
 
8.87 mg of FB1 / 50 mg/ml = 0.177 ml of FB1 stock solution 50 ppm 
9.03 mg of FB2 / 50 mg/ml = 0.181 ml of FB2 stock solution 50 ppm 
9.03 mg of FB3 / 50 mg/ml = 0.181 ml of FB3 stock solution 50 ppm 
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2) The calculated volumes of Fumonisin stock solution are placed in a 4 ml vial, dried under 
nitrogen, resuspended in 1 ml of KOH 2 M and allowed to rest overnight at room temperature. 
3) The day after the solution was extracted twice with 1 ml of acetonitrile. Organic phases are 
collected and dried under nitrogen.  
4) Once dried the organic phase was resuspended with 1ml of MeOH to obtain a 1 ml of 5 
ppm solution for each hydrolysed Fumonisin. 
 
4.5.2  MS/MS detection  
In order to develop an MRM  detection method, 5 ppm standard solutions of each hydrolysed 
Fumonsin were prepared. The calculated volumes were taken from stock solutions and placed 
into vials, dried under a nitrogen flow and resuspended in a final volume with methanol in 
order to obtain the desired concentration. Analytes were infused in the mass spectrometer in 
order to develop the parameters necessary for the MRM detection method. The operative 
conditions of the mass spectrometer, used for MRM analysis of Fumonisins, are reported in 
the next tables.  
 
Tab. 74: Conditions of the ion souce used in the MRM analysis of hydrolysed Fumonisin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Value 
Polarity ES+ 
Capillary  4.00 kV 
Cone  30.00V 
Extractor  2.00 V 
RF Lens  0.2 V 
Source Temperature  120 °C 
Desolvation Temperature  450 °C 
Cone Gas Flow  50 L/hr 
Desolvation Gas Flow  450 L/hr 
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Tab. 75: Mass analyzer conditions used in the MRM analysis of hydrolysed Fumonisin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Once the detection method was developed, it was necessary to set the parameters for the 
chromatographic separation of the analytes. A standard solution of the three Fumonisins was 
prepared and  several test were performed in order to achieve the baseline separation of the 
analytes in HPLC using a 2.5 x 25 mm, 5µ, C18 X-Terra column. The flow rate used in the 
analysis was 0.2 ml/min, with an injection volume of 10 µl. The gradient used for the HPLC 
analysis of HFBs was the same as that used for  FBs and is reported in the following Table.  
 
 
 
 
 
 
 
 
Parameter Value 
LM 1 Resolution  15.9 
HM 1 Resolution  9.0 
Ion Energy 1 0.5 
Entrance 1 
Collision energy specific for each transition 
Exit 2 3 
LM 2 Resolution 15.0 
HM 2 Resolution 15.0 
Ion Energy 2 1.0 
Multiplier (V) 650 
Gas Cell Pirani Pressure 2.99e-3 
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Tab. 76: Mobile phase gradient used in the MRM analysis of Fumonisin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.5.3  Calibration and matrix effect 
Linearity of response was first evaluated by calibration curves. Five standard solutions, each 
containing all the three HFBs, were prepared in a final volume of methanol in order to obtain 
the desired concentration. Linearity was checked with single injections of  standard solutions 
in the 50-2000 ppb range; curve equations are reported in the next table. 
 
 
Tab. 77:  Standard calibration curves for Fumonisin B1  B2 and B3. 
 
 
 
 
 
 
 
 
 
 
Time 
 
% A 
 (H2O + 0.2 % HCOOH) 
 
% B  
(ACN + 0.2 % HCOOH) 
0 70 30 
2 70 30 
5 55 45 
25 10 90 
35 10 90 
36 70 30 
50 70 30 
analyte curve equation R2 
 hydrolysed Fumonisin B1 y =  1.46x + 7.96 0.9994 
hydrolysed Fumonisin B2 y =  4.27x - 11.27 0.9992 
hydrolysed Fumonisin B3 y =  4.65x - 11.24 0.9997 
 142
Once the linearity was checked, calibration curves were prepared. The same approach adopted 
for the native form was used for hydrolysed Fumonisins, matrix matched calibration was used 
in order to correct the matrix effect and get more accurate data. 
Matrix matched calibration curves were determined by triplicate injections of standard 
solutions in the range 50-2500 ppb, previously prepared by diluting an opportune stock of the 
three hydrolysed Fumonisins with an extract of  blank maize sample. Calibration curves were 
obtained by plotting the area of the signal of the analyte versus its concentration. 
Matrix matched calibration solutions were injected with each batch of samples. 
 
 
Fig. 78:  Matrix matched calibration curves for hydrolysed Fumonisin HFB1, HFB2 and 
HFB3. 
 
4.5.4  Recovery and Limits of Detection 
As already explained in the Discussion chapter, the extraction recovery of hydrolysed 
Fumonisins can be evaluated only by spiking procedures. However, also this procedure could 
not be the effective representative of the real samples because the masking mechanism cannot 
be reproduced in a laboratory, until it remains unknown. Extraction recovery can be evaluated 
only by spiking native FBs and evaluating the derived HFBs, after sample hydrolysis. 
Hydrolyzed Fumonisin recovery was evaluated by spiking procedure at 250 and 1000 ppb 
levels for HFB1 and HFB2, and at 500-2000 ppb levels for HFB3.  
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(HFB1) y = 15.46x - 555.4 
 
R2  = 0.9958 
 
(HFB2) y = 9.18x - 273.6 
 
R2  = 0.9962 
 
(HFB3) y = 3.01x - 109.09 
 
R2  = 0.9968 
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Five grams of blank maize were spiked with a calculated volume of FB stock solution and 
allowed to rest overnight, in order to evaporate the solvent. The day after, the sample was 
hydrolysed with 50 ml of 2 M KOH  for 60 minutes (10 min. Turrax + 50 min. magnetic 
stirring) at room temperature, then 50 ml of acetronitrile were added. The immiscible phases 
were then homogenised by means of Ultra Turrax for 10 minutes, and the organic phase was 
recovered by centrifuge. 
A known volume of the organic phase was dried by rotavapor, resuspended in an equal 
volume of MeOH/H2O 70:30 mixture, centrifuged, and injected in HPLC. 
Matrix matched calibrations were also injected in order to quantify the analytes. 
Recovery of each analyte was calculated by the following formula: 
 
Recovery% =  (found concentration / reference concentration) x 100 
 
Recovery values at 2 levels was used to calculate the average recovery. 
Limits of the method were evaluated on matrix matched standards of hydrolysed Fumonisins 
at 10 and 5 ppb. The standard was prepared by placing an opportune stock of the three FBs in 
a vial, drying under nitrogen, and resuspending them with an opportune volume of an extract 
of  a blank maize sample. After the analysis, the signal to noise ratio of the peaks of 
Fumonisins, at both levels, was evaluated by a special function of MASSLYNX software 
(Water Micromass Inc.). The software needs inputs as the peak widht at half height, and the 
value of the background noise at the baseline of the peak. The results of software have been 
compared with those generally accepted, for limit evaluation: 
.S/N = 3, Limit of detection , LOD; 
.S/N = 10, Limit of quantification, LOQ; 
In the present work, 10 ppb were considered as limit of quantification for HFB1 and HFB2 
while 50 ppb was considered for HFB3. 
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4.6 The indirect approach 
4.6.1  Sample preparation for free Fumonisins evaluation 
Sample preparation for the analysis of free Fumonisins, on both maize and gluten-free 
products, as well as for the recovery evaluation, was performed as follows: 
. The sample was first ground by means of a mulinex, (spiked sample were let to rest 
overnight); 
. 5 grams of sample are extracted with 50 ml of MeOH/H2O 70:30 solvent mixture for 70 
minutes (10 min. Turrax + 60 min. magnetic stirring); 
 . the surnatant was recovered by centrifuge; one aliquots was directly analyzed to evaluate 
the presence of hydrolysed Fumonisins and to understand if the sample fit in the calibration 
range; 
. highly contaminated samples can be analyzed directly. For low contaminated products a 
known volume of extract is dried by rotavapor and resuspended in a calculated volume of  
MeOH/H2O 70:30 mixture in order to obtain the desired concentration factor; 
. each sample was centrifuged at 12000 rpm for 10 minutes before injection in HPLC. 
Quantitative determination 
Quantification of Fumonisins was performed by applying the following formula: 
 
FB1 (ng/g) =  C x Solvent x Res. / W x Aliquot (ng  x ml / g x ml) 
 
FB2 (ng/g) =  C x Solvent x Res. / W x Aliquot (ng  x ml / g x ml) 
 
FB3 (ng/g) =  C x Solvent x Res. / W x Aliquot (ng  x ml / g x ml) 
i.e.: 
FB1 (ng/g) =  C x 0.5 x H 
 
FB2 (ng/g) =  C x 0.5 x H 
 
FB3 (ng/g) =  C x 0.5 x H 
where: 
. C: Concentration found in the injected solution, by calibration curve 
. Solvent: Volume of solvent used for the extraction (50 ml) 
. Res.: Final volume used to resuspend the sample (2 ml) 
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. W: Weighted sample material (5 g) 
. Aliquot: Volume of extract recovered (40 ml) 
. H: Recovery  
 
Highly contaminated samples were analyzed by injecting directly the extracted surnatant, 
after high speed centrifugation; then the following formula was applied : 
 
FB1 (ng/g) =  C x Solvent / W (ng x ml / ml x g) 
 
FB2 (ng/g) =  C x Solvent / W (ng x ml / ml x g) 
 
FB3 (ng/g) =  C x Solvent / W (ng x ml / ml x g ) 
 
i.e. 
FB1 (ng/g) =  C x 10 x H 
 
FB2 (ng/g) =  C x 10 x H 
 
FB3 (ng/g) =  C x 10 x H 
where: 
. C: Concentration found in the injected solution, by calibration curve 
. Solvent: Volume of solvent used for the extraction (50 ml) 
. W: Weighted sample material (5 g) 
. H: Recovery 
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4.6.2  Sample preparation for total Fumonisins evaluation 
Sample preparation for the analysis of total Fumonisins, on both maize and gluten-free 
products, was performed as follows: 
. 5 grams of previously ground sample were hydrolysed with 50 ml of 2 M  KOH for 60 
minutes (10 min. Turrax + 50 min. magnetic stirring); 
 . 50 ml of ACN were added and homogenised for 10 minutes by Ultra Turrax; 
. the organic phase was recovered by centrifuge; one aliquots was directly analysed, after 
resuspension in a MeOH/H2O 70:30 mixture, to understand if the sample fits in the calibration 
range. 
. highly contaminated samples were analyzed directly. For low contaminated products a 
known volume of organic phase was dried by rotavapor and resuspended in a calculated 
volume of  MeOH/H2O 70:30 mixture in order to obtain the desired concentration factor, 
. each sample was centrifuged at 12000 rpm for 10 minutes before injection in the HPLC. 
Quantitative determination: 
Quantification of hydrolysed Fumonisins was performed by applying the following formula: 
 
HFB1 (ng/g) =  [C x Solvent x Res. / W x Aliquot] (ng x ml / ml x g) 
 
HFB2 (ng/g) =  [C x Solvent x Res. / W x Aliquot] (ng x ml / ml x g) 
 
HFB3 (ng/g) =  [C x Solvent x Res. / W x Aliquot] (ng x ml / ml x g) 
 
i.e.: 
HFB1 (ng/g) =  C x 0.5 x H 
 
HFB2 (ng/g) =  C x 0.5 x H 
 
HFB3 (ng/g) =  C x 0.5 x H 
where: 
. C: Concentration found in the injected solution, by calibration curve 
. Solvent: Volume of solvent used for the hydrolysis/extraction (50 ml) 
. Res.: Final volume used to resuspend the sample (2 ml) 
. W: Weighted sample material (5 g) 
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. Aliquot: Volume of extract recovered (40 ml) 
. H: Recovery 
Highly contaminated samples were analyzed by injecting directly the extracted surnatant 
resuspended in a calculated volume of MeOH/H2O 70:30 mixture, after high speed 
centrifugation. 
The formula used are following reported:  
HFB1 (ng/g) =  [C x Solvent / W x Aliquot] x K  (ng x ml / ml x g) 
 
HFB2 (ng/g) =  [C x Solvent / W x Aliquot] x K (ng x ml / ml x g) 
 
HFB3 (ng/g) =  [C x Solvent / W x Aliquot] x K  (ng x ml / ml x g) 
 
i.e.: 
HFB1 (ng/g) =  C x 10 x K x H 
 
HFB2 (ng/g) = C x 10 x K x H 
 
HFB3 (ng/g) =  C x 10 x K  x H 
where: 
. C: Concentration found in the injected solution, by calibration curve 
. Solvent: Volume of solvent used for the hydrolysis/extraction (50 ml) 
. W: weighted sample material (5 g) 
. H: Recovery  
Total Fumonisins, or FBs equivalent, can be calculated from HFBs, by the following formula: 
 
tot FB1 (or FB1 equivalents ) (ng/g) =  HFB1 (ng/g)x K 
 
tot FB2 (or FB2 equivalents ) (ng/g) = HFB2 (ng/g)x K 
 
tot FB3 (or FB3 equivalents ) (ng/g)  =  HFB3 (ng/g)x K 
where: 
. K : Costant derived from the molecular weights ratio between the hydrolysed form and the 
native form (mw HFB/mw FB). 
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4.6.3 Sample preparation for total Fumonisins extracted 
Evaluation of the total Fumonisin in the extract for free FB evaluation, was performed on 
maize samples as follows: 
. the extract for free FB evaluation was divided in 2 aliquots; 
. the aliquots for total FB evaluation was dried by rotavapor, resuspended in 50 ml of 2 M 
KOH and let to react 1 hour at room temperature with magnetic stirring; 
 . 50 ml of ACN were added and stirred for 10 minutes; 
. the organic phase was recovered by centrifuge and a known volume is directly analysed, 
after resuspension in a MeOH/H2O 70:30 mixture. 
. Each sample was centrifuged at 12000 rpm for 10 minutes before injection in HPLC. 
 
Quantitative determination: 
Quantification of the hydrolysed Fumonisins was performed by applying the following 
formula: 
 
 
HFB1 (ng/g) =  [C x S1 x S2 x Res.  / W x S3 x Aliquot] (ng x ml / ml x g) 
 
HFB2 (ng/g) =  [C x S1 x S2 x Res.  / W x S3 x Aliquot] (ng x ml / ml x g) 
 
HFB3 (ng/g) =  [C x S1 x S2 x Res.  / W x S3 x Aliquot] (ng x ml / ml x g) 
 
i.e.: 
HFB1 (ng/g) =  C x 0.8 x H 
 
HFB2 (ng/g) =  C x 0.8 x H 
 
HFB3 (ng/g) =  C x 0.8 x H 
where: 
. C: Concentration found in the injected solution, by calibration curve 
. S1: Volume of solvent used for the first extraction (50 ml) 
. S2: Volume of solvent used for the hydrolysis/extraction (50 ml) 
. S3: Volume of aliquots from the first extraction (20 ml) 
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. Re+s.: Final volume used to resuspend the sample (2 ml) 
. W: weighted sample material (5 g) 
. Aliquot: Volume of extract recovered (40 ml) 
. H: Recovery 
Total Fumonisins, or FBs equivalent, has been calculated from HFBs, by the following 
formula: 
 
tot FB1 (or FB1 equivalents ) (ng/g) =  HFB1 (ng/g) x K 
 
tot FB2 (or FB2 equivalents ) (ng/g) = HFB2 (ng/g )x K 
 
tot FB3 (or FB3 equivalents ) (ng/g)  =  HFB3 (ng/g )x K 
 
where: 
. K : Costant derived from the molecular weights ratio between the hydrolysed form and the 
native form (mw HFB/mw FB). 
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4.7  Hidden Fumonisin: understanding the masking 
mechanism 
4.7.1  Association with maize protein 
The Osborne fraction were collected as follows:  
. 5 grams of previously ground sample were extracted with 50 ml of bistilled water  for the 
globulin fraction, by magnetic stirring for 60 minutes;  
. the surnatant was recovered by centrifuge and divided in 2 aliquots; 
. the solid residue was recovered and extracted with 50 ml of 0.2 M NaCl for albumins, by 
magnetic stirring for 60 minutes; 
. the surnatant was recovered by centrifuge and divided in 2 aliquots; 
. the solid residue was recovered and extracted with 50 ml of EtOH/H2O 60:40 for 
prolamines, by magnetic stirring for 60 minutes; 
. the surnatant was recovered by centrifuge, and divided in 2 aliquots; 
. the solid residue was recovered and extracted with 50 ml of Isopropanol/Water 50:50 + 2% 
DTT for glutelins, by magnetic stirring for 60 minutes; 
. the surnatant was recovered by centrifuge and divided in 2 aliquots; 
. the solid residue was recovered  and hydrolysed with 50 ml of KOH 2 M  for 60 minutes (10 
min. Turrax + 50 min. magnetic stirring); 
. 50 ml of ACN were added and the mixture was homogenised for 10 minutes by Ultra 
Turrax; 
. a known volume of the organic phase was recovered by centrifuge and resuspended in the 
same volume of  MeOH/H2O 70:30 mixture.  
One aliquot of each Osborne fraction was analyzed for free Fumonisin evaluation by the 
following procedure: 
. a known volume of each fraction was dried by rotavapor and resuspended in a calculated 
volume of a MeOH/H2O 70:30 mixture, in order to fit in the calibration range; 
. the resuspended sample was centrifuged at 12000 rpm for 10 minutes before injection in 
HPLC. 
 
 Quantitative determination: 
Due to the different extraction procedure, data of free FBs in Osborne fraction has been not 
corrected for the recovery. 
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Quantification of Fumonisins was performed by applying the following formula: 
 
 
FB1 (ng/g) =  C x Solvent x Res. / W x Aliquot (ng x ml / ml x g) 
 
FB2 (ng/g) =  C x Solvent x Res. / W x Aliquot (ng x ml / ml x g) 
 
FB3 (ng/g) =  C x Solvent x Res. / W x Aliquot (ng x ml / ml x g) 
 
 
i.e.: 
FB1 (ng/g) =  C  
 
FB2 (ng/g) =  C  
 
FB3 (ng/g) =  C  
where: 
. C: Concentration found in the injected solution, by calibration curve 
. Solvent: Volume of solvent mixture used for the extraction (50 ml) 
. Resuspension: Final volume used to resuspend the sample (2 ml) 
. W: Weighted sample material (5 g) 
. Aliquot: Volume of the aliquot (20 ml) 
 
On the second aliquots of each Osborne fraction total Fumonisins were evaluated by the 
following procedure: 
. the aliquots for total FB evaluation were dried by rotavapor, resuspended in 50 ml of 2 M 
KOH and let to react 1 hour at room temperature with magnetic stirring; 
 . 50 ml of ACN were added and stirred for 10 minutes. 
. a known volume of the organic phase was recovered by centrifuge, dried by rotavapor and 
respuspended in a calculated volume of a MeOH/H2O 70:30 mixture, in order to fit in the 
calibration range; 
. Each sample was centrifuged at 12000 rpm for 10 minutes before injection in HPLC. 
 
 
 152
 Quantitative determination: 
Quantification of hydrolysed Fumonisins was performed by applying the following formula : 
 
 
 
HFB1 (ng/g) =  [C x S1 x S2 x Res.  / W x S3 x Aliquot] (ng x ml / ml x g) 
 
HFB2 (ng/g) =  [C x S1 x S2 x Res.  / W x S3 x Aliquot] (ng x ml / ml x g) 
 
HFB3 (ng/g) =  [C x S1 x S2 x Res.  / W x S3 x Aliquot] (ng x ml / ml x g) 
 
i.e.: 
HFB1 (ng/g) =  C x 0.8 x H 
 
HFB2 (ng/g) =  C x 0.8 x H 
 
HFB3 (ng/g) =  C x 0.8 x H 
where: 
. C: Concentration found in the injected solution, by calibration curve 
. S1: Volume of solvent used for the first extraction (50 ml) 
. S2: Volume of solvent used for the hydrolysis/extraction (50 ml) 
. S3: Volume of aliquots from the first extraction (20 ml) 
. Res.: Final volume used to resuspend the sample (2 ml) 
. W: weighted sample material (5 g) 
. Aliquot: Volume of extract recovered (40 ml) 
. H: Recovery 
Total Fumonisins, or FBs equivalent, has been calculated from HFBs, by the following 
formula: 
 
tot FB1 (or FB1 equivalents ) (ng/g) =  HFB1 (ng/g) x K 
 
tot FB2 (or FB2 equivalents ) (ng/g) = HFB2 (ng/g )x K 
 
tot FB3 (or FB3 equivalents ) (ng/g)  =  HFB3 (ng/g )x K 
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where: 
. K : Costant derived from the molecular weight ratio between the molecular weight of 
hydrolysed form and that of the native form (MW HFB/MW FB). 
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 4.7.2  The α-Zein model 
The operative conditions used for the UPLC-MS  analysis of α-Zein are reported in the next 
tables.  
 
Tab. 78: Conditions of the ion souce used in the UPLC-MS  analysis of α-Zein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tab. 79: Mass analyzer conditions used in the UPLC-MS  analysis of α-Zein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Value 
Polarity ES+ 
Capillary  3.30 kV 
Cone  30.00V 
Extractor  3.00 V 
RF Lens  0.2 V 
Source Temperature  120 °C 
Desolvation Temperature  350 °C 
Cone Gas Flow  50 L/hr 
Desolvation Gas Flow  850 L/hr 
Parameter Value 
LM 1 Resolution 9.4 11.2 
HM 1 Resolution 8.5 14.8 
Ion Energy 1 0.3 eV 
Multiplier (V) 650 
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Separation was performed using a 2.1 x 15 mm, BEH 300 1.7 µm, C18 column. The flow rate 
used in the analysis was 0.2 ml/min, with an injection volume of 10 µl. The gradient used for 
the  
UPLC-MS  analysis of α-Zein, is reported in the next table.  
 
Tab. 80: Mobile phase gradient used in the MRM analysis of Fumonisin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chymotryptic digestion of the α-Zein standard was performed as follows:  
. the chymotrypsin stock solution was prepared dissolving 10 mg of bovine chymotrypsin 
(from Sigma) in 10 ml of  50 mM CH3COOH; 
. The α-Zein standard stock solution was prepared dissolving 10 mg of α-Zein in 10 ml of 
MeOH, 
. Ammonium bicarbonate buffer 50 mM  pH = 7.3  was prepared dissolving the weighted 
amount of salt in 100 ml of bidistilled water, pH was adjusted with NH3. 
. Calculated volumes of each stock were placed in a 4 ml vial in order to have: 
- protein amount = 0.5 mg  
- enzyme/protein ratio  1:25 
- final volume of  200 µl 
- final concentration of methanol = about 30 % 
The control experiment was performed without the enzyme. The solutions were let to react for 
5 hours at 37 °C in a water bath. The reaction was stopped by lowering temperature in a cold 
Time 
 
% A 
 (H2O + 0.2 % HCOOH) 
 
% B  
(ACN + 0.2 % HCOOH) 
0 85 15 
77 50 50 
87 50 50 
89 0 100 
92 0 100 
93 85 15 
108 85 15 
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water bath. Each sample was centrifuged at 12000 rpm for 10 minutes before the UPLC-MS 
analysis under the conditions previously reported.  
 
4.7.3  In vitro reaction between α-Zein and Fumonisin B1 
The in vitro reaction between FB1 and the α-Zein standard was performed as follows:  
. Fumonisin B1 in stock solution was prepared dissolving 1 mg of standard of FB1 (from 
Sigma) in 2 ml of MeOH; 
. the α-Zein standard stock solution was prepared dissolving 10 mg of α-Zein in 10 ml of 
MeOH, 
. the calculated volumes of each stock were placed in a 4 ml vial in order to have different 
molar ratio between FB1 and α-Zein (the amount of FB1 was the same in each test): 
1) FB1 alone at room temperture (control) 
2) FB1 alone heated at 150 °C (control) 
3)  FB1 + α-Zein  molar ratio 5:1 
4) FB1 + α-Zein  molar ratio 1:2 
Each vial was dried under nitrogen, then the samples 2,3 and 4 were let to react 5 hours at  
150 °C for 90 minutes in an oil bath. The reaction was stopped by lowering temperature in a 
cold water bath. Each sample was resuspended in 1 ml of MeOH and centrifuged at 12000 
rpm for 10 minutes before the HPLC-MS/MS  for FB1 analysis with the previous reported 
conditions. 
The experiment was repeated also with an α-Zein chymotryptic digested obtained in the 
previous experiment, by using the same conditions but a minor time (60 min. instead 90 
min.). 
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4.7.4 Preliminary evidence for inclusion-like mechanism of FB1 
masking 
Preliminary experiments on maize prolamine fractions, extracted from highly contaminated 
maize sample, were performed as follows : 
. 20 g of ground maize were extracted twice with 100 ml of  bidistilled water, by magnetic 
stirring for 1 hour,; extracts were discarded, the residue was then air dried over night. The day 
after it was extracted 4 times with ethanol:water 60:40, by stirring for 1 hour. Extracts were 
collected, dried with rotavapor, weighted and resuspended in 50 ml of  methanol. On 4 
aliquots of the prolamines fraction extracted, several treatments able to release the protein 
bound Fumonisin were performed. 
1) The control experiment was carried out by diluting a calculated volume of prolamine 
fraction to a final volume of 200 µl with methanol. 
2) A calculated volume of the resuspended prolamines fraction, corresponding to about 0.5 
mg of solid extract, was diluted  with 1:5 methanol:ammonium bicarbonate buffer. A 
calculated volume of chymotrypsin stock solution was added, in order to have 1:25 
enzyme/solid extract mass ratio, and allowed to react for 5 hours at 37 °C. The reaction was 
then stopped by adding methanol to a final volume of 200 µl. Control was made by diluting 
an equal volume of extract with the same buffer but without enzyme. 
3) A calculated volume of resuspended prolamine fraction, corresponding to about 0.5 
 mg of solid extract, was dried under a nitrogen flow, resuspended in 2 M KOH, then allowed 
to react 1 hour at room temperature. After that, it was extracted twice with acetonitrile, the 
extracts were combined, dried under nitrogen flow, then resuspended in 200 µl methanol. 
4)A calculated volume of resuspended prolamine fraction, corresponding to about 0.5 mg of 
solid extract, was diluted with 8 M urea and allowed to rest 5 hours at room temperature. 
Then it was diluted with methanol to a final volume of  200 µl. 
All samples were centrifugated 10 minutes at 12000 rpm before LC-MS/MS analysis of 
Fumonisin B1 under the condions previously reported.  
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The preliminary ESI-MS titration experiment was performed as follows :  
. Fumonisins B1 in stock solution was prepared dissolving 1 mg of standard of FB1 (from 
Sigma) in 2 ml of MeOH; 
. the α-Zein standard solution was prepared dissolving a weighted amounts of α-Zein in 100 
ml of MeOH/H2O 70:30 mixture, in order to have a 250 µM stock; then it was used to prepare 
a 50 µM dilution; 
. the calculated volumes of each standard solution was placed in a 4 ml vial in order to have a 
different molar ratio between FB1 and α-Zein  
1) FB1 + α-Zein  molar ratio 2 (10:5 µM/µM) 
2) FB1 + α-Zein  molar ratio 1  (5:5 µM/µM) 
3)  FB1 + α-Zein  molar ratio 0.5 (5:10 µM/µM) 
 
Each vial was dried under nitrogen, resuspended with a calculated volume of MeOH, in order 
to obtain the desired concentrations and centrifugated 10 minutes at 12000 rpm before 
infusion in ESI-MS, under the conditions reported in the following tables. 
 
Tab. 81: Conditions of the ion souce used in the ESI-MS titration. 
Parameter Value 
Polarity ES+ 
Capillary  3.20 kV 
Cone  30.00V 
Extractor  4.00 V 
RF Lens  0.2 V 
Source Temperature  100 °C 
Desolvation Temperature  200 °C 
Cone Gas Flow  50 L/hr 
Desolvation Gas Flow  600 L/hr 
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Tab. 82: Mass analyzer conditions used in the ESI-MS titration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 79: Correlation curve between FB1 ion counts in ESI-MS and molar ratio of FB1 
and α-Zein in the infused solutions, violet curve : linear regression, blue curve : 
quadratic regression. 
 
 
 
Parameter Value 
LM 1 Resolution  15 
HM 1 Resolution  15 
Ion Energy 1 1 
Entrance 15 
Collision energy 0 
Exit 2 15 
LM 2 Resolution 15.0 
HM 2 Resolution 15.0 
Ion Energy 2 2.0 
Multiplier (V) 650 
Gas Cell Pirani Pressure < 1e-4 mbar 
y = 137988x - 44487
R2 = 0.957
y = 57236x2 + 10192x - 4327.8
R2 = 1
-50000
0
50000
100000
150000
200000
250000
300000
0 0.5 1 1.5 2 2.5
FB1 / zein molar ratio
FB
1 
io
n 
co
un
ts
 160
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 161
References: 
1. Forgacs, J., and W.T. Carll. 1962. Mycotoxicoses. Adv. Vet. Sci. 7: 273-382. 
2. Bennett, J.W. 1987. Mycotoxins, mycotoxicoses, mycotoxicology and mycopathology. Mycopathlogia 100: 
3-5. 
3. Bennett, J.W. 1987. Mycotoxins, mycotoxicoses, mycotoxicology and mycopathology. Mycopathlogia 100 
3-5. 
4. Moss, M.O. 1996. Mycotoxins. Mycol. Res. 100. 
5. Fink-Gremmels, J. 1999. Mycotoxins: their implications for human and animal health. Vet. Q. 21. 
6. Mannon, J.and E. Johnson. 1985. Fungi down on the farm. New Sci. 105. 
7. Lisker, N., and E. B. Lillehoj. 1991. Prevention of mycotoxin contamination at the preharvest stage, p. 689–
719. In J. E. Smith and R. S. Henderson (ed.), Mycotoxins and animals foods. 
8. Brown, R.L.,D. Bhatnagar, T.E. Cleveland, and J. W. Cary. 1998. Recent advances in preharvest 
prevention of mycotoxin contamination, p. 351–379. In K. K. Sinha and D. Bhatnagar, (ed.), Mycotoxins in 
agriculture and food safety. Marcel Dekker, Inc., New York, N.Y. 
9. Kuiper-Goodman, T. 1998. Food safety: mycotoxins and phycotoxins in perspective, p. 25–48. In  M. 
Miraglia, H. van Edmond, C. Brera, and J. Gilbert (ed.), Mycotoxins and phycotoxins—developments in 
chemistry, toxicology and food safety. Alaken Inc., Fort Collins, Colo. 
10. Van Egmond, H.P. 1989. Aflatoxin M1: occurrence, toxicity, regulation, p.11–55. In H. P. Van Egmond 
(ed.), Mycotoxins in dairy products. Elsevier Applied Science, London. 
11. Rutqvist, L., N.-E. Bjorklund, K. Hult, E. Hockby, and B. Carlsson. 1978. Ochratoxin A as the cause of 
spontaneous nephropathy in fattening pigs. Appl. Environ. Microbiol. 36:920–925. 
12. Pier, A.C., J.L. Richard, and S.J. Cysewski. 1980. Implications of mycotoxinsin animal disease. J. Am. 
Vet. Med. Assoc. 176:719–724. 
13. Bezuidenhout, S. C., W. C. A. Gelderblom, C. P. Gorst-Allman, R. M. Horak, W. F. O. Marasas; G. 
Spiteller, and R. Vleggaar. 1988. Structure elucidation of the Fumonisins, mycotoxins from Fusarium 
moniliforme. J. Chem. Soc. Chem. Commun. 1988:743–745. 
14. Gelderblom, W. C. A., K. Jaskiewicz, W. F. O. Marasas, P. G. Thiel, R. M. Horak, R. Vleggaar, and N. 
P. J. Kriek. 1988. Fumonisins- novel mycotoxins with cancer-promoting activity produced by Fusarium 
moniliforme Appl. Environ. Microbiol. 54:1806–1811. 
15. Rheeder, J.P., Marasas, W.F.O., Vismer, H.F. 2002. Production of fumonisin analogs by Fusarium 
species. Appl. Environ. Microbiol. 68, 2101–2105. 
16. Humpf, H.-U., Voss, K.A., 2004. Effects of food processing on the chemical structure and toxicity of 
fumonisin mycotoxins. Mol. Nutr. Food Res. 48, 255–269. 
17. Marasas, W.F.O., J.D. Miller, R.T. Riley, and A. Visconti. 2001. Fumonisins—occurrence, toxicology, 
metabolism and risk assessment, p, 332–359. In B. A. Summerell, J. F. Leslie, D. Backhouse, W. L. Bryden, and 
L. W. Burgess (ed.), Fusarium. Paul E. Nelson Memorial Symposium. APS Press, St. Paul, Minn. 
18. Rheeder, J.P.,W.F. Marasas, and H. F. Vismer. 2002. Production of fumonisin analogs by Fusarium 
species. Appl. Environ. Microbiol. 68:2102– 2105. 
19. Nelson, P. E., A. E. Desjardins, and R. D. Plattner. 1993. Fumonisins, mycotoxins produced by Fusarium 
species: biology, chemistry and significance. Annu. Rev. Phytopathol. 31:233–252. 
 162
20. Marshall, E. 1983. Yellow rain experts battle over corn mold. Science 221:526–529. 
21. Marasas, W.F.O., J.D. Miller, R.T. Riley, and A. Visconti. 2001. Fumonisins — occurrence, toxicology, 
metabolism and risk assessment, p, 332– 359. In B. A. Summerell, J. F. Leslie, D. Backhouse, W. L. Bryden, 
and L. W. Burgess (ed.), Fusarium. Paul E. Nelson Memorial Symposium. APS Press, St. Paul, Minn. 
22. Plumlee, K.H., and F.D. Galey. 1994. Neurotoxic mycotoxins: A review of  fungal toxins that cause 
neurological disease in large animals. J. Vet. Intern.Med. 8:49–54. 
23. Desjardins, A.E., and R.D. Plattner. 2000. Fumonisin B (1)-nonproducing strains of Fusarium 
verticillioides cause maize (Zea mays) ear infection and ear rot. J. Agric. Food Chem. 48:5773–5780. 
24. Marasas, W.F.O. 1996. Fumonsins: history, world-wide occurrence and VOL. 16, 2003 MYCOTOXINS 
513 impact, p. 1–17. In L. S. Jackson, J. W. DeVries, and L. B. Bullerman (ed.), 
Fumonosins in food. Plenum Press, New York, N.Y. 
25. F.Q. Li, T. Yoshizawa, O. Kawamura, X.Y. Luo, Y.W.Li, J. Agric. Food Chem. 49 (2001) 4122. 
26. F.S. Chu, G.Y. Li, Appl. Environ. Microbiol. 60 (1994) 847. 
27. E.T.P.G. Sydenham, W.F.O. Marasas, G.S. Shepard, D.J. Van Schalkwyk, K.R. Koch, J. Agric. Food 
Chem. 38 (1990) 1900. 
28. S.A. Missmer, L. Suarez, M. Felkner, E. Wang, A.H. Merrill Jr., K.J. Rothman, K.A. Hendricks, 
Environ. Health Perspect. 114 (2006) 237. 
29. G.S. Bondy, J.J. Pestka, J. Toxicol. Environ. Health B: Crit. Rev. 3 (2000) 109. 
30. M.G. Theumer, A.G. Lopez, D.T. Masih, S.N. Chulze, H.R. Rubinstein, Clin. Diagn. Lab. Immunol. 9 
(2002) 149. 
31. WHO - Environment criteria on Fumonisins B1. 2005. 
32. J.W. ApSimon, B.A. Blackwell, O.E. Edwards, A. Fruchier3, J.D. Miller, M. Savard, J.C. Young 
Pure &App.Chem., Vol. 66, Nos lO/ll, pp. 23152318. 1994. 
33. Hartl, M., Humpf, H.-U..1998. Tetrahedron: Asymmetry 9: 1549-1556. 
34. Hartl, M., Humpf, H.-U..2001. J. Org. Chem. 66, 3678-3681. 
35. Hoye, T.R., Jimenez, J.I., Shier W.T. 1994. J. Am. Chem. Soc. 116: 9409-9410. 
36. Harmamge, J.-C., Boyle C.B., Kishy Y. Tetrahedron Lett. 1994. 35: 6819-6822. 
37. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National 
Institutes of Health. 2001. REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF 
FUMONISIN B1. 
38. Krska, R.,Welzig, E., Boudr, H., 2007. Analysis of Fusarium toxins in feed. In: Morgavi, D.P., Riley, R.T. 
(Eds.), 
Fusarium and their Toxins: Mycology, occurrence, toxicity, control and economic impact. Anim. Feed Sci. 
Technol. 
39. Nelson, P.E., Desjardins, A., Plattner, R., 1993. Fumonisins, mycotoxins produced by Fusarium species: 
Biology, chemistry, and significance. Annu. ReV. Phytopathol. 31, 233-252. 
40. Bezuidenhout, S.C., Gelderblom, W.C.A., Gorst-Allman, C.P., Horak, R.M.; Marasas, W.F.O., 
Spiteller, G., Vleggaar, R. Structure elucidation of the Fumonisins, mycotoxins from Fusarium moniliforme. J. 
Chem. Soc., Chem. Commun. 1988,743-745. 
 163
41. Blackwell, B.A., Edwards, O.E., Fruchier, A., ApSimon, J.W., Miller, J.D. NMR structural studies of 
fumonisin B1 and related compounds from Fusarium moniliforme. AdV. Exp. Med. Biol. 1996, 392, 75-91. 
42. Branham, B.E., Plattner, R.D. Alanine is a precursor in the biosynthesis of fumonisin B1 by Fusarium 
moniliforme. Mycopathologia 1993, 124, 99-104. 
43. Plattner, R.D., Shackelford, D.D. Biosynthesis of labeled Fumonisins in liquid cultures of Fusarium 
moniliforme. Mycopathologia. 1992, 117, 17-22. 
44. Caldas, E. D., Sadilkova, K., Ward, B. L., Jones, A. D.,Winter, C. K., Gilchrist, D. G. Biosynthetic 
studies of fumonisin B1 and AAL toxins. J. Agric. Food Chem. 1998, 46, 4734-4743. 
46. Blackwell, B.A., Edwards, O.E., Fruchier, A., ApSimon, J.W., Miller, J.D. NMR structural studies of 
fumonisin B1 and related compounds from Fusarium moniliforme. AdV. Exp. Med. Biol. 1996, 392, 75-91. 
47. Proctor, R.H.; Desjardins, A.E.; Plattner, R.D.; Hohn, T.M. A polyketide synthase gene required for 
biosynthesis of fumonisin mycotoxins in Gibberella fujikuroi mating population A. Fungal Genet. Biol. 1999, 
27, 100-112. 
48.  Proctor, R.H.; Brown, D.W.; Plattner, R.D.; Desjardins, A.E. Co-expression of 15 contiguous genes 
delineates a fumonisin biosynthetic gene cluster in Gibberella moniliformis. Fungal Genet. Biol. 2003, 38, 237-
249. 
49. Butchko, R.A.; Plattner, R.D.; Proctor, R.H. FUM13 encodes a short chain dehydrogenase/reductase 
required for C-3 carbonyl reduction during fumonisin biosynthesis in Gibberella moniliformis. J. Agric. Food 
Chem. 2003, 51, 3000-3006. 
50. Butchko, R.A.E.; Plattner, R.D.; Proctor, R.H. FUM9 is required for C-5 hydroxylation of Fumonisins 
and complements the mitotically defined Fum3 locus in Gibberella moniliformis. Appl. EnViron. Microbiol. 
2003, 69, 6935-6937. 
51. Bojja, R.S., Cerny R.L., Proctor R.H., Du, L. Determining the Biosynthetic Sequence in the early steps of 
the Fumonisin Pathway by Use of Three Gene-Disruption Mutants of Fusarium verticillioides. J. Agric. Food 
Chem. 2004, 52, 2855-2860. 
52. Ding, Y.; Bojja, R.S.; Du, L. Fum3p is a 2-ketoglutarate  dependent dioxygenase required for C-5 
hydroxylation of Fumonisins in Fusarium Verticillioides. Appl. EnViron. Microbiol. 2004 
53. Kellerman, T.S., Marasas, W.F.O., Thiel, P.G., Gelderblom, W.C.A.,Cawood, M.E., Coetzer, J.A.W., 
Leukoencephalomalacia in Tow Horses Induced by Oral Dosing of Fumonisin B1, Onderstopoort J. Vet. Res., 
57, 269–275, 1990. 
54. Harrison, L.R., Colvin, B.M., Greene, J.T., Newman, L.E., Cole, J.R., Pulmonary Edema and 
Hydrothorax in Swine Produced by Fumonisin B1,a Toxic Metabolite of Fusarium moniliforme, J. Vet. Diagn. 
Invest., 2,217–221, 1990. 
55. Gelderblom, W.C A., Marasas, W.F.O., Jaskiewicz, K, Combrink, S.and Van Schalkwyk, D.J., Cancer 
Promoting Potential of Different Strains of Fusarium moniliforme in a Short-term Cancer Initiation/promotion 
Assay, Carcinogenesis, 9, 1405–1409, 1988. 
56. Gelderblom, W.C.A., Kriek, N.P.J., Marasas, W.F.O., Thiel, P.G., Toxicity and Carcinogenicity of the 
Fusarium moniliforme Metabolite, Fumonisin B1, in Rats, Carcinogenesis, 12, 1247–1251, 1991. 
57. Vainio, H., Heseltine, E. and Wilbourn, J., Report on an IARC Working Group Meeting on Some 
Naturally Occurring Substances, Int. J. Cancer, 53, 535–537, 1993 
 164
58. Abbas, H.K., Gelderblom, W.C.A., Cawood, M.E. and Shier, W.T., Biological Activities of Fumonisins, 
Mycotoxins from Fusarium moniliforme, in Jimsonweed (Datura stramonium L.) and Mammalian Cell Cultures, 
Toxicon, 31, 345–353, 1993. 
59. Shier, W.T., Abbas, H.K. and Mirocha, C.J., Toxicity of the Mycotoxins Fumonisins B1 and B2 and 
Alternaria alternata f. sp. lycopersici Toxin(AAL) in Cultured Mammalian Cells, Mycopathologica, 116, 97–
104,1991. 
60. Abbas, H.K., Tanaka, T. and Shier, W.T., Biological Activities of Synthetic Analogs of Alternaria 
alternata Toxin (AAL-toxin) and Fumonisin in Plant and Mammalian Cell Cultures, Phytochemistry, 40, 1681–
1689, 1995. 
61. Shier, W.T., Abbas, H.K. and Badria, F.A., Structure-activity Relationships of the Corn Fungal Toxin 
Fumonisin B1: Implications for Food Safety, J. Toxicol.-Toxin Rev., 15, 398–399, 1996. 
62. Abbas, H.K., Duke, S.O., Shier, W.T., Riley, R.T. and Kraus, G.A., The Chemistry and Biological 
Activities of the Natural Products AALtoxin and the Fumonisins. In Natural Toxins II: Structure, Mechanism of 
Action and Detection, edited by B.R. Singh and A. T. Tu, American Chemical Society, Washington, D.C., 293–
308, 1996. 
63. Abbas, H.K., Duke, S.O., Shier, W.T., Badria, F.A., Ocamb, C.M., Woodward, R.P., Xie, W.,Mirocha, 
C. J. Comparison of Ceramide Synthase Inhibitors with Other Phytotoxins Produced by Fusarium Species, 
J. Natural Toxins, 6, 163–181, 1997. 
64. Shier, W.T., Abbas, H.K. and Badria, F.A., Structure-activity Relationships of the Corn Fungal Toxin 
Fumonisin B1: Implications for Food Safety, J. Nat. Toxins, 6, 225–242, 1997. 
65. Abbas, H.K., Gelderblom, W.C.A., Cawood, M.E. and Shier, W.T., Biological Activities of Fumonisins, 
Mycotoxins from Fusarium moniliforme, in Jimsonweed (Datura stramonium L.) and Mammalian Cell Cultures, 
Toxicon, 31, 345–353, 1993. 
66. Humpf, H.-U., Schmelz, E.-M., Meredith, F.I. and Merrill, A.H., NPalmitoyl-HFB1: A New Metabolite 
of Hydrolyzed Fumonisin (HFB1) in Rat Liver Microsomes, Revue Med. Vet., 149, 576, 1998. 
67. Humpf, H. U., Schmelz, E. M., Meredith, F. I., Vesper, H., Vales, T.R., Wang E., Menaldino, D.S., 
Liotta, D.C. Merrill, A.H., Acylation of Naturally Occurring and Synthetic 1-Deoxysphinganines by Ceramide 
Synthase. Formation of N-palmitoyl-aminopentol Produces a Toxic Metabolite of Hydrolyzed Fumonisin, AP1, 
and a New Category of Ceramide Synthase Inhibitor, J. Biol. Chem., 273, 19060–19064, 1998. 
68. Shephard, G.S., Thiel, P.G. and Sydenham, E.W. Initial Studies on the Toxicokinetics of Fumonisin B1 in 
Rats. Fd. Chem. Toxic., 30, 277–279, 1992. 
69. Shephard, G.S., Thiel, P.G., Sydenham, E.W., Alberts, J.F. and Gelderblom, W.C.A., Fate of a Single 
Dose of the 14C-labelled Mycotoxin Fumonisin B1 in Rats, Toxicon, 30, 768–770, 1992. 
70. Norred, W.P., Plattner, R.D. and Chamberlain, W.J., Distribution and Excretion of [14C]Fumonisin B1 
in Male Sprague-Dawley Rats, Natural Toxins, 1, 341–346, 1993. 
73. Voss, K.A., Bacon, C.W., Norred, W.P., Chapin, R.E., Chamberlain, W.J., Plattner, R.D. and 
Meredith, F.I., Studies on the Effects of Fusarium moniliforme Culture Material in Rats and the Biodistribution 
of [14C]Fumonisin 
B1 in Pregnant Rats, Nat. Toxins, 4, 24–33, 1996. 
 165
74. Shephard, G.S., Sydenham, E.W., Thiel, P.G. and Alberts, J.F., Biliary Excretion of the Mycotoxin 
Fumonisin B1 in Rats, Fd. Chem. Toxic., 32, 489–491, 1994. 
75. Shephard, G.S., Thiel, P.G., Sydenham, E.W. and Snijman, P.W., Toxicokinetics of the mycotoxin 
Fumonisin B2 in rats. Fd. Chem. Toxic., 33, 591–595, 1995. 
76. Shephard, G.S. and Snijman, P.W., Elimination and Excretion of a Single Dose of the Mycotoxin 
Fumonisin B2 in a Non-human Primate, Food and Chem. Toxicol., 37, 111–116, 1999. 
77. Shephard, G.S., Thiel, P.G., Sydenham, E.W., Alberts and Cawood, M.E., Distribution and Excretion of 
a Single Dose of the Mycotoxin Fumonisin B1 in a Non-human Primate, Toxicon, 32, 735–741, 1994. 
78. Shephard, G.S., Thiel, P.G., Sydenham, E. . and Savard, M.E., Fate of a Single Dose of 14C-Labelled 
Fumonisin B1 in Vervet Monkeys, Natural Toxins, 3, 145–150, 1995. 
79. Prelusky, D.B., Savard, M. E. and Trenholm, H. L., Pharmacokinetic Fate of 14C-Labelled Fumonisin B1 
in Swine, Natural Toxins, 2, 73–80, 1994. 
80. Vudathala, D.K., Prelusky, D.B., Ayroud, M., Trenholm, H.L. and Miller, J.D., Pharmacokinetic Fate 
and Pathological Effects of 14C Fumonisin B1 in Laying Hens, Natural Toxins, 2, 81–88, 1994. 
81,82. Wang, E., Norred, W.P., Bacon, C. W., Riley, R.T., Merrill, A.H., Inhibition of Sphingolipid 
Biosynthesis by Fumonisins, J. Biol. Chem., 266, 14486–14490, 1991. 
83. Merrill, A.H., Wang, E., Gilchrist, D.G. and Riley, R.T., Fumonisins and Other Inhibitors of De Novo 
Sphingolipid Biosynthesis, Advances in Lipid Research, 26, 215–234, 1993. 
84. Merrill A.H. and Jones, D.D., An Update of the Enzymology and Regulation of Sphingomyelin 
Metabolism, Biochim. Biophys. Acta, 1044, 1–12, 1990. 
85. Wang, E., Ross, P.F., Wilson, T.M., Riley, R.T., and Merrill, A.H. Increases in Serum Sphingosine and 
Sphinganine and Decreases in Complex Sphingolipids in Ponies Given Feed Containing Fumonisins, 
Mycotoxins Produced by Fusarium moniliforme, J. Nutr., 122, 1706, 1992.  
86. Norred, W.P., Plattner, R.D., Dombrink-Kurtzman, M.A., Meredith, F. I., Riley, R.T., Mycotoxin-
induced Elevation of Free Sphingoid Bases in Precision-cut Rat Liver Slices: Specificity of the Response and 
Structure-activity Relationships, Toxicol. & Appl. Pharmacol., 147, 63–70, 1997. 
87. Yoo, H.-S., Norred, W.P., Wang, E., Merril, A. H., Riley, R.T., Fumonisin Inhibition of De Novo 
Sphingolipid Biosynthesis and Cytotoxicity are Correlated in LLC-PK1 Cells, Toxicol. Appl. Pharmacol., 114, 
9–15, 1992.  
88. Schmelz, E.M., Dombrink-Kurtzman, M.A., Roberts, P.C., Kozutsumi, Y., Kawasaki, T. and Merrill, 
A.H. Induction of Apoptosis by Fumonisin B1 in HT29 Cells is Mediated by the Accumulation of Endogenous 
Free Sphingoid Bases, Toxicol. Appl. Pharmacol., 148, 252–260, 1988. 
89. Norred, W.P., Wang, E., Bacon, C. W., Riley, R. T., Merrill, A. H., In Vitro Toxicology of Fumonisins 
and the Mechanistic Implications, Mycopathologia, 117, 73–78, 1992. 
90. Riley, R.T., Wang, E., Schroder, J.J., Smith, E. R., Plattner, R.D., Abbas, H. K., Yoo, H.-S. and 
Merrill, A. H., Evidence for Disruption of Sphingolipid Metabolism as a Contributing Factor in the Toxicity and 
Carcinogenicity of Fumonisins, Natural Toxins, 4, 3–15, 1996. 
91. Abbas, H.K., Tanaka, T., Duke, S.O., Porter, J.K., Wray, E.M., Hodges, L., Sessions, A.E., Wang, E., 
Merrill, A. H. and Riley, R. T., Fumonisin- and AAL-toxin-induced Disruption of Sphingolipid Metabolism 
with 
 166
Accumulation of Free Sphingoid Bases, Plant Physiol., 106, 1085–1093, 1994. 
92. Wang, E., Ross, P.F., Wilson, T.M., Riley, R. T., and Merrill, A.H., Increases in Serum Sphingosine and 
Sphinganine and Decreases in Complex Sphingolipids in Ponies Given Feed Containing Fumonisins, 
Mycotoxins Produced by Fusarium moniliforme, J. Nutr., 122, 1706, 1992. 
93. Rogolsky, M., Nonenteric Toxins of Staphylococcus aureus. Microbiol. Rev., 43, 320, 1979. 
94. Shier, W.T., The Fumonisin paradox: a review of research on oral bioavailability Fumonisin B1, a 
mycotoxin produced by Fusarium moniliforme Biochem. J. Toxicol.—Toxin Reviews, 19(2), 161–187 (2000). 
95-98. European Mycotoxins Awareness Network. www.mycotoxin.org  
99. Opinion of the Scientific Panel on Contaminants in Food Chain on a request from the Commission related to 
Fumonisins as undesirable substances in animal feed. The EFSA Journal (2005) 235, 1 - 32 
100. Shephard, G.S., Chromatographic Determination of the Fumonisin Mycotoxins, Journal of 
Chromatography A, 815, 31-39 (1998) 
101. Dutton, M.F., Fumonisins, Mycotoxins of Increasing Importance: Their Nature and Their Effects, 
Pharmacological and Therapeutics, 70, 2, 137-161 (1996) 
102. Scott, P.M., Fumonisins, International Journal of Food Microbiology, 18, 257-270 (1993) 
103. Norred W.P., Fumonisins – Mycotoxins produced by Fusarium moniliforme, Journal of Toxicology and 
Environmental Health, 38, 309-328 (1993) 
104. Krska, R.,Welzig, E., Boudr, H., 2007. Analysis of Fusarium toxins in feed. In: Morgavi, D.P., Riley, 
R.T. (Eds.), Fusarium and their Toxins: Mycology, occurrence, toxicity, control and economic impact. Anim. 
Feed Sci. Technl. 
105. Berthiller, F., Rainer, S., Adam, G., Krska, R,. Formation, determination and significance of masked 
and other conjugated mycotoxins. Anal. Bioanal. Chem. pubblished online 2009. 
106. Leonard K., Bushnell W.  Fusarium head blight of wheat and barley. American Phytopathological Society, 
St Paul (2004). 
107. Poppenberger B., Berthiller F., Lucyshyn D,. Sieberer T., Schuhmacher R., Krska R., Kuchler K., 
Glössl J., Luschnig C., Adam G.,  J. Bio.l Chem. 278: 47905–47914, 2003. 
108. Berthiller F., Dall’Asta C., Schuhmacher R., Lemmens M., Adam G., Krska R. J. Agric. Food Chem. 
53:3421–3425, 2005. 
109. Berthiller F., Dall'Asta C., Corradini R., Marchelli R., Sulyok M., Krska R., Adam G., Schuhmacher 
R.  
Food Addit Contam 26:507–511, 2009. 
110. Jarvis, B.B., Wang, S., Cox, C., Rao, M.M., Philip, V., Varaschin, M.S., Barros C.S., Nat Toxins 4:58–
71, 1996. 
111. Hajslova J., Paper presented at the 12th international IUPAC symposium on mycotoxins and phycotoxins, 
Istanbul, 2007. 
112. Howard, P.C., Churchwell, M.I., Couch, L.H., Marques, M.M., Doerge, D.R., J. Agric Food Chem., 
46:3546–3557, 1998 
113. Howard, P.C., Churchwell, M.I., Couch, L.H., Marques, M.M., Doerge, D.R., J. Agric. Food Chem., 
46:3546–3557, 1998. 
114. Poling ,S.M., Plattner R.D., Weisleder D., J. Agric. Food Chem, 50:1318–1324, 2002. 
 167
115. Seefelder, W., Hartl, M, Humpf, H.U., J. Agric. Food Chem., 49:2146–2151, 2001. 
116. Seefelder, W., Knecht, A., Humpf, H.-U., J. Agric. Food Chem., 51:5567–5573, 2003. 
117. Shier, W.T., Abbas H.K., Abou-Karam M., Badria F.A., Resch P.A., J Toxicol-Toxin Rev 22:591–616, 
2003 
118. Shier W.T., Abbas H.K., Badria F.A., J Nat Toxins 6:225–242, 1997. 
119. Park, J.W., Scott, P.M.,  Lau, B.P.-Y., Lewis, D.A., Food Add. Cont., Vol. 21, No. 12, pp. 1168–1178, 
2004 
120. Seefelder W., Knecht, A., Humpf, H.-U., J. Agric. Food Chem. 51:5567–5573, 2003. 
121.  Humpf H.-U-, Voss K-A., Mol. Nutr. Food. Res. 48:255–269, 2004. 
122.  FAO report 2007. www.fao.org 
123. National Agricultural Statistics Service. www.usda.gov 
124. American Association of Cereals Chemist. www.aaccnet.org 
125. Corn Refiners Association. www.corn.org 
126. Saunders, S.D.,  Filmore, I.M., Voss, K.A., Environmental Health Perspectives • VOLUME 109, 2, 2001. 
127. Katta S.K., Cagampang A.E., Jackson L.S., Bullerman L.B., Distribution of Fusarium molds and 
Fumonisins in dry-milled corn fractions. Cereal Chem 74:858–863, 1997. 
128. Sforza, S., Cavatorta, V., Galaverna, G., Dossena, A., Marchelli, R., International Dairy Journal 19 
(2009) 582–587. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 168
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 169
Acknowledgements 
The author thanks prof. Rosangela Marchelli and dott. Chiara Dall’Asta for the support during 
these 3 years. Thanks also to all the peoples that have supported and collaborated to this work, 
in particular prof. Arnaldo Dossena, prof. Gianni Galaverna, prof. Stefano Sforza and dott. 
Andrea Faccini, from the Organic and Industrial Chemistry Department, University of  
Parma. 
Moreover, special thanks to prof. Rudolf Krska, prof. Rainer Schuhmacher and dott. Franz 
Berthiller, from the Analytical Chemistry Department, IFA-Tulln BOKU, Vienna (Austria), 
for the working period spent in Tulln. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 170
Curriculum Vitae 
Mattia Mangia born in Parma in 1982 and got the Bachelor Degree in Food Science and 
Technology (University of Parma, 110/110), in 2005, with a thesis titled “Safety and quality 
parameters of red wine: Ochratoxin A and Resveratrol”. In 2006 he got the Master Degree in 
Food Science and Technology (University of Parma, 110/110 Honors) with a graduation 
thesis entitled “Aflatoxin and Ochratoxin production from different fungal biotypes”. During 
the Bachelor Degree (3 years) and the Master Degree (2 years), he received a multisubject 
education characterized by a “core curriculum” based on Organic and Food Chemistry, 
Biochemistry and Molecular Biology, Product and Process Planning, Food Microbiology and 
Human Nutrition. In January 2007 he got the professional abilitation in Food Science and 
Technology. In 2007 Mattia Mangia start the Ph.D. in Food Science and Technology 
(University of Parma), under the supervision of  prof. Rosangela Marchelli. 
The Ph.D. work has been focused on the development of a LC-MS/MS method for the 
evaluation of hidden Fumonisins. The application of the method to several batches of gluten 
free products and raw cereal let to discover that hidden FBs are widespread along the maize 
chain. Moreover, further experimental data collected in the work strongly suggest a non-
covalent interaction between FB1 and the α-Zein (the principal endosperm protein of maize), 
with an inclusion-like mechanism, to explain the masking mechanism of Fumonisins.  
 
SCIENTIFIC ACTIVITY: 
1) Poster titled : ‘Free and masked Fumonisins in corn and corn-based products’ 
M. Mangia, G. Galaverna, C. Dall’Asta, S. Sforza, A. Dossena e R. Marchelli. 
Mycotoxins Symposium 25-26 October 2007 Karlsruhe, Germany. 
 
2) Oral communication titled : ‘Free and masked Fumonisins in corn and corn-based 
products’ 
12° Mold Meeting AGES (Austrian Authority for food safety)                     
5-6 December 2008, Linz, Austria. 
 
3) Pubblication on ISI journal titled :  
‘Free and bound  Fumonisins in gluten-free food products’ 
C. Dall’Asta, G. Galaverna, M. Mangia., S. Sforza, A. Dossena, R. Marchelli. 
MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53. 
 171
4) Pubblication on ISI journal titled:  
‘Masked Mycotoxins: an Emerging Issue for Food Safety’ 
G. Galaverna, C. Dall’Asta,  M. Mangia, A. Dossena, R. Marchelli. 
CZECH JOURNAL OF FOOD SCIENCE, 2009, 27 (special issue) 
 
5) Pubblication on ISI journal titled:  
‘Difficulties in fumonisin determination: the issue of hidden Fumonisins’ 
C. Dall’Asta,  M. Mangia, F. Berthiller, A. Molinelli, M. Sulyok, R. Schuhmacher, R. Krska,               
G. Galaverna, A. Dossena, R. Marchelli. 
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2009, pubblished on line. 
 
6) Oral communication titled : ‘Hidden Fumonisins in maize and gluten free food product’ 
14° Workshop on the development of the Italian Ph.D. research on Food Science Technology 
and Biotechnology.                     
16-18 September 2009, Oristano, Italia.  
 
7) Poster titled: ‘Maize prolamines: hypothetical role in Fumonisins masking’ 
1° MS Food Day - Barilla Inc.                     
2-3 December 2009, Parma, Italy.  
 
 
 
 
 
 
